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ABSTRACT 
Meso 1,9-diketones (six to seven stereocenters) are readily obtained by stepwise or 
simultaneous two-directional aldol reactions of tetrahydro-4H-thiopyran-4-one with a 
thiopyran-derived aldehyde.  Enantioselective enolizations of these diketones with the 
lithium amide from (R,R)-bis(1-phenylethyl)amine I occur with simultaneous kinetic 
resolution to give the mono-TMS enol ethers in >90% yields based on recovered starting 
material (BORSM) and >90% ee. The developed methodology was applied in synthetic 
studies towards the asymmetric synthesis of denticulatin A.   
S S S
OH O HOOO OO
meso
S S
OH OOO
meso
S S S
O
Me
O
Me
O
Me
OO
S S
O OOO
+
a hexapropionate synthon
S S S
Me
O
Me
O
Me
OO OTMS
TMSCl
S S S
Me
O
Me
O
Me
O
TMS
O
TMS
O
+
Me
O
Me
O
Me
OOH O
>90% yield (BORSM)
>95% ee
>95% yield
thiopyran route to
polypropionate
I
meso
Ph N
Li
Ph
 
 
 iii
MOM
OOO
7
10
OO
OHOHOH
denticulatin A (10-S)
7
10
O
O O
OH
OH H
10
7
intramolecular
ketalization
+
OO
Si
t -But-Bu
MOM
O
TES
O
7
10
TES
OOBnBr O
S S S
TES
O OBn
TES
O
TMS
O O
S S S
TES
O OBn
TES
O
TMS
O
TMS
O
+
S S S
TES
O OBn
TES
O
meso
O O
ent-230
TMSCl
meso
S S S
OH O HOOO OO
7
10
7
10
7
10
7
10
OOO
7
10
OO
Si
t -But-Bu
>90% yield (BORSM)
>90% ee
Si
t-But-Bu
synthetic studies
towards denticulatin A
meso  
 
 
 iv 
 
ACKNOWLEDGMENTS 
My most sincere gratitude goes to my research supervisor, Dr. Dale E. Ward for his 
enthusiasm, guidance and confidence to allow me to work independently and to pursue 
interests not directly related to this thesis.  I would also like to thank him for his 
insightful discussions and advice during the preparation of this dissertation. 
Many thanks to my advisory committee members (Dr. Marek Majewski, Dr. David 
R. J. Palmer and Dr. Sam Attah-Poku) for their suggestions and careful assessment of my 
progress during my academic program. 
I wish to thank the past and present members of the Ward group and in particular, 
Marcelo Sales, Jianheng Shen, Kayode Akinnusi and Vishal Jheengut. 
Lastly, financial support from the University of Saskatchewan, the Natural 
Sciences and Engineering Research Council (Canada) and the Walter C. Sumner 
Foundation is gratefully acknowledged. 
 
 v
 
 
 
 
Dedicated to the memory and inspiration 
of my beloved sister, 
 
Shelly Olive Gillis 
 
 vi 
 
TABLE OF CONTENTS 
page
 
PERMISSION TO USE....................................................................................................... i 
ABSTRACT........................................................................................................................ ii 
ACKNOWLEDGMENTS ................................................................................................. iv 
LIST OF TABLES........................................................................................................... viii 
LIST OF FIGURES ........................................................................................................... ix 
LIST OF SCHEMES.......................................................................................................... xi 
LIST OF ABBREVIATIONS.......................................................................................... xvi 
1.  INTRODUCTION ..........................................................................................................1 
1.1.  Marine polypropionate natural products...............................................................1 
1.2.  The denticulatins...................................................................................................3 
1.2.1.  Isolation, structure determination and biosynthesis ...................................3 
1.2.2.  Synthetic studies and total syntheses..........................................................6 
1.2.2.1.  Ziegler's synthesis ............................................................................7 
1.2.2.2.  Hoffmann's synthesis......................................................................12 
1.2.2.3.  Paterson's synthesis ........................................................................19 
1.2.2.4.  Oppolzer's synthesis .......................................................................22 
1.2.3.  Comparative analysis of syntheses...........................................................27 
1.3.  Total synthesis of polypropionate natural products............................................29 
1.3.1.  Iterative strategies for polypropionate synthesis ......................................35 
1.3.2.  Thiopyran route to polypropionates .........................................................44 
1.4.  Conclusions.........................................................................................................51 
1.5.  Objectives of this thesis ......................................................................................51 
2.  RESULTS AND DISCUSSION...................................................................................55 
2.1.  Enantioselective desymmetrization ....................................................................55 
2.1.1.  Sequential enantiotopic group selective desymmetrization .....................55 
2.1.2.  Chiral lithium amides ...............................................................................59 
2.1.3.  Model study ..............................................................................................62 
2.1.3.1.  Synthesis of meso 1,9-diketone 233 ...............................................63 
 vii
2.1.3.2.  Sequential enantiotopic group selective enolization of meso 1,9-
diketone 233..............................................................................................70 
2.1.3.4.  Determination of absolute configuration........................................75 
2.1.3.5.  Desulfurization of hexapropionate synthon 271 ............................77 
2.2.  Synthetic studies towards the asymmetric synthesis of (−)-denticulatin A........81 
2.2.1.  Synthetic plan ...........................................................................................81 
2.2.1.1.  Synthesis of meso 1,9-diketones ....................................................83 
2.2.1.2.  Sequential enantiotopic group selective enolization of meso 1,9-
diketone 308..............................................................................................89 
2.2.1.3.  Alkylation and desulfurization .......................................................91 
2.2.1.4.  Synthesis towards triketone 106.....................................................99 
2.3.  Conclusions.......................................................................................................103 
3.  EXPERIMENTAL......................................................................................................106 
3.1.  General methods ...............................................................................................106 
3.2.  Spectral data......................................................................................................107 
3.3.  Materials ...........................................................................................................108 
3.4.  Experimental procedures and spectral data ......................................................109 
APPENDIX A..................................................................................................................193 
Determination of enantiomeric purity ......................................................................193 
230⋅HCl .............................................................................................................193 
Mono-silyl enol ether (−)-261 ...........................................................................194 
Mono-silyl enol ether (−)-315 ...........................................................................194 
APPENDIX B ..................................................................................................................196 
X-ray crystallographic data.......................................................................................196 
ORTEP diagram of bis-silyl enol ether 262 ......................................................196 
ORTEP diagram of syn triol 297 .......................................................................197 
LIST OF REFERENCES.................................................................................................198 
CURRICULUM VITAE..................................................................................................216 
 
 
 viii 
 
LIST OF TABLES 
page  
 
Table 1.1.  Deprotection of triketones. ..............................................................................11 
Table 1.2.  Total syntheses of the denticulatins. ................................................................29 
Table 1.3.  Diastereoselective Mukaiyama aldol and stereoselective hydrogen transfer 
processes...................................................................................................................41 
Table 1.4.  Acyl halide-aldehyde cyclocondensation of chiral (non-racemic) 
aldehydes. .................................................................................................................43 
Table 2.1.  Rac-proline catalyzed aldol reaction of 206 with (±)-207. ..............................66 
Table 2.2.  (S)-proline catalyzed aldol reaction of 206 with (±)-207. ...............................67 
Table 2.3.  Time course study of (S)-proline catalyzed aldol reaction of 206 with (±)-
207. ...........................................................................................................................68 
Table 2.4.  (S)-proline catalyzed aldol reaction of 206 with (±)-207 with acid or base 
additives.a .................................................................................................................69 
Table 2.5.  Enantioselective enolization of 233 with 230/TMSCl.....................................71 
Table 2.6.  1H NMR chemical shifts for 272 and 273.a .....................................................75 
Table 2.7.  Enantioselective enolization of 308 with ent-230/TMSCl. .............................90 
 
 
 ix 
 
LIST OF FIGURES 
page
 
 
Figure 1.1.  Classification of polyketides. ...........................................................................1 
Figure 1.2.  Biologically active natural products. ................................................................2 
Figure 1.3.  Mollusca polypropionate natural products. ......................................................3 
Figure 1.4.  Generalized structure of polypropionate natural products. ............................29 
Figure 1.5.  Possible stereoisomers for polypropionates. ..................................................30 
Figure 1.6.  Stereotriads A-D.............................................................................................30 
Figure 1.7.  Streptomyces erythreus macrolides. ...............................................................31 
Figure 2.1.  Calculated mole fractions of products and ee produced in a hypothetical 
reaction with an enantiotopic group selectivity (s = k1/k2) of 6. ..............................59 
Figure 2.2.  Aggregate solution structures of chiral lithium amides..................................61 
Figure 2.4.  Calculated and observed mole fractions of 261 (?) and 262 (?) and ee of 
261 (?) produced in the reaction of 233 with 230/TMSCl as a function of 
conversion of 233. ....................................................................................................73 
Figure 2.5. Model for establishing the absolute configuration of 261...............................76 
Figure 2.6. ORTEP diagram of syn triol 297. ....................................................................84 
Figure 2.7.  Calculated and observed mole fractions of 315 (?) and 316 (?) and ee of 
316 (?) produced in the reaction of 308 with 230/TMSCl as a function of 
conversion of 308. ....................................................................................................91 
Figure 2.8.  Structure determination of 318sa and 319sa. .................................................92 
Figure 2.9.  Structure determination of 322. ......................................................................94 
Figure 2.10.  Structure determination of 329a. ..................................................................96 
Figure 2.11. Syntheses of (−)-discodermolide 4. ...............................................................97 
 x
Figure 2.12.  Attempted determination of the relative configuration of C-alkylation 
products. .................................................................................................................102 
Figure A.1.  Determination of enantiomeric purity of 230·HCl. .....................................193 
Figure A.2.  Determination of enantiomeric purity of 261. .............................................194 
Figure A.3.  Determination of enantiomeric purity of 315 (83% ee). .............................195 
Figure A.4.  Determination of enantiomeric purity of 315 (93% ee). .............................195 
 
 
 xi 
 
LIST OF SCHEMES 
page
 
 
Scheme 1.1. ..........................................................................................................................1 
Scheme 1.2. ..........................................................................................................................4 
Scheme 1.3. ..........................................................................................................................5 
Scheme 1.4. ..........................................................................................................................5 
Scheme 1.5. ..........................................................................................................................6 
Scheme 1.6. ..........................................................................................................................7 
Scheme 1.7. ..........................................................................................................................8 
Scheme 1.8. ..........................................................................................................................8 
Scheme 1.9. ..........................................................................................................................9 
Scheme 1.10.......................................................................................................................10 
Scheme 1.11.......................................................................................................................11 
Scheme 1.12.......................................................................................................................12 
Scheme 1.13.......................................................................................................................13 
Scheme 1.14.......................................................................................................................14 
Scheme 1.15.......................................................................................................................14 
Scheme 1.16.......................................................................................................................15 
Scheme 1.17.......................................................................................................................16 
Scheme 1.18.......................................................................................................................17 
Scheme 1.19.......................................................................................................................17 
 xii
Scheme 1.20.......................................................................................................................18 
Scheme 1.21.......................................................................................................................19 
Scheme 1.22.......................................................................................................................20 
Scheme 1.23.......................................................................................................................20 
Scheme 1.24.......................................................................................................................20 
Scheme 1.25.......................................................................................................................21 
Scheme 1.26.......................................................................................................................22 
Scheme 1.27.......................................................................................................................23 
Scheme 1.28.......................................................................................................................24 
Scheme 1.29.......................................................................................................................25 
Scheme 1.30.......................................................................................................................26 
Scheme 1.31.......................................................................................................................26 
Scheme 1.32.......................................................................................................................27 
Scheme 1.33.......................................................................................................................28 
Scheme 1.34.......................................................................................................................33 
Scheme 1.35.......................................................................................................................34 
Scheme 1.36.......................................................................................................................35 
Scheme 1.37.......................................................................................................................36 
Scheme 1.38.......................................................................................................................37 
Scheme 1.39.......................................................................................................................38 
Scheme 1.40.......................................................................................................................39 
Scheme 1.41.......................................................................................................................40 
Scheme 1.42.......................................................................................................................40 
Scheme 1.43.......................................................................................................................41 
Scheme 1.44.......................................................................................................................42 
 xiii
Scheme 1.45.......................................................................................................................45 
Scheme 1.46.......................................................................................................................46 
Scheme 1.47.......................................................................................................................46 
Scheme 1.48.......................................................................................................................47 
Scheme 1.49.......................................................................................................................47 
Scheme 1.50.......................................................................................................................48 
Scheme 1.51.......................................................................................................................48 
Scheme 1.52.......................................................................................................................50 
Scheme 1.53.......................................................................................................................52 
Scheme 1.54.......................................................................................................................53 
Scheme 1.55.......................................................................................................................53 
Scheme 1.56.......................................................................................................................54 
Scheme 2.1. ........................................................................................................................56 
Scheme 2.2. ........................................................................................................................56 
Scheme 2.3. ........................................................................................................................57 
Scheme 2.4. ........................................................................................................................57 
Scheme 2.5. ........................................................................................................................60 
Scheme 2.6. ........................................................................................................................60 
Scheme 2.7. ........................................................................................................................61 
Scheme 2.8. ........................................................................................................................62 
Scheme 2.9. ........................................................................................................................63 
Scheme 2.10.......................................................................................................................64 
Scheme 2.11.......................................................................................................................65 
Scheme 2.12.......................................................................................................................65 
Scheme 2.13.......................................................................................................................69 
 xiv
Scheme 2.14.......................................................................................................................70 
Scheme 2.15.......................................................................................................................74 
Scheme 2.16.......................................................................................................................74 
Scheme 2.17.......................................................................................................................75 
Scheme 2.18.......................................................................................................................77 
Scheme 2.19.......................................................................................................................77 
Scheme 2.20.......................................................................................................................78 
Scheme 2.21.......................................................................................................................79 
Scheme 2.22.......................................................................................................................80 
Scheme 2.23.......................................................................................................................80 
Scheme 2.24.......................................................................................................................81 
Scheme 2.25.......................................................................................................................83 
Scheme 2.26.......................................................................................................................84 
Scheme 2.27.......................................................................................................................85 
Scheme 2.28.......................................................................................................................85 
Scheme 2.29.......................................................................................................................86 
Scheme 2.30.......................................................................................................................87 
Scheme 2.31.......................................................................................................................88 
Scheme 2.32.......................................................................................................................89 
Scheme 2.33.......................................................................................................................92 
Scheme 2.34.......................................................................................................................93 
Scheme 2.35.......................................................................................................................95 
Scheme 2.36.......................................................................................................................98 
Scheme 2.37.......................................................................................................................99 
Scheme 2.38.....................................................................................................................101 
 xv
Scheme 2.39.....................................................................................................................104 
Scheme 2.40.....................................................................................................................105 
 
 
 xvi 
 
LIST OF ABBREVIATIONS 
α   observed optical rotation in degrees 
[α]D   specific rotation (expressed without units; the 
   actual units, (deg⋅mL)/(g⋅dm), are understood) 
Ac   acetyl 
anhyd   anhydrous 
ap   apparent (spectral) 
aq   aqueous 
Ar   aryl 
atm   atmosphere(s) 
Bn, Bzl  benzyl 
bp   boiling point 
br   broad (spectral) 
Bu, n-Bu  normal (primary) butyl 
t-Bu   tert-butyl 
Bz   benzoyl (not benzyl) 
°C   degrees Celsius 
calcd   calculated 
Chx   cyclohexyl 
CI   chemical ionization; configuration interaction 
CLA   chiral lithium amide 
 xvii
cm-1   wavenumber(s) 
concd   concentrated 
COSY   correlation spectroscopy 
m-CPBA  meta-chloroperoxybenzoic acid 
CSA   camphorsulfonic acid 
δ   chemical shift in parts per million downfield from 
   tetramethylsilane 
d   day(s); doublet (spectral); deci 
d   density 
DDQ   2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
de   diastereomeric excess 
DEPT   distortionless enhancement by polarization transfer 
dil   dilute 
DIBAL-H  diisobutylaluminum hydride 
DMAP   4-(N,N-dimethylamino)pyridine 
DME   1,2-dimethoxyethane 
DMF   dimethylformamide 
DMP   Dess-Martin periodinane 
DMSO   dimethyl sulfoxide 
dr   diastereomeric ratio 
DRIFT   diffuse reflectance infrared Fourier transform spectroscopy 
ee   enantiomeric excess 
eq   equation 
equiv   equivalents 
 xviii
er   enantiomeric ratio 
ESI   electrospray ionization 
Et   ethyl 
FAB   fast atom bombardment 
FCC   flash column chromatography 
g   gram(s); prefix to NMR abbreviation denoting 
   gradient-selected (e.g., gCOSY, gHSQC) 
GC   gas chromatography 
h   hour(s) 
hfc   3-(heptafluoropropylhydroxy-methylene)camphorate 
HMBC  heteronuclear multiple bond correlation 
HMPA   hexamethylphosphoric triamide (hexamethylphosphoramide) 
HRMS   high-resolution mass spectrometry 
HSQC   heteronuclear single quantum correlation 
Hz   hertz 
IR   infrared 
J   coupling constant (in NMR spectrometry) 
k   kilo 
K   kelvin(s) (absolute temperature) 
L   liter(s) 
LAH   lithium aluminum hydride 
LDA   lithium diisopropylamide 
LHMDS  lithium hexamethyldisilazane, lithium bis(trimethylsilyl) 
   amide 
 xix
lit.   literature (abbreviation used with period) 
LRMS   low-resolution mass spectrometry 
μ   micro 
m   multiplet (spectral); meter(s); milli 
M   molar (moles per liter); mega 
M+   parent molecular ion 
max   maximum 
Me   methyl 
MEM   (2-methoxyethoxy)methyl 
MHz   megahertz 
min   minute(s); minimum 
mM   millimolar (millimoles per liter) 
mol   mole(s); molecular (as in mol wt) 
MOM   methoxymethyl 
mp   melting point 
MS   mass spectrometry 
MTPA   2-methoxy-2-(trifluoromethyl)-2-phenylacetic acid 
MTPACl  2-methoxy-2-(trifluoromethyl)-2-phenylacetyl chloride 
MW, mol wt  molecular weight 
m/z   mass-to-charge ratio 
N   normal (equivalents per liter) 
NBS   N-bromosuccinimide 
NCS   N-chlorosuccinimide 
 xx
nm   nanometer(s) 
NMR   nuclear magnetic resonance 
NOE   nuclear Overhauser effect 
NOESY  nuclear Overhauser effect spectroscopy 
obsd   observed 
PCC   pyridinium chlorochromate 
PDC   pyridinium dichromate 
Ph   phenyl 
PMA   phosphomolybdic acid 
ppm   part(s) per million 
PPTS   pyridinium para-toluenesulfonate 
Pr   propyl 
i-Pr   isopropyl 
PTLC   preparative thin layer chromatography 
PTSA   para-toluenesulfonic acid 
q   quartet (spectral) 
rel   relative 
rt   room temperature 
s   singlet (spectral); second(s) 
t   triplet (spectral) 
TBDMS, TBS  tert-butyldimethylsilyl 
TBDPS, TPS  tert-butyldiphenylsilyl 
temp   temperature 
 xxi
TES   triethylsilyl; triethylsilane 
Tf   trifluoromethanesulfonyl (triflyl) 
TFA   trifluoroacetic acid 
TFAE   2,2,2-trifluoro-1-(9-anthryl)ethanol 
THF   tetrahydrofuran 
THP   tetrahydropyran-2-yl 
TIPS   triisopropylsilyl 
TLC   thin-layer chromatography 
TMEDA  N,N,N′,N′-tetramethyl-1,2-ethylenediamine 
TMS   trimethylsilyl; tetramethylsilane 
TOF   time-of-flight 
Tr   triphenylmethyl (trityl) 
UV   ultraviolet 
vis   visible 
vol   volume 
v/v   volume per unit volume (volume-to-volume ratio) 
wt   weight 
w/w   weight per unit weight (weight-to-weight ratio) 
 
 1 
CHAPTER 1 
1.  INTRODUCTION 
1.1.  Marine polypropionate natural products 
Polyketide-derived natural products represent a large class of biologically active 
compounds that have found many applications.1, 2  They are synthesized by bacteria, 
fungi and plants by polyketide synthase (PKS) enzymes through decarboxylative 
condensation of simple coenzyme A activated esters (Scheme 1.1.).  The polyketides  
O
SCoA
O
SCoAHO
O
S-ACP
O O
+ polyketides
PKSPKS
ACP = acyl carrier protien
1 2 3
 
Scheme 1.1. 
possess very diverse structures which can be divided into subgroups:  fatty acids, 
polypropionates and aromatic polyketides.  Polypropionates can be further classified into 
three groups:  polyether antibiotics, macrolides and spiroketals (Figure 1.1.).  Some of the  
polyketides
fatty acids aromatic polyketides
polypropionates
macrolides
polyether antibioticsspiroketals
 
Figure 1.1.  Classification of polyketides. 
  2
most biologically active compounds are the polypropionates and as a result, their study 
has been a very active area of research.  While investigations of terrestrial derived 
polypropionates have received much attention, the understanding of marine 
polypropionates and their biosynthetic processes is in its infancy.3  Indeed, some very 
interesting compounds possess numerous biological activities.  For example, (−)-
discodermolide,4 isolated from the sponge Discodermia dissoluta is found to be a potent 
microtubule-stabilizing agent.  The mode of action, similar to that of taxol, arrests cells at 
the G2/M phase of the cell cycle.  This antimitotic action is also shared with other marine 
polypropionate compounds such as peloruside A5 and dictyostatin6 (Figure 1.2.).   
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Figure 1.2.  Biologically active natural products. 
The most important source of marine polypropionate compounds are the Mollusca.3  
While a few isolated compounds have no apparent biological activities, many are 
important for therapies against respiratory infections, Legionnaires disease and for 
  3
infections in patients sensitive to penicillin antibiotics.  They show cytotoxic antibiotic, 
antifungal and antiviral properties.  The structural diversity of compounds isolated from 
Mollusca presents some intriguing questions with respect to their biosynthetic pathways 
(Figure 1.3.).  By what means are these complex molecules assembled?  Are they  
O
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OHO O
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O
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Figure 1.3.  Mollusca polypropionate natural products. 
synthesized by the same PKS system as for terrestrial organisms?  In fact, it has been 
noted that some marine polypropionates are artifacts of isolation and the actual 'active' 
compound may be some other precursor.3  The pharmaceutical potential of Mollusca 
polypropionates are unlikely to be realized until a more complete understanding of their 
chemical properties and biosynthetic pathway emerges.   
1.2.  The denticulatins 
1.2.1.  Isolation, structure determination and biosynthesis 
In 1983, Faulkner and co-workers isolated two polypropionate metabolites from an 
air-breathing marine mollusk Siphonaria denticulata that displayed ichthyotoxic activity 
  4
towards goldfish.7  Perhaps one of the simplest marine polypropionates, the structural 
OOHOHOO
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Scheme 1.2. 
elucidation of denticulatin A 9 and denticulatin B 10 (Figure 1.3. and Scheme 1.2.)  were 
determined by a combination of NMR and X-ray analysis.  The denticulatins exist 
predominantly as hemiketals formed by addition of C5-OH onto C9-carbonyl to give a 
pyran ring with all carbon substituents in equatorial positions and hydroxyl groups in 
axial positions.  The events leading to the formation of the hemiketal is an interesting 
issue.  Perhaps a C9 monoketone undergoes cyclization followed by oxidation at C3 and 
C11.  There are three modes of cyclization available for triketone 13 (Scheme 1.2.).  If the 
cyclization were to be driven solely by steric contributions, compound 15 would be 
formed as all carbon substituents are equatorial.  However, because of hydrogen-bonding 
between the axial hydroxyl groups, the thermodynamically favored cyclization mode is 
C5-OH onto C9-carbonyl.   
  5
The denticulatins were the first marine polypropionates for which investigations 
confirmed the operation of a polypropionate biosynthesis rather than an acetate-
methionine route (Scheme 1.3.).3, 8  This was accomplished by feeding and injection  
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Scheme 1.3. 
experiments using 14C labeled propionate and acetate.  From theses studies, the first three 
cycles of a biosynthetic pathway to denticulatin A have been proposed (Scheme 1.4.).3   
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Scheme 1.4. 
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Despite these impressive results, further insights will only be available if additional 
material is available.  As for many natural products, quantities obtained from natural 
sources are typically small (i.e. 0.12 mg/animal for denticulatin A)7 and chemical 
synthesis plays a major role in both biosynthetic studies and also for the application of 
such materials for medicinal and/or agrochemical uses. 
1.2.2.  Synthetic studies and total syntheses 
As part of a study to derivatize denticulatin A, Davies-Coleman and co-workers 
subjected the metabolite to the Sharpless AD-mix dihydroxylation reagent and rather than 
the expected diol, they obtained funiculatin A (Scheme 1.5.).9, 10  This observation was  
denticulatin A (10-S)-9
O
O O
OH
OH H
10
7 O
10
OO
H
funiculatin A (10-S)-25  
Scheme 1.5. 
speculated to have resulted from the presence of K2CO3 in the reaction mixture.  In fact, 
subjection of denticulatin A to K2CO3 alone furnished several polypropionate products.  
The susceptibility of denticulatin A and other marine polypropionates to skeletal 
rearrangements under mild conditions suggest that the isolated compounds may represent 
non-enzymatic cyclization products (i.e. kinetic or thermodynamic) of unstable acyclic 
natural products.   
In order to further investigate the chemical properties of the denticulatins and other 
marine polypropionates, total synthesis plays a significant role because of the limited bio-
availability of such materials.  There have been four total syntheses of the denticulatins,11 
the first being denticulatin B by Ziegler and co-workers in 199012.  Since then, there have 
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been three other elegant syntheses by the Hoffmann,13, 14 Paterson,15, 16 and Oppolzer17, 18 
groups. 
1.2.2.1.  Ziegler's synthesis 
The basic strategy employed by Ziegler and co-workers involved the preparation of 
p-methoxyacetophenylidene protected triketone 26i that, after mild deprotection, 
spontaneously cyclized to the denticulatins.12  The triketone 26 was prepared from an 
aldol reaction of ketone 27 and keto aldehyde 28 followed by oxidation (Scheme 1.6.).   
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Enders' RAMP hydrazone alkylation
 
Scheme 1.6. 
Access to keto aldehyde 28 was achieved by two enolate Ireland-Claisen protocols using 
both enantiomers of (E)-allylic alcohol 30 and (S)-3-methyl-γ-butyrolactone 31.  This 
method was described earlier by Ziegler and co-workers as a general approach for the 
                                                 
i An acetonide protecting group proved to be resistant to hydrolytic conditions. 
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asymmetric synthesis of polypropionates.19, 20  The synthesis of keto aldehyde 28 began 
with an Ireland-Claisen rearrangement of the diethyl orthoester 35ii (Scheme 1.7.) and 
(R)-allylic alcohol 30iii to give lactone 36 which was subjected to a Criegee oxidation 
sequence to provide acetonide 37 in 81% yield over 5 steps (Scheme 1.7.).  Acetonide 37  
(S)
OEtO
8
OH 6
+
33 35
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37
8 8
5 steps
81% yield
6
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62% yield
OO
8 6
CN
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8 6
39
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74% yield
O 6 (S)
O
OMe
OH
8
32 34
2 steps
37% yield
90% ee
4 steps
15% yield
97% ee
H
EtO
83% yield
 
Scheme 1.7. 
was subjected to ozonolysis, LAH reduction, tosylation, and cyanide substitution to 
provide cyano acetonide 38 in 62% yield over 4 steps.  Cyano acetonide 38 was then 
carefully hydrolyzed and esterified with (S)-allylic alcohol 30iii to give ester 39 in 74% 
overall 2 steps.  Enol silylation of ester 39 by treatment with LDA/TBSCl gave (E)-O-
silylketene acetonide that underwent an Ireland-Claisen rearrangement to give, after 
dilute acid hydrolysis, hydroxy lactone 41 in 84% yield over 2 steps (Scheme 1.8.).   
39
OO
O
TBS
O
O
OH O
41
8 6 8 6
OO
8 6
40
TBS
O O
2 steps
84% yield  
Scheme 1.8. 
                                                 
ii Prepared from commercially available (S)-3-hydroxy-2-methylpropionate in 3 steps in 19% yield and 
97% ee. 
iii Prepared from commercially available crotonaldehyde via Grignard addition of diisopropylmagnesium 
chloride and subsequent kinetic resolution by Sharpless epoxidation. 
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Protection of hydroxy lactone 41 as the TBDPS ether was followed by the Criegee 
sequenceiv to give diol 42 in 73% yield over 5 steps (Scheme 1.9.).  Protection of diol 42  
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O OH
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7
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O
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7
7
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TBDPS
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3 steps
68% yield
 
Scheme 1.9. 
using the dimethyl ketal of p- methoxyacetophenone gave 43 as single diastereomer in 
94% yield.  Ozonolysis of 43 followed by a reductive work-up and Swern oxidation gave 
aldehyde 44 that reacted with ethylmagnesium bromide, followed by hydrolysis of the 
TBDPS protecting group and a double Swern oxidation to give the desired keto aldehyde 
45 in 68% yield over 3 steps.  Ziegler and co-workers elegantly applied their 3-methyl-γ-
butyrolactone strategy for the preparation of keto aldehyde 45.  Despite the rather lengthy 
synthesis, the approach provided keto aldehyde 45 in 1% yield over a total of 29 steps.  
This was truly an amazing accomplishment, reflecting an average yield per step of 86%.  
                                                 
iv DIBAL-H replaced LAH in the Criegee sequence. 
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The other component required for the aldol reaction was ketone 27.  This was easily 
prepared by alkylation of the RAMPv hydrazone of 3-pentanone with allylic bromide 47vi 
to provide ketone 27 in 56% yield and 89% ee over 2 steps (Scheme 1.10.).  With  
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51
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+
97% yield 56% yield
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85% yield
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(R)-proline 48
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58% yield
 
Scheme 1.10. 
ketone 27 and keto aldehyde 45 available, Ziegler and co-workers generated the lithium 
enolate of ketone 27 using LDA and subsequently added keto aldehyde 45 which gave a 
mixture of three of the four possible aldol products in a ratio of 1.0:3.6:2.1 with a 
combined yield of 86% (Scheme 1.11.).  Swern oxidation of this mixture gave a 2.7:1.0 
mixture of triketone (10-S)-53 and triketone (10-R)-54, respectively, in a combined yield 
of 81%.  Careful fractionation of these triketones gave enriched samples that were 
separately subjected to mild deprotection using 5% oxalic acid in aqueous THF.  
Denticulatin A 9 and denticulatin B 10 were isolated as a mixture that reflected the 
starting ratios of triketones (Scheme 1.11. and Table 1.1.).  The data in Table 1.1.  
                                                 
v Prepared from commercially available (R)-proline in 6 steps in 58% yield.  RAMP is also commercially 
available, albeit ca. $20,000/mol. 
vi Yield for the preparation of allylic bromide 47 is not reported, however the cited procedure for (E)-2-
methyl-2-butenyl bromide from tiglic acid occurs in 3 steps in 50% yield. 
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Scheme 1.11. 
Table 1.1.  Deprotection of triketones. 
enriched triketones 
(10-S)-53:(10-R)-53 
denticulatins 
(10-S)-9:(10-R)-10 (% yield) 
recovered triketones 
(10-S)-53:(10-R)-54 (% yield) 
4.6:1.0 6.0:1.0 (33) 2.9:1.0 (54) 
1.0:4.7 1.0:8.0 (45) 1.0:1.5 (40) 
 
indicated that the triketones do not completely isomerize prior to hydrolysis and 
cyclization.  These results were obtained when the deprotection was allowed to progress 
to only ca. 50% conversion.  Further conversion lead to significant amounts of 
dehydration products.  To summarize, Ziegler and co-workers synthesized enriched 
samples of denticulatin A and denticulatin B in 0.3% and 0.4% yield, respectively over a 
longest linear sequence of 32 steps starting from (S)-3-hydroxy-2-methylpropionate.  A 
remarkable synthesis, this reflects an average yield per step of 83%. 
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1.2.2.2.  Hoffmann's synthesis 
In 1991, Hoffmann and co-workers published the second total synthesis of the 
denticulatins.13, 14  Similar to Ziegler's synthesis, Hoffman and co-workers prepared a 
protected triketone from an aldol reaction of ketone 27 with aldehyde 56 followed by 
deprotection and oxidation (Scheme 1.12.).  A significant improvement was achieved as 
aldehyde 56 was obtained in 8% yield over 12 steps (Zeigler and co-workers prepared 
keto aldehyde 45 in 1% yield over 29 steps) by a route involving three crotylboration 
reactions (Scheme 1.12. and Scheme 1.13.).  The synthesis of aldehyde 56 began with the  
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Scheme 1.12. 
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Scheme 1.13. 
addition of 61 to propionaldehyde 58 to give alcohol 64 in 79% yield and 98.5% ee.  TBS 
protection of 64 followed by ozonolysis provided aldehyde 65 that was used in a second 
crotylboration reaction using 66vii to give 67 in 95% yield and 95% de.  Sequential 
protection and ozonolysis of 67 furnished aldehyde 68 in 83% yield.  Chain extension of 
68 to aldehyde 56 required an alternative approach as the high 1,3-anti 
diastereoselectivity found for aldehyde 68 had to be reversed to give the desired 1,3-syn 
relative configuration.  To this end, Hoffmann and co-workers developed α-substituted 
crotylboronate 69viii for the crotylboration of aldehyde 68 to give a 3:1 mixture of  
                                                 
vii Prepared from commercially available pinacol and triisopropoxyborane in 4 steps in 38% yield. 
viii Prepared from commercially available pinacol and (S)-butyn-2-ol in 4 steps in 48% yield. 
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Scheme 1.14. 
homoallylic alcohols 70 and 71 in a combined yield of 85% (Scheme 1.14.).  DDQ 
oxidation of the desired 70 followed by ozonolysis furnished aldehyde 56 in 8% yield 
over a total of 12 steps.  The remaining fragment required for the final aldol coupling, 
ketone 27, was prepared from racemic alcohol 72ix by an Ireland-Claisen rearrangement  
O
O
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OH
O O
73 27
2 steps
53% yield
OH
72
2 steps
40% yield
98% ee  
Scheme 1.15. 
                                                 
ix Prepared by kinetic resolution of commercially available (±)-2-methyl-1-penten-3-ol via Sharpless 
epoxidation. 
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via the (E)-enolate of ester 57 to provide acid 73 that was directly converted into the 
desired ketone 27 in 53% yield over 2 steps (Scheme 1.15.).  The boron-mediated aldol 
reaction of ketone 27 with aldehyde 56 furnished two adducts 74 and 75 in 88% 
combined yield in 75% de (Scheme 1.16.).  As is clearly evident from the structures,  
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Scheme 1.16. 
the two diastereomers arise from the two different enantiomers of ketone 27.  Hoffmann 
and co-workers speculated that compounds 74 and 75 likely resulted from the reduced 
enantiopurity of ketone 27.  It has been noted that ketone 27 has a high propensity to 
racemize upon storage or distillation.  Removal of the TBS protecting group in 74 proved 
to be very troublesome and the diol 76 was obtained in variable yields (20-85%) even 
after considerable experimentation.  The variability was suggested to be a result of the 
high lability of the p-methoxybenzylidene acetal.  Collins oxidation of diol 76 provided 
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the desired triketones (10-S)-77 and (10-R)-78 as a 1:1 mixture with a combined yield of 
61% (Scheme 1.17.).  Despite the hardship Hoffmann et al. had in preparing the desired  
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Scheme 1.17. 
triketones, further difficulties were faced as deprotection could not be achieved under 
numerous conditions without obtaining mainly elimination products.  Instead of changing 
the p-methoxybenzylidene acetal protecting group, Hoffmann and co-workers questioned 
if it were possible to synthesize hemiketal 79 resulting from the C7-OH addition onto C3-
carbonyl of diol 80 and whether this compound will spontaneously isomerize to the 
denticulatins (Scheme 1.18.).  Aldehyde 82 was prepared from 81 in 88% yield over 3 
steps (Scheme 1.19.).  Addition of (E)-crotylboronate 69 to aldehyde 82 gave, after 
cyclization, 83 and 84 as a 4:1 mixture, respectively in 75% yield.  Ozonolysis of 83 
furnished second generation aldehyde 85 (Scheme 1.20.) in 85% yield which was used in  
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Scheme 1.18. 
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Scheme 1.19. 
a boron-mediated aldol reaction with ketone 27 to provide two aldol adducts 86 and 87 in 
89% combined yield and 78% de (Scheme 1.20.).  Dess-Martin oxidation of 86 furnished 
diketone 88 in 85% yield.  At this stage, only the deprotection of the p-methoxybenzyl 
ether protecting group was required to facilitate isomerization to the denticulatins.  
Again, attempted deprotection of 88 under numerous conditions failed or resulted in 
decomposition.  After considerable experimentation, deprotection of 88 was achieved by 
using lithium in ammonia on the corresponding dianion preformed using LDA.   
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Scheme 1.20. 
This process furnished a 1.5:1.0 mixture of denticulatin A and denticulatin B, 
respectively in 58% combined yield.  To summarize, Hoffmann and co-workers 
synthesized denticulatin A and denticulatin B as a mixture in 2% overall yield over a 
longest linear sequence of 17 steps starting from trans-stilbene (average yield per step of 
80%). 
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1.2.2.3.  Paterson's synthesis 
In 1992, Paterson and Perkins presented an alternative route for the synthesis of 
denticulatin B by exploiting boron- and titanium-mediated aldol couplings (Scheme 
1.21.).15, 16  As with the previous syntheses, a protected triketone 89 was prepared.  In this  
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Scheme 1.21. 
case, a di-tert-butylsilylene protected triketone was prepared with the expectation that 
deprotection could be effected under mild HF⋅pyridine deprotection.  The synthesis began 
with a boron-mediated aldol reaction of ketone 97x with aldehyde 96 followed by in situ 
                                                 
x Prepared from commercially available (R)-methyl 3-hydroxy-2-methylpropionate in 3 steps in 59% yield 
and 97% ee. 
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LiBH4 reduction to furnish the diol 98 in 81% yield (Scheme 1.22.).xi  Sequential 
protection and hydroboration of 98 provided 99 in 77% yield in 2 steps (Scheme 1.22.).   
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Scheme 1.22. 
Conversion of 99 to required ketol 101 was achieved by debenzylation, oxidation, and 
ethylmagnesium bromide addition in 70% yield over 3 steps (Scheme 1.23.).  With ketol  
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Scheme 1.23. 
101 available, aldehyde 90 was prepared from alcohol 102ix by an Ireland-Claisen 
rearrangement of the (Z)-O-silylketene of ester ent-57 followed by LAH reduction and 
subsequent PCC oxidation of the resulting alcohol to give aldehyde 90 in 42% yield and 
80% ee over 3 steps (Scheme 1.24.).  The titanium-mediated aldol reaction of ketone 101   
OH
102
2 steps
30% yield
98% ee
O
11
73
O
O
ent-57
11
OH
O
11
90
72% yield
2 steps
59% yield 80% ee
 
Scheme 1.24. 
                                                 
xi A one-pot procedure. 
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with aldehyde 90 provided two aldol adducts, 103 and 104 in 90% yield and 83% de 
(Scheme 1.25.).  The minor aldol adduct 104 results from reaction of the minor  
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Scheme 1.25. 
enantiomer of aldehyde 90 (80% ee).  Double Swern oxidation of 103 and subsequent 
silyl deprotection using buffered HF⋅pyridine afforded pure denticulatin B in 54% yield.  
Paterson and Perkins were also able to equilibrate triketone 89 using SiO2 or Et3N (i.e. 
C10 epimerization).  Silyl deprotection of the resulting mixture of C-10 epimers using 
buffered HF⋅pyridine provided a 1:2 mixture of denticulatin A and denticulatin B, 
respectively with a combined yield of 78%.  To summarize, Paterson and Perkins 
achieved the first stereoselective synthesis of denticulatin B in 10% yield over a longest 
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linear sequence of 12 steps starting from (R)-methyl 3-hydroxy-2-methylpropionate.  A 
synthesis that reflects an average yield per step of 82%.   
1.2.2.4.  Oppolzer's synthesis 
The first stereoselective synthesis of denticulatin A was achieved by Oppolzer and 
co-workers in 1995.17, 18  Denticulatin B was also prepared from a common intermediate 
en route to denticulatin A (Scheme 1.26.).  As seen in the stereoselective synthesis of  
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Scheme 1.26. 
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denticulatin B by Paterson and Perkins, Oppolzer et al. selected the di-tert-butylsilylene 
triketones 89 and 106 for the synthesis of the denticulatins (Scheme 1.26.).  Triketones 89 
and 106 were envisioned to arise via titanium-mediated aldol couplings (after oxidation) 
of ketol 114 with aldehyde 90 and ketone 27 with aldehyde 107.  The required aldol 
components were prepared from meso dialdehyde 109xii and chiral N-propionylsultam 
108xiii.  Boron-mediated aldol reaction of chiral N-propionylsultam 108 with meso  
O
7
O
TBS
O
+
108 109 110
75% yield
O
7
OO
Si
t -Bu t-Bu
2 steps
92% yield
S
S
N
O2S
OO
OH
TBSO
7
N
O2S
N
O2S
O
34
O
7
OO
Si
t -Bu t-Bu
S
S SBn
O
7
OO
Si
t -Bu t-Bu
S
S
O
7
OO
Si
t -Bu t-Bu
O
112
113 107
111
93% yield
85% yield
85% yield
B-enolate
 
Scheme 1.27. 
dialdehyde 109 provided aldol adduct 110 as a cyclized lactol in 75% yield.  
Simultaneous silyl deprotection and ethanedithiol trapping was achieved in the presence 
of ZnI2 to give a diol that was subsequently protected to give di-tert-butylsilylene 
dithiolane 111 in 92% yield over 2 steps (Scheme 1.27.).  Removal of the chiral auxiliary 
                                                 
xii Prepared from commercially available 2,4-dimethyl-1,4-pentadiene-3-ol in 3 steps in 63% yield. 
xiii Prepared from commercially available (−)-camphorsulfonic acid in 5 steps in 67% yield. 
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was best performed using the ate-complex derived from AlMe3 and lithium 
benzylthiolate which furnished benzyl thioester 112 in 93% yield.  Ethylmagnesium 
bromide addition to 112 followed by dithiolane deprotection using buffered mercury 
perchlorate provided the desired aldehyde 107 in 72% yield over 2 steps.  Access to 
ketone 27 commenced with alkylation of chiral N-propionylsultam 108 with allylic 
bromide 47vi via the sodium enolate to give 115 in 69% yield (Scheme 1.28.).  Removal 
of the chiral auxiliary and ethylmagnesium bromide addition to resulting benzyl thioester  
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Scheme 1.28. 
116 provided ketone 27 in 99% yield and 99.9% ee.  Titanium-mediated aldol reaction of 
ketone 27 with aldehyde 107 provided aldol adducts 117 and 118 in 61% combined yield 
and 90% de (Scheme 1.29.).  Minor aldol adduct 118 was oxidized using Dess-Martin 
periodinanexiv to give triketone 89 that was reported by Paterson and Perkins in their 
synthesis of denticulatin B.  Swern oxidation of the major aldol adduct 117 furnished 
triketone 106 that was deprotected using buffered HF⋅pyridine to give denticulatin A and 
denticulatin B as a 20:1 mixture respectively, in 89% yield (Scheme 1.29.).  This  
                                                 
xiv Swern oxidation was unsuccessful.  
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Scheme 1.29 
represents the first stereoselective synthesis of denticulatin A that was accomplished in 
14 steps and 14% overall yield (average yield per step of 87%). 
Oppolzer and co-workers also applied their methodology for the synthesis of 
denticulatin B via aldol coupling of ketol 114 and aldehyde 90 that was similarly 
achieved by Paterson and Perkins (Scheme 1.21. and Scheme 1.26.).  Preparation of 
aldehyde 90 was achieved by reduction of 115 with lithium triethylborohydride followed 
by oxidation of 120 with PCC to give the desired aldehyde in 82% yield over 2 steps and 
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>99.9% ee (Scheme 1.30.).  Access to the desired ketol was obtained by a sequence of 
reactions that first involved dithiolane deprotection of 111 using buffered mercury  
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Scheme 1.30. 
perchlorate which provided aldehyde 121 in 92% yield.  Ethylmagnesium bromide 
addition to aldehyde 121 provided a 2:1 mixture of alcohols 122 in 95% yield (Scheme 
1.31.).  Lithium triethylborohydride reduction of this mixture followed by Dess-Martin  
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Scheme 1.31. 
oxidation furnished keto aldehyde ent-107 in 74% yield over 2 steps.  Ethylmagnesium 
bromide addition to aldehyde ent-107 provided ketols (3-S)-123 (60% yield) and (3-R)-
124 (21% yield).  Titanium-mediated aldol coupling of aldehyde 90 and ketol (3-S)-123 
provided aldol adduct 125 in 89% yield.  Similarly, titanium-mediated aldol coupling of 
aldehyde 90 and ketol (3-R)-124 provided aldol adduct 126 in 71% yield (Scheme 1.33.).  
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Swern oxidation of 125 or 126 furnished desired triketone 89 in quantitative yield that 
was deprotected using buffered HF⋅pyridine to give pure denticulatin B in 78% yield 
(Scheme 1.32.).  To summarize, Oppolzer and co-workers achieved an improved  
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Scheme 1.32. 
stereoselective synthesis of denticulatin B in 12% yield over a total of 16 steps (average 
yield per step of 87%). 
1.2.3.  Comparative analysis of syntheses 
All total syntheses of the denticulatins exploited aldol related chemistry to effect 
fragment coupling.  All routes rely on acyclic precursor A (Scheme 1.33.) as the 
penultimate intermediate.  This precursor was assembled by substrate-controlled aldol 
reactions of 27 and B for denticulatin A or C and 90 for denticulatin B  
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Scheme 1.33. 
(Scheme 1.33. and Table 1.2.).  Each research group applied their own methodologies for 
the synthesis of the required aldol coupling partners.  Ziegler and co-workers used 
enolate Ireland-Claisen protocols involving both enantiomers of 30 and (S)-3-methyl-γ-
butyrolactone 35 to arrive at B.  Hoffmann and co-workers implemented several 
crotylboration maneuvers to prepare an equivalent of aldehyde B.  Paterson and Perkins 
synthesized ketol C from a boron-mediated aldol reaction of ketone 95 and aldehyde 94.  
Lastly, Oppolzer applied an enantiotopic group selective aldolization route for the 
preparation of both B and C.  While the syntheses overlap to some extent, the route of 
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Oppolzer and co-workers' is noteworthy in that it was adaptable for the synthesis of 
denticulatin A or denticulatin B.   
Table 1.2.  Total syntheses of the denticulatins. 
 denticulatin % yielda number 
of stepsb 
longest linear 
sequence 
average yield 
per stepc 
 A:B B     
Ziegler 6:1 - 0.3 46 32d 83 
Ziegler 1:8 - 0.4 46 32d 83 
Hoffmann 1.5:1 - 2 26 17e 80 
Paterson - pure 10 17 12f 82 
Oppolzer 20:1 - 14 23 14g 87 
Oppolzer - pure 12h 21 16g 87 
a Yields calculated based on commercially available starting materials over the longest linear sequence. 
b Total number of synthetic manipulations including preparation of starting materials and reagents.   
c Calculated based on the longest linear sequence.  d Based on (S)-3-hydroxy-2-methylpropionate.  e Based 
on trans-stilbene.  f Based on (R)-methyl 3-hydroxy-2-methylpropionate.  g Based on (−)-camphorsulfonic 
acid.  h 18% yield when combined with material deriving from (3-R)-124. 
 
1.3.  Total synthesis of polypropionate natural products 
Polypropionate natural products are characterized by structure with alternating 
methyl groups and oxygen functionalities (alcohol, ketone and/or carboxyl) along a 
contiguous carbon chain (Figure 1.4.).  Among the approximately 5000-10,000 known 
R R R
OH
O
n
R = O, H/OH, H/H
n = 0, 1, 2,...integer
* * *
* = stereogenic center
 
Figure 1.4.  Generalized structure of polypropionate natural products. 
polypropionates, only 1% of them possess biological activity.  Despite this rather low 
value, it surprisingly represents five times the average for natural products.21  The 
considerable interest in polypropionate natural products is due to their biological 
applications and stereochemical complexity.22-26  For more than three decades, synthetic 
chemists have made significant contributions to the development and advancement of 
asymmetric synthetic methodologies.21, 27, 28  The inherent challenge for the synthesis of 
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polypropionates derives from the long sequence of stereocenters.  For example, a 
dipropionate can have up to four different stereoisomers, a tripropionate (16), a 
tetrapropionate (64), a pentapropionate (256), a hexapropionate (1024) and a 
heptapropionate (4096) (Figure 1.5.).  In some cases, the relative and/or absolute  
OH OH OH OH OH O
OH OH OH OH O
OH OH OH O
OH OH O
OH O
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4 stereoisomers
tripropionate
16 stereoisomers
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64 stereoisomers
pentapropionate
256 stereoisomers
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2 stereocenters
4 stereocenters
6 stereocenters
8 stereocenters
10 stereocenters
OH OH OH OH OH OH
heptapropionate
4096 stereoisomers
12 stereocenters
O
OH OH
OH
OH
OH
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Figure 1.5.  Possible stereoisomers for polypropionates. 
configurations of isolated polypropionates are not known and to resolve this problem, the 
synthesis of all stereoisomers is required.29, 30  In 1987, Hoffmann introduced the term 
'stereotriad' for the analysis of sequences possessing three consecutive stereocenters 
(Figure 1.6.).28  Coupling of chiral (non-racemic) stereotriad fragments allows the  
OH OH OH OH
syn,syn anti,syn syn,anti anti,anti
A B C D  
Figure 1.6.  Stereotriads A-D. 
construction of more elaborate polypropionate structures.31-36  However, this union is 
complicated by double stereodifferentation and introduces a major obstacle to be 
overcome in any total synthesis.28, 37-45  As a result, numerous reactions have been 
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developed for the synthesis of polypropionate structures.  For example, aldol,31, 46-63 
crotylation,42, 45, 64-69 Diels-Alder,70-76 Wittig,77 Tischtschenko,78 alkylation,79-84 
propargylation-reductive coupling,85, 86 acetalization,87 hydroformylation,88 formate 
reduction,89 allyltitanation58, 78, 90, 91 and allenylstannylation92 reactions have found 
numerous applications in polypropionate syntheses.  Other approaches involving 
cyclopropane,93 oxabicylic,70, 94-96 1,3-polyol,97, 98 acyl halide99 and γ-lactone19, 20, 100 
intermediates have also proved to be very convenient methods for the synthesis of 
polypropionate compounds.  Despite the plethora of approaches available, the 
asymmetric synthesis of polypropionate compounds continues to be a synthetic challenge 
because very few methods can be generally applied for the preparation of the numerous 
polypropionate motifs found in various natural products (Figure 1.6.).xv   
In Nature, polypropionates are assembled by polyketide synthase (PKS) enzymes 
through an iterative decarboxylative condensation of methylmalonyl CoA to a growing 
polyketide chain generating (up to) two stereocenters per iteration.  The first PKS 
elucidated was for the erythromycin antibiotics (Figure 1.7.) isolated from Streptomyces 
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O
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R OH
O
O
H
H
MeO
HO
NMe2
OH
erythromycin A, R = OH 128
erythromycin B, R = H 129
 
Figure 1.7.  Streptomyces erythreus macrolides. 
                                                 
xv Considering both enantiomeric series of stereotriads A-D, there are 8 possible stereoisomers. 
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erythreus.26  In fact, the intermediate 6-deoxyerythronolide B 127,101 isolated from 
blocked mutants of Streptomyces erythreus proved to be instrumental for this objective.  
The erythromycin polyketide synthase consists of 7 enzymes and is a so-called type Ixvi 
polyketide synthase.102  In an iterative fashion, 6-deoxyerythronolide B 127, is 
biosynthesized from one molecule of propionyl CoA 1 and six molecules of 
methylmalonyl CoA 2 (Scheme 1.34.).  The PKS possesses six modules that consist of 
several enzymes (AT, KS and ACP) along with additional enzymes involved with 
functional group manipulations.  The first step of chain elongation involves 
decarboxylative condensation of ACP bound methyl malonic acid 139 with KS bound 
propionate 138 (Scheme 1.35.).  Subsequent acyl transfer of the newly formed ACP 
bound polypropionate and preparation of the second ACP bound methyl malonic acid 139  
                                                 
xvi There are three types of PKS:  Type I, consist of multifunctional enzymes that are organized into 
modules which are responsible for the catalysis of one cycle of polyketide chain elongation.  Type II, 
consist of dissociable multienzyme complexes.  Type III, consists of dissociable homodimeric enzymes. 
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Scheme 1.34. 
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Scheme 1.35. 
sets the stage for a second iteration in as few as two steps.  Reiteration of this process 
with the growing KS bound polypropionates and intervening functional group 
manipulations produces 6-deoxyerythronolide B in only 6 carbon-carbon bond forming 
reactions.   
Polypropionate natural products and their related compounds have benefited 
humans on several different levels and their significance cannot be overstated.  
Convenient, flexible and efficient methods are still required for the synthesis of 
polypropionate compounds.  Despite the numerous synthetic approaches for 
polypropionate synthesis, very few have been applied in an iterativexvii fashion that 
attempts to mimic the elegant approach displayed in Nature.   
                                                 
xvii Defined in this context where a particular reaction or sequence of reactions were iterated 3 or more 
times. 
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1.3.1.  Iterative strategies for polypropionate synthesis 
Many of the iterative strategies developed to date involve the reaction of chiral 
(non-racemic) or achiral aldehydes with chiral (non-racemic) or achiral reagents 
generating (up to) two new stereocenters for each step.  For an iterative strategy, the 
aldehyde must be prepared from the product resulting from the chain elongating step 
(Scheme 1.36.).  There are two major obstacles for an iterative strategy:  1) the number of 
reagent
chiral
(non-racemic)
or
achiral
R
OR O
chiral
(non-racemic or racemic)
repeat
+
chain
elongation
143
aldehyde
re-introduction
chiral
(non-racemic)
or
achiral
R = alkyl and/or silyl
FG = f unctional group
R CHO
R
OH
FG
(steps)
 
Scheme 1.36. 
synthetic manipulations required for aldehyde re-introductionxviii and 2) the enantio- and 
diastereoselectivities of the chain elongation steps.  In Nature, as few as two steps are 
performed for each iteration and the enantio- and diastereoselectivities are controlled by 
enzymes (Scheme 1.34. and Scheme 1.35.).  As was discussed earlier (Figure 1.5.) the 
number of possible stereoisomers increases exponentially with the number of stereogenic 
centers.  Often, the major challenge faced by synthetic chemists involves establishing the 
desired configurations of the polypropionate compound.  Over the past 15 years, several 
iterative strategies have emerged and have found various applications for the synthesis of 
polypropionate compounds.  The following examples are presented to provide a 
representation of iterative approaches.  All of the examples have shown the capacity to 
control the stereochemical outcome of different reactions by exploiting substrate- and/or 
reagent-control.   
                                                 
xviii That is, the efficiency of preparing the required aldehyde for the next iteration. 
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In 1990, Danishefsky and Myles disclosed a Lewis acid catalyzed diene aldehyde 
cyclocondensation (LACDAC) reaction that was applied in an iterative fashion for the 
synthesis of racemic 6-deoxyerythronolide B (Scheme 1.37.).75  The strategy exploited  
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Scheme 1.37. 
substrate-controlled Diels-Alder reactions of diene 144 with various aldehydes in the 
presence of different Lewis acids (e.g. ZnCl2 or BF3⋅OEt2) to produce dihydropyrones.  
Processing the dihydropyrones into their corresponding aldehydes (6 steps) permitted 
iteration of the sequence.  Although the approach was iterative, a major limitation was the 
6 steps (ca. 35-41% yields) required before the next iteration.   
In a related synthesis, Hoffmann and co-workers presented an impressive 
asymmetric synthesis of (9-S)-dihydroerythronolide A 160 (Scheme 1.38.).64  The 
strategy employed four reagent-controlled crotylboration reactions utilizing chiral (non-
racemic) crotylboronates and chiral (non-racemic) aldehydes where, after the first 
iteration, only 2 steps were required to prepare for iterative chain elongation.   
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Scheme 1.38. 
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A more general approach was developed by Hanessian and co-workers that utilized 
Wittig methodology.  The basis of the approach involved substrate-controlled methyl 
cuprate additions to protected chiral (non-racemic) γ-alkoxy-α,β-unsaturated esters 
followed by a Davis α-hydroxylation to complete the installation of a propionate 
fragment (Scheme 1.39.).77  Iteration was achieved by a three step sequence that provided  
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Scheme 1.39. 
the next aldehyde to be used for chain elongation.  Unlike the previous examples, this 
approach sequentially installed the desired stereocenters after chain elongation.  As a 
result of the inherent stereochemical outcome of the conjugate addition and subsequent 
hydroxylation and in combination with an optional Mitsunobu inversion, stereotriads B-D 
(Figure 1.6.) can be obtained by this method.  Although stereotriad A (Figure 1.6.) is not 
accessible by this approach, it could be obtained by an oxidation-reduction sequence.   
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In 1999, Paterson and Scott reported a boron-mediated aldol reaction strategy for 
the synthesis of polypropionate compounds.  The strategy exploited substrate-controlled 
aldol reactions of preformed chiral (non-racemic) (E)-enol borinate 167 (or ent-167) with 
various aldehydes (Scheme 1.40.).46, 63  The sequence was made iterable by a 4 step 
protocol that provided the desired aldehydes for subsequent iterations.  Similarly, during 
the synthesis of oleandolide, Paterson and co-workers also demonstrated reagent-
controlled boron-mediated aldol reactions of chiral (non-racemic) (Z)-enol borinates 170 
and 173 derived from (S)-ketone 95 and (−)-Ipc2BOTf/i-Pr2EtN or (+)-Ipc2BOTf/i-
Pr2EtN with aldehydes 171 or 173, respectively (Scheme 1.41.)103.  By application of the 
appropriate reaction conditions, Paterson and co-workers demonstrated that a diverse 
library of polypropionate compounds could be accessed with different relative and/or 
absolute configurations.   
O
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Scheme 1.41. 
Guindon and co-workers also exploited an aldol-type process that permitted access 
to all stereotriads A-D (Figure 1.6.).53, 55, 104  The basis of the methodology involved 
Lewis acid-mediated (AlMe3, Bu2BOTf, BF3⋅OEt2 or (i-PrO)TiCl3) substrate-controlled 
Mukaiyama aldol reactions105 of different chiral (non-racemic) aldehydes with 
tetrasubstituted enoxysilane 177 in tandem with a Lewis acid-mediated (Bu2BOTf or 
AlMe3) stereoselective hydrogen transfer using Bu3SnH.  Subjecting the resulting β-
hydroxy ester 179 to a 3 step sequence allowed the strategy to be reiterated (Scheme 
1.42. and Table 1.3.). 
OBn O OMe
OTMS
Br
176
177 OBn OH
Br
OMe
O
178
OBn OH
OMe
O
179
1st iteration
62% yield
OBn OBn O
180
3 steps
85% yield repeat81% yield
 
Scheme 1.42. 
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Table 1.3.  Diastereoselective Mukaiyama aldol and stereoselective hydrogen 
transfer processes. 
aldehyde Lewis 
acid 
% de (% yield) Lewis 
acid 
% de (% yield) 
OBn OBn O
180  
(i-PrO)TiCl3
177  
OBn OBn OH
Br
OMe
O
181, >95% (77)
Bu2BOTf
Bu3SnH
OBn OBn OH
OMe
O
183, >95% (89)  
   
AlMe3
Bu3SnH
OBn OBn OH
OMe
O
184, >95% (83)  
 
BF3·OEt2
177  
OBn OBn OH
Br
OMe
O
182, >95% (89)
AlMe3
Bu3SnH
OBn OBn OH
OMe
O
185, >95% (81)  
   
Bu2BOTf
Bu3SnH
OBn OBn OH
OMe
O
186, >95% (90)  
 
Similarly, by application of titanium-mediated aldol reactions, Crimmins and Slade 
reported a thiazolidinethione chiral auxiliary approach that was used for the formal 
synthesis of 6-deoxyerythronolide B (Scheme 1.43.).54  The sequence was iterated five 
times during a 23 step synthesis.  This was an excellent example where a chiral auxiliary 
was used for an iterative approach to a polypropionate natural product.   
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Scheme 1.43. 
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Lastly, Nelson and co-workers reported an asymmetric catalytic approach 
employing a [2+2] cycloaddition reaction of ketene 191 (derived from propionyl 
chloride) with achiral aldehyde 190 in the presence of 10 mol % of chiral (non-racemic) 
192 for the total synthesis of (−)-pironetin (Scheme 1.44.).99  Nelson and co-workers also  
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Scheme 1.44. 
demonstrated that the same approach could be applied to chiral (non-racemic) aldehydes 
(Table 1.4.).  In these cases, the authors suggested that the diastereoselectivities of the 
reactions were enhanced by double stereodifferentiation.xix  By employing either 
diastereomer of quinine derived catalysts (196 and 197, β-lactones (199-205) were 
selectively obtained in good yields and in high diastereomeric excess.   
 
 
 
 
 
 
 
 
                                                 
xix Although Nelson and co-workers referred to this as double stereodifferentiation, these were actually 
diastereoselective reactions since catalyst 196 and 197 are diastereomers (not enantiomers). 
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Table 1.4.  Acyl halide-aldehyde cyclocondensation of chiral (non-racemic) 
aldehydes. 
catalyst aldehyde β-lactone % de (% yield) 
196 
TMS
O PhO
198  
TMS
O PhO
O
199  
≥95 (83) 
197 
TMS
O PhO
200  
TMS
O PhO
O
201  
≥91 (81) 
196 
TMS
O PhO
202  
TMS
O PhO
O
203  
≥95 (81) 
197 
TMS
O
TMS
OO
204
Ph
 
TMS
O
TMS
OO Ph
205
O
 
≥95 (83) 
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Overcoming the challenges inherent to the synthesis of polypropionate compounds 
during the last three decades has greatly contributed to the development of 'asymmetric 
synthesis' (i.e. acyclic control).  Although the aforementioned approaches presented very 
interesting and unique features that were exploited for the synthesis of various 
polypropionate compounds, many strategies required access to expensivexx chiral (non-
racemic) starting materials and/or reagents.  As a result, there is a continuous demand for 
                                                 
xx Either in terms of cost and/or effort required for preparation. 
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effective protocols that are both highly efficient and cost-effective with controllable 
access to chiral (non-racemic) polypropionate compounds.   
1.3.2.  Thiopyran route to polypropionates 
Among all the strategies used for the synthesis of polypropionate compounds, the 
aldol reaction has found numerous applications and has been successfully applied for the 
total syntheses of many polypropionate natural products.105-110  While the occurrence of 
acylic aldol reactions are frequently encountered, cyclic variants are less common.  In 
particular, thiopyran-derived compounds are useful templates to facilitate access to 
polypropionate synthetic targets.111-115  An attractive strategy for polypropionate 
synthesis involves aldol reactions of tetrahydro-4H-thiopyran-4-one derivatives followed 
by desulfurization.112, 116   
During the last decade, extensive exploration of this approach was conducted by 
Ward and co-workers.116-124  Efforts to effect rapid access to stereochemically diverse 
tetrapropionate and hexapropionate synthonsxxi via iterative two-directional and 
simultaneous aldol reactions of tetrahydro-4H-thiopyran-4-one derivatives with 1,4-
dioxa-8-thispiro[4.5]-decane-6-carboxaldehyde 207 or meso/dl 1,4-dioxa-8-
thiaspiro[4.5]decane-6-10-dicarboxaldehyde 208, respectively were investigated (Scheme 
1.45.).  The challenge of selectively preparing hexapropionate 214 is revealed when 
considering the 512 possible diastereomers (i.e. 1024 possible stereoisomers).   
                                                 
xxi Defined as a structural unit within a molecule which is related to a possible synthetic operation. 
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Scheme 1.45. 
Disconnection of the carboxyl group of hexapropionate 214, functional group 
manipulations and adjustments of oxidation states provides bisaldol adducts 212 and 213, 
where the number of possible diastereomers is reduced (by design) to only 20.  For 
example, bisaldol adduct 211a was obtained by simultaneous two-directional boron-
mediated aldol coupling of thiopyranone 206 and meso dialdehyde 215 (Scheme 1.46.).  
Moreover, 11 of the 20 possible bisaldol adducts were obtained by iterative two-
directional aldol couplings of thiopyranone 206 (or silyl enol ether 218) and aldehyde 
207 (Schemes 1.47-1.51).   
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Scheme 1.51. 
Perhaps the most impressive (or unique) result was the aldol coupling of (±)-209as 
with (±)-207 that provided meso bisaldol adduct 212a in 82% yield (Scheme 1.48.).  A 
remarkable outcome considering that such a union could produce eight diastereoisomers 
(four each from the like and unlike combinations of the reactant enantiomers where the 
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like combination refers to the same absolute configurations at C-6′ of (±)-209as and C-6 
of (±)-207, while unlike refers to the opposite absolute configurations at C-6′ of (±)-
209as and C-6 of (±)-207).xxii  The aldol couplings of (±)-209 or (±)-210 with (±)-207 
offers the opportunity to exploit double stereodifferentation (DS)37-45, 125, 126 and Ward et 
al. elegantly demonstrated that reactions of β-hydroxy ketones (e.g. (±)-207) with (±)-
209 occurred with high DS and high MKExxiii, while reactions of β-alkoxy ketones (e.g. 
(±)-207) with (±)-210 occurred with low DS and low MKE.  For example, reaction of 
(±)-209as and (±)-207 gave meso bisaldol adduct 212a in 82% yield (Scheme 1.48.) 
which resulted from a combination of reactants where the absolute configurations at C-6′ 
of (±)-209as and C-6 of (±)-207 are unlike.  This aldol coupling occurred with high DS 
and MKE and the unlike reaction is remarkably diastereoselective.  Alternatively, 
reaction of (±)-210as and (±)-207 furnished two bisaldol adducts (±)-213a and (±)-213b 
in 34% and 32% yield, respectively (Scheme 1.48.).  Examination of bisaldol adducts 
(±)-213a and (±)-213b reveal that (±)-213a resulted from a like reaction while (±)-213b 
resulted from an unlike reaction.  This aldol coupling occurred with low DS and MKE 
(ca. 1.1); however, both the like and unlike reactions are remarkably diastereoselective 
(only one product from each like and unlike reactions).  Despite the low DS and MKE, 
such a result offered the opportunity to exploit double stereodifferentation for the 
synthesis of bisaldol adducts (−)-213a and (−)-213b by employing chiral (non-racemic) 
starting materials.  Indeed, Ward and co-workers were successful in selectively 
                                                 
xxii The combination of reactant enantiomers that leads to product 212 (or 213) is conveniently 
characterized by comparing the configurations at C-6′ and C-6′′ of bisaldol adduct 212 (or 213). 
xxiii Mutual kinetic enantioselection (or resolution) is the reaction between two chiral racemic compounds 
that produce chiral racemic product(s) and can be evaluated by the sum of the products resulting from a like 
combination of starting materials divided by the sum of the products resulting from an unlike combination 
of starting materials. 
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synthesizing bisaldol adducts (−)-213a and (−)-213b by reaction of (−)-209as with (S)-
207 and (R)-207 in 70% and 55% yield, respectively.  The diastereoselectivities for the 
aldol couplings of 209 and 210 were rationalized by cyclic titanium-enolates 219 and 220  
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Scheme 1.52. 
(Scheme 1.52.) and considering three stereocontrol elements; the enolate and aldehyde 
diastereoface selectivities and the aldol relative topicity.122  Aldol couplings of β-hydroxy 
ketones (209) occurred with substantial MKE and gave a major (or sole) product that 
resulted from: 1) Felkin diastereoface addition of 207 to give 1′′,6′′-syn relative 
configuration; 2) addition of enolate 219 to give 3,5-cis relative configuration; and 3) 
5,1′′-anti aldol relative topicity.  Aldol couplings of β-alkoxy ketones (210) occurred 
with low MKE that gave two products from reactions that have the same diastereoface 
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selectivity of enolate 220 (3,5-trans) and aldehyde 207 (1′′,6′′-syn) but differ in the aldol 
relative topicity (5,1′′-anti vs. 5,1′′-syn).  The effects of DS and MKE were attenuated 
using β-alkoxy ketones (210) and provided access to different bisaldol adducts.  By 
extension to the other diastereomers of 209 and 210 (Schemes 1.48-1.51.), Ward and co-
workers demonstrated that 11 of the 20 possible bisaldol diastereomers can be produced 
in 2-3 steps which should serve as a source of stereochemically diverse hexapropionate 
synthons for polypropionate synthesis. 
1.4.  Conclusions 
The development of methodologies for the total synthesis of polypropionate natural 
products embodies a very active area of research.  Many different strategies have been 
developed; however, new methodologies applying more efficient and cost effective 
strategies are required.  In particular, general methods that provide controlled access to 
any given stereoisomer.  Equally important is the development of protecting group 
chemistry that enables efficient functional group manipulations of substrates that are 
compatible with other functional groups and/or reagents. 
 
1.5.  Objectives of this thesis 
An advantage of the thiopyran template (i.e. thiopyran route to polypropionates) is 
the possibility of desymmetrization of meso (and chiral) diastereomers of bisaldol 
adducts 221 by extension of the well-established enantioselective enolization of six-
membered cyclic ketones (Scheme 1.53.).127, 128  Enantiotopic group selective processes  
  52
S S S
OH O OH
S S S
O O O
S S S
O O OO
OO OO
+ +
OO
+ +
207 207206 206 206208
desulfurize
reduce
11 of the 20 possible
diastereomers can be
obtained selectively
221
OH OH OH
O
OH OH OH
512 possible
diastereomers
214
a hexapropionate
a hexapropionate synthon
S S S
OH O OH
desymmetrize
carboxylate
O O O OTMS
chiral lithium
amide
TMSCl
222
thiopyran route to
polypropionates
aldol aldol
steps
 
Scheme 1.53. 
where the two enantiotopic groups can sequentially react are very powerful methods to 
obtain highly enantiomerically enriched products in good to excellent yields.129  The 
requirements of this approach are:  1) ease of access to Cs (or Ci) symmetric starting 
materials, 2) a group selective reaction with at least modest group selectivity (E >6:1) and 
3) ease of recycling bis-reacted material.  Ketone enolization is an ideal reaction for these 
processes because it is both synthetically useful and easily reversible.  Reversibility of 
enantiotopic group selective processes are especially important to improve the efficiency 
and efficacy of processes with modest enantioselectivities.  Enantiotopic group selective 
enolization of meso diketones was unknown until this work; however, examples of 
kinetic resolution and enantioselective desymmetrization of chiral and achiral Cs (or Ci) 
symmetric ketones by enolborination127 or by enolization with chiral lithium amides130-137 
are known (Scheme 1.54.).  Kinetic resolution and enantioselective desymmetrization are  
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Scheme 1.54. 
equivalent to an enantiotopic group selective reaction; groups on enantiomeric substrates 
are enantiotopic by external comparison, while groups on Cs (or Ci) symmetric substrates 
are enantiotopic by internal comparison.138  The requirement to apply an enantioselective 
enolborination or enolization demands access to suitably protected meso diketones.  Ward 
and co-workers established a synthetic route to a meso 1,9-diketone 233 (Scheme 1.55.) 
however, they were unable to effect enantioselective enolborination; unreacted 233 was 
recovered after treatment with (−)-Ipc2BCl and sparteine.121  Alternatively,  
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1) DIBAL-H, 231
2) KH, MeI, 232
3) Amberlyst® 15
62% yield S S S
Me
O
Me
O
Me
O
meso 233
O O
 
Scheme 1.55. 
  54
enantioselective enolization of meso 233 could be achieved by reaction with chiral 
lithium amide (CLA) 230 and TMSCl.  . The research objectives in this thesis were:   
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Scheme 1.56. 
 
1) establishment of an efficient process (i.e. including recycling) for the enantioselective 
enolization of meso 1,9-diktone 233, 2) determination of the absolute configuration of the 
resulting mono-silyl enol ether, 3) desulfurization of a hexapropionate synthon and 4) 
application of the developed methodology (i.e. thiopyran route to polypropionates) for 
the asymmetric synthesis of (−)-denticulatin A (Scheme 1.56.) 
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CHAPTER 2 
2.  RESULTS AND DISCUSSION 
2.1.  Enantioselective desymmetrization 
During the last several decades, there has been increasing interest in the preparation 
of enantiomerically pure compounds because of their biological and agricultural roles.  
There are three fundamentally different approaches for the preparation of 
enantiomerically pure compounds:  1) the use of enantiopure starting materials provided 
by Nature (i.e. the chiral pool), 2) separation of enantiomers by chemical or physical 
means (i.e. resolution) and 3) preparation from achiral starting materials using chiral 
reagents or chiral catalysts (i.e. 'asymmetric synthesis').139  The asymmetric synthesis of 
enantiomerically pure compounds from Cs (or Ci) symmetric or meso starting materials 
(i.e. enantioselective desymmetrization) is proving to be a powerful synthetic tool.140  In 
order to effect such transformations, chiral reagents or chiral catalysts are required to 
differentiate enantiotopic faces or groups present in the reactant.141  While many of the 
methods developed involve enantiotopic face selective reactions, non-enzymatic142 
examples involving group selective reactions are less common.   
2.1.1.  Sequential enantiotopic group selective desymmetrization 
Enantiotopic group selective reactions can be classified into two types:  1) external 
group selective processes (i.e. kinetic resolution) and 2) internal group selective 
processes (i.e. enantiotopic group selective desymmetrization).143  An interesting feature 
of processes where the enantiotopic groups can react sequentially is the coupling of an 
enantiotopic group selective desymmetrization (i.e. 'asymmetric synthesis') with a kinetic 
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resolution to produce products with enhanced levels of enantiopurity (Scheme 2.1.).121, 
129, 144-146  One of the earliest examples of a sequential enantiotopic group (SEG)  
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Scheme 2.1. 
selective desymmetrization was reported by Sugimoto and co-workers where they 
demonstrated oxidation of achiral aromatic sulfides with NaIO4 and H2O2 in the presence 
of bovine serum albumin (Scheme 2.2.).147  More recently, Nelson and co-workers  
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Scheme 2.2. 
achieved a catalytic desymmetrization of Ci symmetric bis-epoxide 242 by enantiogroup 
selective epoxide hydrolysis using Jacobsen's chiral salen catalyst 241 during their work 
  57
towards the synthesis of an advanced intermediate for the total synthesis of 
hemibrevetoxin B (Scheme 2.3.).148, 149  Other examples involving catalytic benzoylation  
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Scheme 2.3. 
and silylation of cyclic meso diols have also recently appeared (Scheme 2.4.).150, 151   
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Scheme 2.4. 
While these recent examples illustrated the benefits of coupling an enantiotopic group 
selective desymmetrization with a kinetic resolution, convenient and cost effective 
  58
methods for the preparation of stereochemically complex and multifunctional substrates 
are still unknown.   
The requirements for any successful SEG selective desymmetrization necessitate 
the ease of access to Cs (or Ci) symmetric starting materials and a group selective reaction 
with at least a modest group selectivity (s >6:1).  Furthermore, a group selective reaction 
where the bis-reacted material can be easily recycled is especially important for those 
reactions that proceed with modest selectivity.  The benefits of SEG selective 
desymmetrizations are readily illustrated using the well-known theoretical framework for 
such processes.  Figure 2.1. illustrates the calculated129 results for a hypothetical process 
(Scheme 2.1.) where the enantiotopic group selectivity (s = k1/k2) is 6.  The yield of 
products (P+Q) rises and then decreases as the yield of B increases. However, the 
enantiopurity of the intermediate product (P+Q) continuously increases with conversion 
to reach any arbitrarily high ratio of P/Q.  In this case, the maximum yield of 
desymmetrized product (P+Q) is 66% with 87% ee (P/Q = 14).  In principle, higher levels 
of enantiopurities can be reached with an appropriate sacrifice in yield.  For this example, 
the same reaction at higher conversion provides 50% yield of desymmetrized product that 
is 97% ee.  The exploitation of the ee enhancement feature of SEG selective 
desymmetrizations can be successfully achieved with reactions possessing only modest 
group selectivity; provided the bis-reacted material can be efficiently recycled.   
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Figure 2.1.  Calculated mole fractions of products and ee produced in a hypothetical 
reaction with an enantiotopic group selectivity (s = k1/k2) of 6. 
(i.e., assuming k1 = k4; k2 = k3). 
2.1.2.  Chiral lithium amides 
In 1980, Whitesell and Felman reported the first example of an enantioselective 
deprotonation of a cyclic meso epoxide to give allylic alcohol 252 using chiral lithium 
amides (CLA) (Scheme 2.5.).152  The preferred mechanism involves an initial 
coordination of the CLA followed by a syn β-elimination of the enantiotopic pseudo-axial 
protons (i.e. external comparison) of the two enantiomeric conformers 252 and ent-252.  
Since this initial report, the enantioselective deprotonation of achiral Cs symmetric 
substrates has resulted in the development of methodologies for the synthesis of a wide 
range of natural products and other optically active materials.128  For example, the 
enantioselective enolization of achiral Cs symmetric cyclic ketones has developed into a  
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Scheme 2.5. 
very powerful strategy for several applications to natural product synthesis.137, 153-157  For 
conformationally locked cyclohexanones, there is a stereoelectronic preference for the 
removal of the axial protons (Scheme 2.6.).128  The effect of adding lithium chloride was  
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Scheme 2.6. 
shown to enhance the levels of enantioselectivities and is believed to occur through 
reaction of a different  aggregated form of the chiral lithium amides (Figure 2.2.).  In 
general, optimal levels of enantioselectivities were observed via internal quench 
conditions (lithium chloride pre-mixed with chiral lithium amide during addition to a 
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solution of ketone and TMSCl)158-161 where the mixed dimer 256 is implicated for the 
more enantioselective processes.   
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Figure 2.2.  Aggregate solution structures of chiral lithium amides. 
While chiral lithium amides were successfully used for the enantioselective 
enolizations of various achiral Cs symmetric ketones,128 kinetic resolution of chiral 
ketones are much less frequent.  Koga and co-workers demonstrated kinetic resolution of 
2-substituted cyclohexanones and established protocols to provide enantioenriched 
ketones in good yields and enantiopurities (Scheme 2.7.).135  Although enantioselective  
O
R1
R2
R3
CLA
HMPA, TMSCl
THF
O
R1
R2
R3
OTMS
R1
R2
R3
+
R1 R2 R3
a
b
c
d
e
f
t-Bu
Ph
i-Pr
Me
Me
i-Pr
H
H
H
H
t-Bu
H
H
H
H
H
H (cis)
Me (t rans)
(±)-258a-f
(S)-259a, b, c
(R)-259d
(2R,4R)-259e
(2S,5R)-259f
(R)-260a, b, c
(S)-260d
(4S ,6S)-260e
(3S,6R)-260f
42-45% yield
>90% ee
33-52% yield
>90% ee
 
Scheme 2.7. 
enolization of achiral Cs symmetric and racemic ketones is well-established, there are no 
examples of enantioselective enolization of achiral meso diketones, where two 
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independently activated enantiotopic axial hydrogens can react sequentially and thereby 
exploit the ee enhancement feature of a SEG selective enolization.   
2.1.3.  Model study 
With the requisite access to a meso 1,9-diketone 233 established (Scheme 1.55., 
Section 1.4.), the synthetic potential of a sequential enantiotopic group selective 
enolization using a chiral lithium amide can be investigated (Scheme 2.8.).  While there 
are more than twenty chiral lithium amides available,128 chiral lithium amide 230 (or ent-
230) was chosen because the precursor amine  is commercially available and has been 
successfully used in numerous enantioselective enolizations of Cs symmetric ketones. 
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Scheme 2.8. 
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2.1.3.1.  Synthesis of meso 1,9-diketone 233 
While the established procedure for the preparation of meso 212a was sufficient to 
carry out this study, several key improvements were accomplished during the course of 
this work.  For example, meso bisaldol adduct 212a was previously prepared by aldol 
coupling of (±)-207 with the lithium enolate of 206 generated by reaction of 218 with 
methyllithium, followed by a second aldol coupling of the resulting aldol adduct (±)-
209as with (±)-207 (Scheme 2.9.).  The two-step sequence provided meso bisaldol adduct 
212a in 42% yield; an impressive result considering that six stereocenters are formed in  
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Scheme 2.9. 
only two reactions.  The required aldehyde (±)-207 was prepared following a modifiedxxiv 
Swern oxidation162, 163 of alcohol (±)-263 (Scheme 2.10.);118 however, the yield often 
varied  (ca. 10-80%) and was especially problematic on larger scales (i.e. 5-20 g).  The 
addition of dimethyl sulfide was believed to reduce chlorination (i.e. via chloride 
exchange) of cyclic sulfide (±)-264 or Swern activated (±)-266 and attenuate the 
formation of decomposition productsxxv (Scheme 2.10.).  While this method was 
amenable up to ca. 1 g scale, yields at higher scales varied and could be extremely poor 
at 10 g of (±)-263 (i.e. <30% yield of aldehyde (±)-207 with no recovered  
                                                 
xxiv Addition of 1.0-2.0 equiv of dimethyl sulfide with (±)-263 during addition to Swern reagent. 
xxv The significant challenge to optimize this reaction was the absence of any appreciable amounts of 
decomposition product(s) in the crude material after work-up.  This implies that they are water-soluble or 
volatile materials and as a result the only measurement for optimization was the crude mass recovery. 
  64
S
OHOO i) DMSO
ii) (COCl)2
(±)-263
S
OOO
(±)-207
10-80%
yields
S
OOO
S
OHOO
Cl
S
decomposition
iii) i-Pr2EtN
S
OOO S
Cl
DMS
DMS
(±)-264
(±)-265
(±)-266
 
Scheme 2.10. 
starting material).  After considerable experimentation,xxvi it was discovered that 
replacing dimethyl sulfide with 1 equiv of i-Pr2EtN during the addition of the aldehyde to 
the Swern reagent consistently provided a 85-89% yield of aldehyde (±)-207, 
accompanied with 3-5% yield of recovered alcohol (±)-263 on 1-25 g scales  This result 
suggests that the decomposition products result from the presence of HCl during the 
Swern activation of alcohol (±)-263 (Scheme 2.11.).  Surprisingly, the presence of i-
Pr2EtN does not destroy the Swern reagent.  This implies that the rate of Swern activation 
of alcohol (±)-263 is faster than destruction of Swern reagent.  Thus, this example 
represents a very mild procedure for oxidation of sensitive compounds.  It would be 
interesting to see whether this modification would benefit other difficult oxidations.164   
 
                                                 
xxvi Reaction optimizations were performed on ca. 1 g of (±)-263. 
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With access to a scaleable and convenient method for the preparation of aldehyde 
(±)-207, the first aldol reaction was investigated.  Ward and co-workers recently 
demonstrated the enantioselective synthesis of chiral (non-racemic) aldol adduct (−)-
209as by (S)-proline (or 217) catalyzed direct aldol reaction of ketone 206 with aldehyde 
(±)-207 that occurred with dynamic kinetic resolution (Scheme 2.12).111, 120  Similarly,  
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Scheme 2.12. 
the synthesis of (±)-209as can be prepared from 206 and (±)-207 using rac-proline.xxvii  
Interestingly, the synthesis of aldol adduct (±)-209as can be prepared via proline 
                                                 
xxvii Investigations done concurrently and in collaboration with Dr. Vishal Jheengut. 
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catalyzed aldol reaction under solvent-free conditions facilitated by sonication and/or 
acid additives.  Solvent-free aldol reactions of 206 and (±)-207 were investigated by 
varying the amount of added water, time, temperature and under sonication with rac-
proline (Table 2.1.).  While aldol reactions of 206 and (±)-207 at room temperature or 38 
°C did not provide any significant amounts of aldol adducts (entries 1 and 2), under 
sonication aldol adducts were observed (entries 5 and 8).  The presence of water has been 
reported165, 166 to have a beneficial affect for enantio- and diastereoselectivities for proline 
catalyzed reactions; however, excess water appears to completely inhibit the reaction at 
22 °C and 38 °C under sonication (entries 6 and 7).  In light of these results, the amount 
of water was reduced to 2 equiv which resulted in high conversion and high 
diastereoselectivity of aldol adduct (±)-209as (entry 8).   
Table 2.1.  Rac-proline catalyzed aldol reaction of 206 with (±)-207. 
entrya 206 
(equiv) 
H2O 
(equiv) 
sonication 
time (d) 
total 
time (d) 
temp 
(°C) 
conversionb 
(%) 
dec 
(%) 
1 1.5 5 0 2 22 0  
2 1.5 5 0 1 38 5 >95 
4 1.5 5 2 4 22 0 0 
5 1.5 5 1 2 38 42 90 
6 1.5 10 2 4 22 0  
7 1.5 10 1 1 38 0  
8 1.5 2 3 3 38 94 93 
a Reactions with (±)-207 (ca. 0.5 mmol) and (S)-proline (0.5 equiv).  b Conversion with respect to (±)-207.  
c Calculated from the ratio of 209as:209ss by 1H NMR analysis of crude reaction mixture.   
 
Interestingly , aldol reaction of 206 with (±)-207 using (S)-proline (Table 2.2.) according 
to the optimized conditions for rac-proline (entry 8, Table 2.1.) furnished nearly racemic 
aldol adduct (±)-209as.  At this point, it was decided that further optimizations would be  
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Table 2.2.  (S)-proline catalyzed aldol reaction of 206 with (±)-207. 
entrya 206 
(equiv) 
H2O 
(equiv) 
sonication 
time (d) 
total 
time (d)
temp 
(°C) 
conversionb 
(%) 
dec eed 
(%) 
1 1.5 0 0 7 22 0   
2 1.5 0 2 2 22 0   
4 1.5 0 3 3 38 86 86 13 
5 3 0 3 3 38 96 83 6 
6 6 0 3 3 38 96 92  
7 1.5 1 3 3 38 92 93 11 
8 1.5 2 3 3 38 90 88 13 
9 3 2 3 3 38 93 89  
10 6 2 3 3 38 88 92  
11 1.5 4 3 3 38 75 90 17 
12 3 4 3 3 38 78 88  
13 6 4 3 3 38 83 90  
14 1.5 8 3 3 38 44 >95  
15 1.5 2 1 1 38 34 >95  
16 1.5 2 1 2 22 42 >95  
17 1.5 2 1 4 22 65 >95  
a Reactions with (±)-207 (ca. 0.5 mmol) and (S)-proline (0.5 equiv).  b Conversion with respect to (±)-207.  
c Calculated from the ratio of 209as:209ss by 1H NMR analysis of crude reaction mixture.  d ee was 
calculated assuming a linear correlation of optical purity and enantiomeric excess; [α]D (max) for (−)-209as 
= −47 at ambient temperature (ca. 23 °C), c = 1.0, CHCl3. 
 
conducted using (S)-proline as this would offer a more economicalxxviii approach for the 
preparation of aldol adduct (±)-209.  Additional optimizations involving varying the 
amount of ketone, water, time and temperature under sonication gave results essentially 
identical to those obtained with rac-proline (entry 7, Table 2.2. vs. entry 8, Table 2.1.).  
The low enantiopurity along with the high diastereoselectivity was intriguing and 
prompted a time-course study to investigate any conversion dependency of the 
enantioselectivity (Table 2.3.).  Indeed, higher enantiopurities of (−)-209as were higher at 
low conversion which suggests a possible kinetic resolution mechanism.167-169  The 
presence of water clearly enhances the enantiopurity of the aldol adduct, while the 
diastereoselectivities obtained with 1-4 equiv of water were quite similar.   
                                                 
xxviii (S)-proline is ca. 40× cheaper than its racemate.  
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Table 2.3.  Time course study of (S)-proline catalyzed aldol reaction of 206 with (±)-
207. 
entrya H2O 
(equiv) 
sonication 
time (d) 
total 
time (d) 
temp 
(°C) 
conversionb 
(%) 
dec  
(%) 
eed 
(%) 
1 0 0.5 0.5 38 43 87 21 
2 0 2 2 38 86 86 13 
3 1 0.5 0.5 38 27 >95 55 
4 1 1.5 1.5 38 50 >95 47 
5 1 3 3 38 92 93 11 
6 2 0.5 0.5 38 23 >95 64 
7 2 3 3 38 90 88 13 
8 4 0.5 0.5 38 13 >95 77 
9 4 2 2 38 57 92 43 
10 4 3 3 38 75 90 17 
a Reactions with (±)-207 (ca. 0.5 mmol), 206 (1.5 equiv) and (S)-proline (0.5 equiv).  b Conversion with 
respect to 207.  c Calculated from the ratio of 209as:209ss by 1H NMR analysis of crude reaction mixture.  
d ee was calculated assuming a linear correlation of optical purity and enantiomeric excess; [α]D (max) for 
(−)-209as = −47 at ambient temperature (ca. 23 °C), c = 1.0, CHCl3. 
 
This result suggests that aldehyde (±)-207 does not readily isomerize under solvent free 
conditions compared to the aldol reaction.  Addition of bases to the reaction mixture 
dramatically reduced the diastereoselectivities with no effect on enantiopurities (entries 1 
and 2, Table 2.4.).  For example, the addition of imidazole resulted in an equilibrium ratio 
for 209as:209ss of 1:1.5, with both aldol adducts in low enantiopurity (entry 2).  
However, the addition acetic acid facilitated the aldol reaction without the requirement of 
sonication at room temperature or 38 °C (entry 4).  Adapting the reaction conditions in 
entry 4 (Table 2.4.), nearly racemic 209as (<20% ee) was obtained in 90% yield on gram 
scale.  This procedure has several advantages over the previously reported lithium-
enolate procedure.118  It is simple and cost effective and the requirements of low 
temperatures and inert atmosphere are avoided.  Lastly, the aldol adduct (±)-209as can be 
obtained by simple trituration of the crude reaction mixture allowing the procedure to be 
easily performed on multigram scales.   
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Table 2.4.  (S)-proline catalyzed aldol reaction of 206 with (±)-207 with acid or base 
additives.a 
entrya additive 
(equiv) 
sonication 
time (d) 
total 
time 
(d) 
temp 
(°C) 
conversionb 
(%) 
dec 
(%) 
[α]Dd 
1 Bu3N (1.0) 3 3 38 79 69 −7 
2 imidazole (1.0) 3 3 38 83e  −7f 
3 AcOH (0.3)  2 22 56 >95 −12 
4 AcOH (0.3)  2 38 98 >95 −9 
a Reactions with (±)-207 (ca. 0.5 mmol), 206 (1.5 equiv), water (2.0 equiv) and (S)-proline (0.5 equiv).  b 
Conversion with respect to (±)-207.  c Calculated from the ratio of 209as:209ss by 1H NMR analysis of 
crude reaction mixture.  d At ambient temperature (ca. 23 °C); c = 1.0, CHCl3; [α]D (max) for (−)-209as = 
−47.  e Equilibrium ratio for 209as:209ss (1:1.5).  f [α]D +8 for (+)-209ss; [α]D for ent-209ss of 90% ee:  
[α]D −48, c = 1.3, CHCl3).119 
 
The second aldol coupling of (±)-209as with (±)-207 was accomplished according 
to the reported titanium-enolate method using i-Pr2EtN/TiCl4.117  While this procedure 
furnished meso bisaldol adduct 212a (Scheme 2.9.) in 40-60% yields, further 
improvements were attained using i-Pr2EtN/(i-OPr)TiCl3170 that provided yields of 78-
85% on multigram scales (Scheme 2.13.).  As noted earlier (Section 1.3.2.), this is an  
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Scheme 2.13. 
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impressive (perhaps unique) result whereby the coupling of two racemic reactants 
furnished a meso product.  Finally, the synthesis of the desired meso diketone for the 
SEG enolization study was achieved by a reduction, protection and deprotection sequence 
on meso bisaldol adduct 212a that furnished meso 1,9-diketone 233 (Scheme 2.13.).  This 
synthetic route provided the rapid assembly of stereochemically complex hexapropionate 
synthons (i.e. meso bisaldol adduct 212a and meso 1,9-diketone 233; 6-7 stereocenters) 
on multigram scale and should be applicable to a number of synthetic endeavors. 
 
2.1.3.2.  Sequential enantiotopic group selective enolization of meso 1,9-diketone 233 
Enantioselective enolization of meso 1,9-diketone 233 was successfully achieved 
by deprotonation with 230 (Scheme 2.14.).121  The yield and ee of 261 are dependent on  
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Scheme 2.14. 
the reaction enantioselectivity and conversion.129  The reaction of 233 with 230 was 
analyzed at various conversions by rapid cannulation of a THF solution of 230 (0.5-2 
equiv) at −78 °C to a THF solution of 230 (0.2-0.3 mmol) and TMSCl (10 equiv) at −100 
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°C (Table 2.5.).  Under these optimized conditions,xxix 261 was obtained in 78% yield 
with >98% ee.  Using similar conditions, reactions using 230 were more selective than 
those using 230⋅LiCl159, 161, 171 (entries 2 and 6).  The expected feature of ee enhancement 
with increased conversion is evident (entries 1-3; 4, 6 and 8).  At low conversions, the er 
of 261 should approximate the enantiotopic group selectivity for the reaction.129  
Reactions using small amounts of 230 or 230⋅LiCl (entries 1 and 4) performed poorly,  
 
Table 2.5.  Enantioselective enolization of 233 with 230/TMSCl. 
isolated yields (%) entrya 230 
(# equiv) 
1H NMR ratiob 
233:261:262 233 261 (%ee)c 262 
1 0.5d 71:26:3 70 22 (86) 3 
2 1.0d 16:69:12 20 61 (90) 12 
3 1.4d 2:74:24  73 (92)  
4 0.5 86:14:0 78 15 (81)  
5 1.2 52:46:10    
6 1.3 26:67:8 25 61 (94) 8 
7 1.4 14:76:9    
8 1.5 4:80:15  78 (98)  
9 1.7 0:62:38  58 (>98) 34 
a A THF solution of 230 or 230⋅LiCl was rapidly cannulated (ca. 30 sec) to a THF solution of 233 (0.2-1.5 
mmol) and TMSCl (10 equiv) at −100 °C.  b Crude products after work-up.  c Determined by 1H NMR in 
the presence of (+)-Eu(hfc)3/CF3CO2Ag.  d Using 230⋅LiCl. 
 
giving 261 in low ee accompanied by an amount of 262 that far exceeded expectations.  
That is, the product distributions in entries 1 and 4 are similar to a nonselective reaction 
(e.g. using LDA as base).  By contrast, a reaction with an enantiotopic group selectivity 
of 9:1 would not be expected to give 3% of the bis-product until ca. 50% conversion.129  
                                                 
xxix Reactions conducted at −78 °C were very capricious and much less enantioselective.  Slow addition of 
230 was less enantioselective.  External quench (i.e. addition of TMSCl after addition of 230) gave 
considerably lower conversions. 
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In order to establish the reaction selectivity,xxx the experimental data was compared to 
those calculated for an idealized group selective process at various enantiotopic group 
selectivities (s) and mole fractions (χ) according to the equations 2.1.-2.4.129   
χ261 = χ2331/s + 1 − χ233 
 
(eq 2.1.) 
χent-261 = χ233s/s + 1 − χ233 
 (eq 2.2.) 
χ262 = 1 − χ233 − χ261 − χent-261 
 (eq 2.3.) 
ee = (χ261 − χent-261)/(χ261 + χent-261) 
 (eq 2.4.) 
The observed product distributions (261 and 262) and ee of 261 formed in the reaction of 
233 with 230 correspond closely with those predicted from a model reaction with an 
enantioselectivity of ca. 17:1 (Figure 2.4.).  Although an enantioselectivity of 17:1 is  
 
 
                                                 
xxx Assuming the enantiotopic carbonyl groups underwent enolization independently (i.e. Scheme 2.8., s = 
k1/k2; k1 = k4, k2 = k3). 
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Figure 2.4.  Calculated and observed mole fractions of 261 (?) and 262 (?) and ee of 
261 (?) produced in the reaction of 233 with 230/TMSCl as a function of 
conversion of 233. 
(i.e., assuming s = 19 (---), s = 17 (⎯) and s = 15 (− −)). 
lower than that observed for deprotonation of Cs symmetric cyclohexanones under similar 
conditions,128 261 is easily obtained with greater enantiopurity because of the ee 
enhancement feature of SEG desymmetrizing reactions.  The lower selectivity may result 
because the initial coordination of lithium amide to ketone is an enantioselective step for 
meso 1,9-diketone 233 (kon) (Scheme 2.15.) but not for Cs symmetrical ketone 268 
(Scheme 2.16.).xxxi  If the enantioselectivity for the coordination step is lower than that 
for the deprotonation step (as expected), then dissociation (koff) of the complex must be 
much faster than deprotonation to prevent attenuation of the overall enantioselectivity.   
                                                 
xxxi The only enantioselective step for Cs symmetrical ketones is the deprotonation of the axial α-hydrogen. 
0.              0.5                                     0.9            0.95                                 0.99
t 233
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Scheme 2.16. 
Reactions of 233 with 230 under the optimized conditions gave the corresponding mono-
silyl enol ether 261 in good yields and with excellent enantiopurities.  This process is 
extremely efficient (>90% yield based on recovered diketone 233) as bis-silyl enol ether 
262 is easily recycled to diketone 233 on treatment with HF(aq) (>95% yield) (Scheme 
2.14.). 
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2.1.3.4.  Determination of absolute configuration 
The absolute configuration of 261 was determined by 1H NMR analysis of the (R)- 
and (S)-O-acetylmandelate esters 272 and 273 of the derived alcohol 271 (Scheme 2.17  
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Scheme 2.17. 
 
Table 2.6.  1H NMR chemical shifts for 272 and 273.a 
(R)
S S S
O
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O
Me
O
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OO
2
35
62''6''
5'' 1'
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1''
O
(S)AcO
Ph
 
273 
(R)
S S S
O
Me
O
Me
O
Me
OO
2
35
62''6''
5'' 1'
2'
5'
6'
1''
O
(R)AcO
Ph
 
272 
proton δ for 273 δ for 272 Δδ (273−272) 
HC-5'' (α) 1.77 1.89 −0.12 
HC-5'' (β) 2.03 2.36 −0.33 
HC-4'' 5.08 4.97 +0.11 
HC-3'' 2.23 2.13 +0.10 
HC-1'' 2.90 2.16 +0.74 
HC-5 1.77 1.44 +0.33 
HC-4 3.96 3.71 +0.25 
HC-3 1.77 1.61 +0.16 
HC-3' 2.71 2.68 +0.03 
HC-1' 4.00 3.95 +0.05 
H3COC-1'' 3.41 2.94 +0.47 
H3COC-4 3.45 3.32 +0.13 
H3COC-1' 3.31 3.29 +0.02 
a In cases where assignment of δH was difficult because of overlapping signals in the 1H NMR, HSQC cross 
peaks were used to assign the δH value. 
 
and Table 2.6.).172  The 3'',4''-cis relative configurations for 271, 272 and 273 were 
assigned based on the appearance of HC-4'' as a broad singlet (all J's <3 Hz) in the 1H 
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NMR spectra.  The NMR assignments for 272 and 273 (Table 2.6.) were based on 
chemical shifts and multiplicity were confirmed by 1D and/or 2D heteronuclear 
correlation experiments (i.e. gsCOSY, gsHSQC and/or gsHMBC).  Accordingly, the 
signs of the observed Δδ's indicated that the absolute configuration at C-4'' was (R) when 
using chiral lithium amide 230 (Figure 2.5.).172  The formation of 261 involves  
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Figure 2.5. Model for establishing the absolute configuration of 261. 
 
preferential abstraction of the axial pro-(S)-hydrogen from the α-methylene group from 
233 as expected considering the known173 enantioselectivity for deprotonation of Cs 
symmetrical cyclohexanones with 230 (Scheme 2.18.).   
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Scheme 2.18. 
2.1.3.5.  Desulfurization of hexapropionate synthon 271 
With access to an enantiomerically enriched hexapropionate synthon (i.e. ketol 
271), demonstration of the thiopyran route to polypropionates was accomplished by 
desulfurization of ketol 271 using Raney Ni (Scheme 2.19.).  Oxidation of acyclic ketol 
278 gave meso 279, indicating that desulfurization had occurred without loss of 
stereochemical integrity.   
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Scheme 2.19. 
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In summary, enantiotopic group selective enolization of meso 1,9-diketone 233 
occurs with simultaneous kinetic resolution to give mono-silyl enol ether 261 with 
enhanced enantiopurity and in excellent overall yield.  The thiopyran route to 
polypropionates can be applied for the asymmetric synthesis of stereochemically complex 
natural products.  For example, by strategically synthesizing a suitably protected meso 
1,9-diketone from readily available meso bisaldol adduct 212a, application of a SEG 
selective enolization followed by desulfurization permits access to enantioenriched 
hexapropionate synthons that could be used for the synthesis 6-deoxyerythronolide B  
sequential enantiotopic
group selective enolization
S S S
OR OR OR
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S S S
OR OR ORO O O
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ent-230
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+
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OHOH O OH
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(seco acid)
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carboxylate
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S S S
OH O HOOO OO
desulf urize
 
Scheme 2.20. 
(Scheme 2.20.)31, 54, 174.  In fact, meso 1,9-diketone 281 was prepared and desymmetrized 
as above to obtain 282, an intermediate towards 6-deoxyerythronolide B (Scheme 
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2.21.).xxxii  Extending the same principle to 1,9-diketones derived from chiral (non-
racemic) bisaldol 212e permits an opportunity for application of a sequential  
S
MOM
O
S S
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O
4 steps
40% yield
O O
S
MOM
O
S S
MOM
OO OTMS
281 282
69% yield
(>90% BORSM)
96% ee
meso 212a
230
TMSCl
6-deoxyerythronolide B 127  
Scheme 2.21. 
diastereoselective group selective enolization that would allow access to additional 
polypropionate natural products (Scheme 2.22.).  Indeed, demonstration of this approach 
was established by the reaction of 1,9-diketone 287 with 230 and TMSCl (Scheme 
2.23.).xxxiii  The thiopyran route to polypropionates offers the opportunity to access tetra- 
and hexapropionate synthons for the asymmetric synthesis of various targets.  Enantio- 
and/or diastereoselective enolization of meso 1,9-diketones provides access to 
enantioenriched materials that can accommodate many synthetic endeavors.   
                                                 
xxxii Work done by Dr. Mohammed A. Rasheed. 
xxxiii Work done by Mr. Garrison Beye. 
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2.2.  Synthetic studies towards the asymmetric synthesis of (−)-denticulatin A 
The denticulatins (Section 1.2.1.) represent an ideal polypropionate natural product 
that could be synthesized via the thiopyran route (Scheme 2.24.).  The previous syntheses 
involved fragment coupling of chiral (non-racemic) fragments where an aldol reaction 
found several successful applications.  While Ziegler and Hoffman had problematic 
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7
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denticulatin B (10-R)-10
O
O O
OH
OH H
10
7 intramolecular
ketalization
290
 
Scheme 2.24. 
deprotection of hydroxyl protecting groups towards the end of their syntheses, Paterson 
and Oppolzer were successful with the deprotection and subsequent cyclization of di-tert-
butylsilylene triketone 290 for their syntheses of the denticulatins.  As a result, triketone 
290 emerges as an ideal target for application of the thiopyran route and it was decided to 
evoke the recently developed sequential enantiotopic group selective enolization to gain 
access to a hexapropionate synthon that would demonstrate the thiopyran route as a 
viable approach. 
2.2.1.  Synthetic plan 
It was envisioned that triketone 290 could be prepared via an alkylation-
desulfurization-oxidation strategy employing a suitably protected ketone 292 (Scheme 
2.25.).  The required 10,12-trans relative configuration would be controlled by the 
corresponding fixed trans enolate of ketone 292, while access to ketone 292 would result 
from an enantioselective enolization of meso 1,9-diketone 294 using ent-230.  The 
required relative configuration at C-7 would be controlled by a stereoselective reduction 
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of readily available meso bisaldol 212a.  While there is some flexibility for hydroxyl 
protecting groups, this approach demands access to a substrate where the cyclic di-tert-
butylsilylene protecting group can be installed at C5-OH and C7-OH.  The required diol 
could be obtained from the protected meso trihydroxydiketone 294 with orthogonal R1 
and R2 protecting groups.  After a desymmetrization and alkylation followed by a 
reduction and R1 deprotection sequence, a 5,9,11-triol would result that allows isolation 
of the C5-OH group; for example, acetonide formation on the 9,11-diol.  Subsequent 
removal of the R2 protecting group at C-7 would reveal a 5,7-diol and allow installation 
of the desired silylene protecting group. 
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Scheme 2.25. 
2.2.1.1.  Synthesis of meso 1,9-diketones 
Two conceptually different approaches were attempted for the synthesis of meso 
1,9-diketone 294.  The first approach involved the initial reduction of meso 212a using 
Et2BOMe/NaBH4 that gave the desired all syn triol in 70% yield as a single diastereomer 
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(Scheme 2.26.).  The relative configuration of 297 was unambiguously established by X-
ray crystallography (Figure 2.6.).xxxiv  The next step involved exposure of syn triol 297 to  
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7
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Scheme 2.26. 
 
Figure 2.6. ORTEP diagram of syn triol 297. 
 
FeCl3⋅SiO2175, 176 in acetone at room temperature for 2 hours that furnished acetonide 298 
in 74% yield (Scheme 2.27.).  Ketal deprotection of 298 using identical conditions but  
                                                 
xxxiv The numbering system according to the denticulatins (Scheme 2.24.) will be used in this section. 
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Scheme 2.27. 
under reflux for 1 hour provided 299 in >95% yield.  This transformation was simplified 
as 299 can be obtained in a one-pot sequence from syn triol 297 in 70% yield (Scheme 
2.27.).  At this stage, it was necessary to establish conditions that would remove the 
acetonide of 299.  Successful deprotection of the acetonide in 299 would enable the 
differentiation of the C5-OH/C9-OH from the C7-OH by internal acetal formation 
(Scheme 2.28.).111  However, attempted deprotection of acetonide 299 under various  
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Scheme 2.28. 
conditions (e.g. H+/THF(aq) or H+/MeOH) failed to yield the desired product and this 
approach was eventually abandoned.  Alternatively, regioselective protection of syn triol 
297 by reaction with MOMCl and i-Pr2EtN in the presence of n-Bu4NI for 2 days 
provided meso bis-MOM alcohol 303 in 70% yield; however, allowing the reaction to 
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extend to 3 days furnished 302xxxv in 74 % yield (Scheme 2.29.).  Subsequent benzylation 
of meso bis-MOM alcohol 303 using KH/BnBr gave 304 in 93% yield.   
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Scheme 2.29. 
The next step required ketal deprotection of 304 to provide a protected meso 1,9-diketone 
for the enantioselective enolization.  This was accomplished by subjection of 304 to 
FeCl3⋅6H2O175 in 20% acetone in dichloromethane for 4 hours that resulted in a mixture 
of MOM protected and hydroxy diketones that upon re-installation of the MOM groups 
                                                 
xxxv Attempts to recycle tris-MOM 302 failed to provide syn triol 297. 
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provided 306 in 54 % yield (Scheme 2.29.).  Alternatively, reaction of 304 with 
FeCl3⋅SiO2176 in acetone at reflux furnished diol diketone 307 in 55% yield that upon 
MOM protection provided the desired meso bis-MOM diketone 306 in 60% yield.  
Interestingly, this reaction also produced the methylidene acetal 305 in 45% yield.  
Although 305 was an unexpected product for this reaction, there is an example where the 
formation of a methylidene acetal resulted from the deprotection of a MOM protected 
substrate using similar conditions.175  Presumably, 305 resulted from the cyclization of a 
free hydroxyl onto the oxonium ion intermediate resulting from hydrolysis of the second 
MOM group (Scheme 2.30.). Although both 305 and 306 could potentially be used for  
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Scheme 2.30. 
the enantioselective enolization, they were insufficiently soluble in numerous organic 
solvents, including THF.  The low solubility likely contributes to the poor yields for the 
preparation of meso 1,9-diketone 306 (Scheme 2.29.).  As an alternative, exposure of diol 
diketone 307 to TESOTf and 2,6-lutidine provided meso bis-silyl 1,9-diketone 308 in 
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83% yield (Scheme 2.29.) that proved to be soluble in THF and represents a suitably 
protected substrate for subjection to an enantioselective enolization.  In light of this 
result, access to diol diketone 307 was slightly modified as syn triol 297 was allowed to 
react with TMSCl and i-Pr2EtN for 2 days that furnished meso bis-silyl alcohol 312 in 
85% and meso mono-silyl diol 311 in 15% (Scheme 2.31.).  Fortunately, recycling of 297  
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Scheme 2.31. 
was efficiently achieved by treatment of 311 with HF(aq) that gave syn triol 297 in near 
quantitative yield.  Benzylation of 312 using KH/BnBr furnished 314 in 81% yield and 
bis-benzylated 313 in 15% yield; the latter was recycled to syn triol 297 under Birch 
conditions (e.g. Li/NH3) in quantitative yield.  This protocol for the synthesis of 314 is 
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very efficient as both by-products resulting from silylation and benzylation (i.e. 311 and 
313) are quantitatively converted back to starting syn triol 297.  The overall yield of 314 
is 94% based on recovered starting syn triol 297 over a total of four steps (average yield 
per step >98%).  A one-pot silyl and ketal deprotection of 314 using FeCl3⋅6H2O 
provided diol diketone 307 in 93% yield that was converted to the bis-TES ether 308 by 
treatment with 2,6-lutidine and TESOTf (Scheme 2.29.).xxxvi   
2.2.1.2.  Sequential enantiotopic group selective enolization of meso 1,9-diketone 308 
Enantioselective enolization of meso 1,9-diketone 308 was successfully achieved 
by deprotonation with ent-230 (Scheme 2.32.).  Again, the yield and ee of 315xxxvii were  
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Scheme 2.32. 
dependent on the reaction enantioselectivity and conversion.129  Modelling of the product 
distributions and ee's of 315 at various conversions in the reaction of 308 with ent-230  in 
the presence of TMSCl suggests a reaction enantioselectivity of ca. 8:1 using conditions 
                                                 
xxxvi In principle, with access to diol diketone 307 many different protecting groups could have been used.  
The triethylsilyl protecting group was chosen with the expectation of higher solubility in organic solvents.  
In fact, the initial trimethylsilyl protecting group was chosen by design as its hydrolysis during ketal 
deprotection of 314 was anticipated. 
xxxvii The absolute configuration of 315 is based on analogy as determined for 261 with 230.  
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identical to those that gave a 17:1 enantioselectivity with meso 1,9-diketone 233 (Table 
2.7. and Figure 2.7.).  While this lower enantioselectivity is intriguing,xxxviii it again  
Table 2.7.  Enantioselective enolization of 308 with ent-230/TMSCl. 
isolated yields (%) entrya 308 
(# equiv) 
1H NMR ratiob 
308:315:316 308 315 (%ee)c 316 
1 1.5 71:26:3    
2 1.7 43:49:8    
3 1.7 26:56:18    
4 1.1 18:61:21 23 59 (92) 14 
5 1.4 16:62:22 24 59 (92) 19 
6 1.5 9:66:23 9 66 (93) 17 
7 1.3 6:44:50 11 44 (94) 35 
8d 1.4 20:59:21    
9e 1.5 18:64:18 29 52 (82) 20 
10f 1.4 7:48:45    
a A THF solution of ent-230 or ent-230⋅LiCl was rapidly cannulated (ca. 30 sec) to a THF solution of 308 
(0.2-1.5 mmol) and TMSCl (10 equiv) at −100 °C.  b Crude products after work-up.  c Determined by 1H 
NMR analysis of the corresponding Mosher's esters of ketol 323.  d Slow addition of ent-230 (ca. 5 min).  e 
Using ent-230⋅LiCl.  f External quench (i.e. addition of ent-230 followed by TMSCl). 
 
highlights the benefits of the ee enhancement feature of the SEG desymmetrizing 
reaction.  Efforts to increase the enantioselectivity (entries 8 and 10) by either slow 
addition of ent-230 or by external quench gave no substantial improvements.  Under 
similar conditions, reactions using ent-230 were more selective than those using ent-
230⋅LiCl (entry 9 vs. entry 6).  As was seen for meso 1,9-diketone 233 (Section 2.1.3.2.), 
unexpectedly large amounts of bis-product 316 were also observed at low conversions 
(entries 1 and 2).  Although the enantioselectivity of the enolization of 308 is somewhat 
lower than that observed from the meso 1,9-diketone 233, mono-silyl enol ether 315 was 
obtained with satisfactory yield and ee.  This process is very efficient (>90% yield based 
                                                 
xxxviii The exact role of the triethylsilyl group is unclear; however, it is likely that the lack of coordination 
sites is important (i.e. MOM vs. TES). 
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on recovered diketone 308) as bis-silyl enol ether 316 can be easily recycled to diketone 
308 by treatment with 10% sat. aqueous NaHCO3 in 50% methanol in THF.   
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Figure 2.7.  Calculated and observed mole fractions of 315 (?) and 316 (?) and ee of 
316 (?) produced in the reaction of 308 with 230/TMSCl as a function of 
conversion of 308. 
(i.e., assuming s = 8 (⎯) and s = 5 (---)). 
2.2.1.3.  Alkylation and desulfurization 
With access to the protected desymmetrized hexapropionate synthon 315, 
establishing reaction conditions for addition of the 2-methyl-2-pentyl group and for 
desulfurization were required (Scheme 2.25.).  To ascertain the viability of these 
processes, model substrates 210sa and 317sa were chosen for study (Scheme 2.33.).xxxix  
In both cases, C-alkylation of the Li-enolates derived by treatment with t-BuLi at −78 °C 
followed by addition of (2E)-1-bromo-2-methyl-2-pentene and HMPA occurred to give 
                                                 
xxxix 209sa aldol adduct was chosen since it has the identical stereochemical array as compared to 315.   
0.              0.5                                     0.9            0.95                                 0.99
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ca. 20:1 mixtures of diastereomeric C-alkylated products.  These alkylations of 210sa and 
317sa were very efficient as the yields based on recovered starting materials were >95% 
in both cases.  Equally important, the double bonds in 318sa and 319sa survived the  
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Scheme 2.33. 
subsequent Raney Ni desulfurizations to give the desired 320sa and 321sa, respectively, 
in good overall yields (Scheme 2.33.)..  Analysis of the proton coupling constants 
observed in the NMR spectra of 318sa and 319sa (i.e. JHC-1'-HC-3, JHeqC-2-HC-3 and JHaxC-2-HC-
3) and observations of positive NOE's between H2CC-5 and HC-3 reveal that, in each 
case, the major diastereomer has the desired 3,5-trans relative configuration (Figure 2.8.).   
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Figure 2.8.  Structure determination of 318sa and 319sa. 
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Processing of silyl enol ether 315 required several synthetic manipulations to arrive  
at a suitably protected substrate for C-alkylation (Scheme 2.34.).  Reduction of 315 using  
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Scheme 2.34. 
Zn(BH4)2 gave an 8:1  mixture of diastereomeric alcohols that upon fractionation 
provided 322 in 77% yield.  The 3,4-trans relative configuration for 322 was assigned 
based on the appearance of HC-3 as a  ddd (i.e. J = 4, 10, 10 Hz ) in the 1H NMR spectra 
(Figure 2.9.).  Hydrolysis of silyl enol ether in 322 gave ketol 323 in near quantitative 
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yield that was subsequently protected as the MOM ether to give 324 in 91% yield.  
Subjecting ketone 324 to the C-alkylation conditions that were developed using model  
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Figure 2.9.  Structure determination of 322. 
substrates 210sa and 317sa (Scheme 2.33.) resulted in very low conversions (ca. 5-10%); 
however, with efficient recovery of ketone 324.  Fortunately, by using excess t-BuLi (i.e. 
10 equiv) a 3:1 mixture of diastereomeric C-alkylated products 325 and 326xl was 
obtained.  Fractionation of this crude mixture gave 325 and 326 in 48% and 16% yields, 
respectively, along with 25% of recovered ketone 324 (86% yield based on recovered 
ketone 324).  Efforts to improve the diastereoselectivity of the alkyation by employing 
either LDA or NaHMDS resulted in low conversion, isomerization and/or elimination 
products.  While the yield of this reaction was only modest, it was thought sufficient to 
move forward.   
Reduction of 325 using NaBH3CN furnished alcohol 327 as the only diastereomer 
in 79% yield (Scheme 2.35).  Interestingly, the TES group in a 1,3-relationship to the 
alcohol in 327 was selectively deprotected by brief exposure to TBAF to give diol 328 in 
95% yield.  Acetylation of diol 328 using Ac2O and DMAP furnished diacetate 329a in 
88% yield.  Considering all four possible diastereomers of 329 that could result from C-
alkylation and reduction, only one diastereomer matches the expected and observed 
vicinal H-H coupling constants for diacetate 329a, which confirms the 10,12-trans 
                                                 
xl The major diastereomer 325 was assumed to be 10,12-trans but was later verified by analysis of the 
vicinal proton coupling constants of diacetate 329a (Figure 2.10.). 
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relative configuration resulting from C-alkylation and the 10,11-trans relative 
configuration from the reduction of 325 (Figure 2.10.).  Desulfurization of diacetate 329a 
using Raney Ni provided partly desulfurized 330, which after re-subjection to Raney Ni  
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Scheme 2.35. 
resulted in a mixture of compounds where the double bond was reduced and/or the benzyl 
protecting group was lost.  As a result, this was not a viable approach to the denticulatins.  
The alternative approach of desulfurization before C-alkylation introduces the challenge 
of controlling the stereoselectivity of the desired C-alkylation.  During the syntheses of 
(−)-discodermolide 4 (or ent-4), several researchers177-184 proposed a chelation controlled 
alkylation (as opposed to an A-strain controlled alkylation) of chiral (Z)-O-enolates as a 
method for introducing the 16,18-cis relative configuration (Figure 2.11.).  However, the 
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major products from alkylation of (Z)-O-enolates formed using lithium or sodium 
hexamethyldisilazide bases had trans relative configuration. (Scheme 2.36.).  After 
extensive experimentation, only Myles and co-workers were able to effect a chelation-
controlled alkylation of 344 that provided a 6:1 diastereomeric mixture of 346.   
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Figure 2.10.  Structure determination of 329a. 
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Figure 2.11. Syntheses of (−)-discodermolide 4. 
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Scheme 2.36. 
These findings suggest that the desired 10,12-trans relative configuration could be 
obtained by C-alkylation of the acylic version of ketone 324 with allyl bromide 47.  
Desulfurization of ketone 324 furnished the desired 347 in 70% yield (Scheme 2.37.).  C-
alkylation of ketone 347 was achieved by exposure of 347 to excess NaHMDS (10 equiv) 
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followed by addition of allyl bromide 47 and TMEDA at −78 °C to give 349 in 65% yield 
(>90% based on recovered ketone 347) with a dr of 4.6:1 (Scheme 2.37.).  To verify that 
the presence of excess NaHMDS does not erode the dr during the reaction, C-alkylated 
349 (dr 4.6:1) was subjected to identical reaction conditions.  C-alkylated 349 with the 
same originating diastereomeric ratio of 4.6:1 was recovered quantitatively.   
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Scheme 2.37. 
At this stage, the relative configuration at C-10 and C-12 in 349 was unknown, 
although the literature precedent (Scheme 2.36.)177-184 supported the desired 10,12-trans 
relative configuration.  It was decided to advance towards triketone 106 with an enriched 
mixture of C-alkylated 349 with the anticipation that isolation of the major diastereomer 
and determination of the relative configuration could be achieved at a later stage in the 
synthesis.   
2.2.1.4.  Synthesis towards triketone 106 
The initial step toward triketone 106 involved silyl deprotection of C-alkylated 349 
(dr 4.6:1) by treatment with 0.1% HF to furnish diol 350 (4.6:1) in 93% yield (Scheme 
2.38.).  Subsequent reduction of 350 (dr 4.6:1) using Et2BOMe/NaBH4 resulted in a 
diastereomeric mixture of triols 351 (dr 6:1:1) in 93% yield.  Acetonide protection of the 
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1,3-diol in 351 (dr 6:1:1) by reaction with 2,2-dimethoxypropane and PTSA provided 
alcohol 352 (dr 6:1:1) in 93% yield.  Analysis of the 13C NMR spectrum of 352 (dr 6:1:1) 
revealed the diagnostic acetonide methyl chemical shifts for a 1,3-syn acetonide (i.e. 30.8 
ppm and 20.3 ppm) for the major dastereomer.185  Hydrogenolysis of 352 (dr 6:1:1) by 
treatment with Li/NH3 furnished diol 353 (dr 6:1:1) in 91% yield that was protected with 
the required di-tert-butylsilylene group by treatment with 2,6-lutidine and t-Bu2Si(OTf)2 
for 7 h that gave partially protected 354 (dr 6:1:1) in 77% yield.  Interestingly, partially 
protected 354 (dr 6:1:1) cyclized on brief treatment with aqueous TFA in THF (15 min) 
to give 355 (dr 6:1:1) in 75% yield.  The structures of 354 and 355 were comfirmed by 
extensive spectroscopic studies.  Of particular note was an XH type IR frequency (3492 
cm-1) for 354 suggesting the presence of hydroxyl group(s).  Indeed, this was further 
supported by deutrium chemical exchange which also assisted in establishing the location 
of the silyl group via HSQC and HMBC 1H-13C NMR correlation experiments (i.e. 
correlation of HOC-5/C-5).  Cyclized 355 did not posses any XH type IR frequencies and 
was also supported by the presence of a HRMS ([M+H]+) molecular ion.   
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Scheme 2.38. 
The next step required the removal of the acetonide and MOM protecting groups.  
Unfortunately, this transformation could not be effected under various conditions (e.g. 
TFA(aq)/THF, TiCl4/PhSH, TiCl4/1,3-propanedithiol, FeCl3⋅6H2O).  Attempted 
deprotection of 355 (dr 6:1:1) using TiCl4/PhSH, TiCl4/1,3-propanedithiol or FeCl3⋅6H2O 
resulted with the loss of the double bond while aqueous TFA in THF resulted with ca. 
  102
1.5:1 mixture of compounds that did not possess the expected chemicals shifts for the 
proposed triol 356.  In light of these results, 355 did not offer any obvious solution to 
access the desired triol 356.  While this concluded the synthetic studies, the strategy to 
assemble complex polypropionate structures by implementation of the thiopyran route 
was clearly demonstrated.   
At this point it was decided to focus on establishing the 10,12 relative configuration 
for the C-alkylation of 347 using allylic bromide 47.  Conformational analysisxli of 
representative structures 358 and 359 for 355 revealed one dominantxlii conformer for 
each diastereomer (Figure 2.12.).  After extensive NOE studies, only one correlation was  
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Figure 2.12.  Attempted determination of the relative configuration of C-alkylation 
products. 
clearly identified between the acetonide methyls and the H3CC-12 (Figure 2.12.).  
Unfortunately, there was no obvious NOE between either the H3CC-10 and HC-12 or 
HC-10 and H2C-13.  Literature examples177-184 suggest that under the reaction conditions 
used for the C-alkylation of 347, a 10,12-trans products would result; however, these 
                                                 
xli Performed using the Sparton '02 for Windows softeware package by Wavefunction, Inc. implementing 
the MMFF94s force field and default settings. 
xlii i.e. >95% population. 
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findings are suggestive for a 10,12-cis C-alkylation.  One plausible rationale is that the 
use of excess NaHMDS promotes a chelation controlled mechanism rather than an A-
strain controlled mechanism (Figure 2.11.).  Ultimately, there is insufficient data to 
conclusively confirm the relative configuration and it is cautioned to form any 
conclusions. 
2.3.  Conclusions 
Until this work, there have been no reports of a sequential enantiotopic group 
selective enolization of meso diketones.  One of the significant challenges for this 
investigation was providing rapid access to the required starting materials.  The thiopyran 
route to polypropionates provided a strategy that involved two aldol couplings of racemic 
substrates and allowed access to meso bisaldol adduct 212a which was used for the 
establishment of a method for desymmetrization of meso diketones (Scheme 2.39.).  
Processing of 212a gave a suitably protected meso diketone 233 which was 
desymmetrized using 230 to give access to enantioenriched (−)-261 with high yields 
(>90% BORSM) and ee's (>95%).  Reduction and desulfurization of (−)-261 gave 
hexapropionate synthon (−)-278 which established the thiopyran route to polypropionates 
and concluded the SEG selective enolization model study.   
Application of the thiopyran route to polypropionates was realized by extension of 
the developed methodology for synthetic studies toward denticulatin A (Scheme 2.40.).  
During this work, several interesting features were elucidated.  Processing of meso bis-
aldol adduct 212a to diol diketone 307 provided a rapid and diverse approach to various 
protected diketones.  Enantioselective enolization of bis-TES diketone 308 using ent-230 
furnished mono-silyl enol ether 315 that was processed to ketone 347.  C-alkylation of 
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347 gave 349 in good yield (65%; >90% BORSM) and was derivatized to fully protected 
355 over 7 steps in 27% yield.   
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CHAPTER 3 
3.  EXPERIMENTAL 
3.1.  General methods 
All solvents were distilled prior to use. Et3N, i-Pr2EtN, i-Pr2NH and TiCl4 were 
distilled from CaH2 (Et3N and i-Pr2EtN were then stored over KOH).  TMEDA was 
distilled over KOH and then stored over KOH.  TMSCl was distilled from Bu3N or CaH2.  
n-BuLi, t-BuLi and NaHMDS were routinely titrated186-188 using BHT with fluorene as 
the indicator.xliii  Anhydrous solvents were distilled under argon atmosphere as follows:  
THF and ether from benzophenone sodium ketyl; CH2Cl2 and toluene from CaH2; MeOH 
from Mg(OMe)2.  All experiments involving air- and/or moisture-sensitive compounds 
were conducted in an oven or flamed dried round-bottom flask capped with a rubber 
septum, and attached via a needle and connecting tubing to an argon manifold equipped 
with mercury bubbler (ca. 5 mm positive pressure of argon).  Low temperature baths 
were ice/water (0 °C), CO2(s)/acetonitrile (−30 - −50 °C), CO2(s)/acetone (−78 °C) and 
liquid nitrogen/ether (−100 °C).  Reaction temperatures refer to that of the bath unless 
otherwise noted. 
PTLC was carried out on glass plates (20×20 cm) precoated (0.25 mm) with silica 
gel 60 F254.  Materials were detected by visualization under an ultraviolet lamp (254 nm) 
and/or by treating a 1 cm vertical strip removed from the plate with a solution of 
phosphomolybdic acid (5%) containing a trace of ceric sulfate in aqueous sulfuric acid 
                                                 
xliii BHT (ca. 100 mg, 0.45 mmol) and fluorene (ca. 10 mg) were dissolved in THF (2 mL) and cooled to 0 
°C under Ar.  The organolithium or sodium hexamethyldisilazide was then added dropwise via syringe 
until an orange end-point persisted.   
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(5% v/v), followed by charring on a hot plate.  Concentration refers to removal of 
volatiles at water aspirator pressure on a rotary evaporator.  Unless otherwise noted, all 
reported compounds were homogeneous by TLC and by NMR. 
FCC was performed according to Still et al.189 with Merck Silica Gel 60 (40-63 
μm). All mixed solvent eluents are reported as v/v solutions. 
3.2.  Spectral data 
HRMS and LRMS were obtained on an API QSTAR® Pulsar Hybrid LC/MS/MS 
system and/or a VG 70E double focusing high resolution spectrometer; only partial data 
are reported.  EI ionization was accomplished at 70 eV and CI at 50 eV with ammonia as 
the reagent gas; only partial data are reported.  IR spectra were recorded on a Bio-Rad 
Fourier transform interferometer using a diffuse reflectance cell (DRIFT);190 only 
diagnostic and/or intense peaks are reported.  Specific rotations ( D][α ) measurements 
were determined on a DigiPol 781-T6U automatic polarimeter and reported as the 
average of 5 measurements with an acceptable STD (i.e. < 0.003° for α < 20°).  NMR 
spectra were obtained on an Avance NMR spectrometer equipped with a 5 mm TXI 
(inverse triple resonance), BBI (inverse broadband) and/or BBO (observe broadband) 
probe.  Spectra were measured in CDCl3 or C6D6 solutions at 500 MHz for 1H and 125 
MHz for 13C.  Signals due to the solvent (13C NMR) or residual protonated solvent (1H 
NMR) served as the internal standard:  CDCl3 (7.26 δH, 77.23 δC); C6D6 (7.16 δH, 128.39 
δC).  The 1H NMR chemical shifts and coupling constants were determined assuming 
first-order behavior.  Multiplicity is indicated by one or more of the following: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), ap (apparent); the list of 
couplings constants (J) corresponds to the order of the multiplicity assignment.  
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Couplings constants (J) are reported to the nearest 0.5 Hz.  The 1H NMR assignments191-
193 were made on the basis of chemical shift and multiplicity and were confirmed, where 
necessary, by homonuclear decoupling,194 gCOSY,191, 193, 195 and/or gNOESY191, 193, 196-199 
experiments.  The 13C NMR assignments191-193 were made on the basis of chemical shift 
and multiplicity (i.e., s = C, d = CH, t = CH2, q = CH3) as determined by 13C-DEPT-
135191, 193, 200 and/or J-modulation193, 201 and/or gHSQC191, 193, 202 experiments and were 
confirmed, where necessary, by gHMBC.191, 203 
3.3.  Materials 
The preparations of the following compounds were described previously:  206118, 
124, 218118, 124, 263118, 210sa118, W-2 Raney Ni,204 DMP,205 MOMCl,206-210 (E)-1-bromo-
2-methylpent-2-ene 4718, 211 and both (R)- and (S)-O-acetylmandelic acid212, 213.  (+)-
(R,R)-bis(1-phenylethyl)amine 230 and ent-230 and their corresponding hydrochloride 
salts are commercially available.  Both 230⋅HCl and ent-230⋅HCl were also prepared 
according to the published procedures.214, 215  The D][α  value reported for ent-230⋅HCl 
varies widely (−71.8, c 4, EtOH;215 −84.1, c 3, EtOH214) and appears to be sensitive to 
solvent, concentration and temperature.  Samples of ent-230⋅HCl were routinely obtained 
with 25-24D][α  −68 to −70 (c 3.0-4.0, EtOH).  These samples were determined to be >99% 
ee by 1H NMR in the presence of (+)-(R)-TFAE as a chiral solvating agent.  All other 
reagents were commercially available and unless otherwise noted, were used as received. 
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3.4.  Experimental procedures and spectral data 
S
OOO
9
10 6
23
 
207 
1,4-Dioxa-8-thiaspiro[4.5]decane-6-carbaldehyde 
 
DMSO (20.9 mL, 23.0 g, 0.29 mol) was added dropwise via syringe to a stirred 
solution of oxalyl chloride (12.8 mL, 19.0 g, 0.15 mol) in CH2Cl2 (560 mL) at −78 °C 
under argon.  After 10 min at −78 °C, a solution of 263 (26.54 g, 0.14 mol) and i-Pr2EtN 
(24.4 mL, 18.1 g, 0.14 mol) in CH2Cl2 (ca. 1 M, 140 mL) was added dropwise over 10 
min via syringe to the reaction mixture.  After 5 min, i-Pr2EtN (53.7 mL, 39.8 g, 0.31 
mol) was added and the reaction mixture was allowed to warm to ca. 0 °C over 30 min.  
The mixture was transferred to a separatory funnel containing ice-cold aqueous 1 N HCl 
and was extracted with CH2Cl2 (3×).  The combined organic layers were washed with sat. 
aqueous NaHCO3, dried over Na2SO4 and concentrated to give crude 207 (24.8 g).  
Fractionation of the residue by FCC (10-50% ethyl acetate in hexane) gave recovered 263 
(0.86 g, 3%) and aldehyde 207 (22.2 g, 85%). 
 
Spectral data for 207 were in accord with that previously reported.118 
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209as 
(R)-3-((S)-Hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)dihydro-
2H-thiopyran-4(3H)-one 
 
A mixture of ketone 206 (4.33 g, 37.2 mmol), aldehyde 207 (3.84 g, 20.4 mmol), 
(S)-proline (1.22 g, 10.6 mmol) and acetic acid (0.36 mL, 6.38 mmol) was stirred at 38 
oC.  After 2 days, the brownish solid reaction mixture was dissolved in dichloromethane, 
passed through a pad of silica, concentrated and triturated with 5% ethyl acetate in 
hexanes to give aldol adduct 209as as a white solid (4.66 g, 75%) ( 25D][α  −9; c 1.0, 
CHCl3).  
 
Spectral data for 209as were in accord with that previously reported.118 
 
 
 
 
 
 
 
  111
S S S
OOH OHOO OO
9'' 7''
10''
2'' 3''
1''
3
26
5
1'
9'
10'
3' 2'
7'  
212a 
(3R,5S)-3-((S)-Hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-5-
((R)-hydroxy((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)dihydro-2H-
thiopyran-4(3H)-one 
 
(i-PrO)TiCl3 (ca. 0.5 M solution in CH2Cl2, 21.5 mL, 10.7 mmol)216 was added 
dropwise via syringe to a stirred solution of the ketone 209as (2.97 g, 9.76 mmol) in 
CH2Cl2  (100 mL) at –78 °C under argon.  After 5 min, i-Pr2EtN (1.79 mL, 1.32 g, 10.2 
mmol) was added dropwise via syringe to the reaction mixture at –78 °C.  After 1 h, 207 
(3.67 g, 19.5 mmol) was added and the mixture was stirred at –78 °C for 2 h and then i-
Pr2EtN (2.55 mL, 1.89 g, 14.6 mmol) was added dropwise via syringe to the reaction 
mixture at –78 °C and the mixture was stirred for an additional 2 h.  The reaction was 
quenched by addition of saturated aqueous NH4Cl and quickly worked up by dilution 
with water and extraction with CH2Cl2.  The combined organic layers were dried over 
Na2SO4 and concentrated.  Fractionation of the residue by FCC gave recovered 207 (2.03 
g, 55%) and meso bisaldol adduct 212a (3.96 g, 82%) as a white solid (mp 166-167 °C). 
 
Spectral data for 212a were in accord with that previously reported.117, 122 
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231 
(3S,4s,5R)-3-((S)-Hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-5-((R)-
hydroxy((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)tetrahydro-2H-thiopyran-
4-ol 
 
DIBAL-H (1.5 M in toluene; 7.0 mL, 10.6 mmol) was added dropwise via syringe 
to a solution of bisaldol 212a (1.04 g, 2.11 mmol) in THF (30 mL) at −78 °C under Ar.  
After 3 h, excess DIBAL-H was quenched by dropwise addition of methanol (ca. 1 mL) 
and the resulting mixture was warmed to room temperature over 15-30 min.  A sat. 
aqueous solution of sodium potassium tartrate (30 mL) was slowly added (caution:  
exothermic) to the well-stirred solution.  After 30 min, the mixture was diluted with water 
and extracted with CH2Cl2 (3×).  The combined organic layers were dried over Na2SO4 
and concentrated to give crude triol 231 (1.04 g) which was an 8:1 mixture of 
diastereomers by 1H NMR.  Fractionation of the crude by FCC (75-100% ethyl acetate in 
hexane) gave the titled triol 231 (890 mg, 86%) as a white solid (mp 109-110 °C). 
 
IR (DRIFT) νmax:  3438, 2901, 1415, 1254, 1049 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.69 (1H, br s, HC-4), 4.13 (2H, dd, J = 2, 7.5 Hz, HC-
1', HC-1''), 4.10-3.92 (8H, m, H2C-2', H2C-3', H2C-2'', H2C-3''), 3.50 (1H, s, HOC-4), 
3.40-3.16 (2H, br s, HOC-1', HOC-1''), 3.08-2.94 (4H, m, HC-2, HC-6, HC-7', HC-7''), 
2.85-2.71 (4H, m, HC-7', HC-7'', HC-9', HC-9''), 2.61 (2H, dddd, J = 1, 3.5, 5, 13 Hz, 
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HC-9', HC-9''), 2.18-2.09 (4H, m, HC-2, HC-6, HC-10', HC-10''), 2.07 (2H, ddd, J = 3, 3, 
10.5 Hz, HC-6', HC-6''), 1.87 (2H, dddd, J = 2, 3.5, 7.5, 12 Hz, HC-3, HC-5), 1.75 (2H, 
ddd, J = 3.5, 11.5, 14.5 Hz, HC-10', HC-10''). 
 
13C NMR (125 MHz, CDCl3):  δ 110.2 (s ×2, C-5', C-5''), 70.6 (d ×2, C-1', C-1''), 64.8 (t 
×2, C-2', C-2'' or C-3', C-3''), 64.7 (d, C-4), 64.5 (t ×2, C-2', C-2'' or C-3', C-3''), 47.2 (d 
×2, C-6', C-6''), 46.2 (d ×2, C-3, C-5), 36.0 (t ×2, C-10', C-10''), 26.8 (t ×2, C-7', C-7'' or 
C-9', C-9''), 26.7 (t ×2, C-7', C-7'' or C-9', C-9''), 24.9 (t ×2, C-2, C-6). 
 
LRMS (EI), m/z (relative intensity):  494 ([M]+, 85), 414 (72), 317 (80), 255 (96), 226 
(60). 
 
HRMS m/z calcd. for C21H34O7S3:  494.1467; found:  494.1469. 
 
Anal. Calcd. for C21H34O7S3:  C, 50.99; H, 6.93. Found:  C, 50.12; H, 7.01. 
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232 
(3S,4s,5R)-4-Methoxy-3-((S)-hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)methyl)-5-((R)-hydroxy((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)methyl)tetrahydro-2H-thiopyran 
 
A solution of the triol 231 (913 mg, 1.85 mmol) in THF (5 mL, plus a 5 mL wash) 
was added dropwise via syringe to a stirred suspension of oil free KH (prepared by 
washing 2 g of a 30% w/v suspension in oil with hexane under Ar; ca. 15 mmol) in THF 
(150 mL) at 0 °C under Ar. The resulting mixture was warmed to room temperature over 
1 h and iodomethane (2.3 mL, 37 mmol) was added.  After 8 h, the mixture was cooled to 
0 °C and methanol (0.75 mL) was added dropwise via syringe (caution:  H2 evolution).  
The mixture was diluted with H2O and extracted with CH2Cl2 (3×) and the combined 
organic layers were dried over Na2SO4, concentrated and fractionated by FCC (50% ethyl 
acetate in hexane) to give the titled 232 (897 mg, 91%). 
 
IR (DRIFT) νmax:  2917, 2827, 1446, 1314, 1260, 1087 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.17 (1H, br s, HC-4), 4.09-3.92 (8H, m, H2C-2', H2C-3', 
H2C-2'', H2C-3''), 3.46 (3H, s, H3COC-4), 3.38 (6H, s, H3COC-1', H3COC-1''), 3.23 (2H, 
dd, J = 2, 9 Hz, HC-1', HC-1''), 2.92-2.79 (6H, m, HC-2, HC-6, HC-7', HC-7'', HC-9', 
HC-9''), 2.63 (2H, ddd, J = 3, 3, 14 Hz, HC-7', HC-7''), 2.51 (2H, dddd, J = 3.5, 3.5, 6, 
13.5 Hz, HC-9', HC-9''), 2.26 (2H, dd, J = 2, 13.5 Hz, HC-2, HC-6), 2.21 (2H, ddd, J = 3, 
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3, 11.5 Hz, HC-6', HC-6''), 2.12 (2H, ddd, J = 3.5, 3.5, 13.5 Hz, HC-10', HC-10''), 1.75-
1.66 (4H, m, HC-3, HC-5, HC-10', HC-10''). 
 
13C NMR (125 MHz, CDCl3): 108.7 (s ×2, C-5', C-5''), 78.3 (d ×2, C-1', C-1''), 74.6 (d, 
C-4), 64.8 (t ×2, C-2', C-2'' or C-3', C-3''), 64.7 (t ×2, C-2', C-2'' or C-3', C-3''), 60.4 (q, 
CH3OC-4), 59.1 (q ×2, CH3OC-1', CH3OC-1''), 50.5 (d ×2, C-3, C-3 or C-6', C-6''), 50.4 
(d ×2, C-3, C-3 or C-6', C-6''), 36.6 (t ×2, C-10', C-10''), 27.6 (t ×2), 26.8 (t ×2), 25.1 (t 
×2). 
 
LRMS (EI), m/z (relative intensity):  536 ([M]+, 8), 504 (3), 472 (4), 345 (18), 203 (50), 
132 (24), 99 (100), 71 (87). 
 
HRMS m/z calcd. for C24H40O7S3:  536.1936; found:  536.1924. 
 
Anal. Calcd. for C24H40O7S3:  C, 53.70; H, 7.51. Found:  C, 53.61; H, 7.21. 
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233 
(3R,3'S)-3,3'-((1S,1'R)-((3R,4s,5S)-4-Methoxytetrahydro-2H-thiopyran-3,5-
diyl)bis(methoxymethylene))bis(dihydro-2H-thiopyran-4(3H)-one) 
 
Amberlyst® 15 (1.6 g) was added to a well-stirred solution of bis-ketal 232 (779 
mg, 1.41 mmol) in acetone (60 mL) and the resulting suspension was heated under 
refluxed for 4 h.  After cooling to room temperature, CH2Cl2 (15 mL) and solid NaHCO3 
(excess) were added.  The mixture was filtered and the combined filtrate and washings 
were concentrated and fractionated by FCC (5-25% ethyl acetate in hexane) to give the 
titled diketone 233 (530 mg, 81%) as a white solid (mp 214-215 °C).  
 
From bis-silyl enol ether 262 
 
10% vol aqueous HF (0.5 mL) was added dropwise to a stirred solution of bis-silyl 
enol ether 262 (54 mg, 0.091 mmol) in THF (5 mL) at room temperature.  After 30 min, 
sat. aqueous NaHCO3 was slowly added (caution:  effervescence) and the resulting 
mixture was diluted with EtOAc and washed sequentially with sat. aqueous NaHCO3 
(3×), brine, dried over Na2SO4 and concentrated to give crude diketone 233.  
Recrystallization of the crude from ethyl acetate gave the titled diketone 233 (39 mg, 
95%).  
 
IR (DRIFT) νmax:  2922, 2838, 1702, 1432, 1331, 1218 cm-1. 
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1H NMR (500 MHz, CDCl3):  δ 4.07 (1H, br s, HC-4), 4.01 (1H, dd, J = 1.5, 9 Hz, HC-
1', HC-1''), 3.48 (3H, s, CH3OC-4), 3.30 (6H, s, CH3OC-1', CH3OC-1''), 3.04-2.76 (12H, 
m), 2.75-2.62 (4H, m, HC-5', HC-5'', HC-3', HC-3''), 1.98 (2H, dd, J = 2, 13 Hz, HC-2, 
HC-6), 1.73 (2H, br ddd, J = 2, 9, 13 Hz, HC-3, HC-5). 
 
13C NMR (125 MHz, CDCl3):  δ 208.6 (s ×2, C-4', C-4''), 77.1 (d ×2, C-1',C-1''), 74.0 (d, 
C-4), 61.5 (q, CH3OC-4), 59.3 (q ×2, CH3OC-1', CH3OC-1''), 54.7 (d ×2, C-3', C-3''), 
48.0 (d ×2, C-3, C-5), 43.9 (t ×2, C-5', C-5''), 29.1 (t ×2, C-2', C-2'' or C-6', C-6''), 28.7 (t 
×2, C-2', C-2'' or C-6', C-6''), 24.5 (t ×2, C-2, C-6). 
 
LRMS (EI), m/z (relative intensity):  448 ([M]+, 7), 301 (11), 197 (9), 159 (14). 
 
HRMS m/z calcd. for C20H32O5S3:  448.1412; found:  448.1399. 
 
Anal. Calcd. for C20H32O5S3:  C, 53.54; H, 7.19. Found:  C, 53.95; H, 6.75. 
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(−)-261 
(R)-3-((S)-Methoxy((3S,4R,5R)-4-methoxy-5-((R)-methoxy((S)-4-(trimethylsilyloxy)-
3,6-dihydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-thiopyran-3-
yl)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
A solution of n-BuLi in hexanes (2.1 M; 0.16 mL, 0.33 mmol) was added dropwise 
via syringe to a solution of (R,R)-bis(1-phenylethyl)amine (0.075 mL, 74 mg, 0.33 mmol) 
in THF (6 mL) at −78 °C under Ar.  After stirring for 30 min at −78 °C the resulting pink 
solution was quickly transferred via cannula (ca. 15-30 sec.) into a well-stirred solution 
of diketone 233 (92 mg, 0.205 mmol) and TMSCl (0.22 mL, 223 mg, 2.05 mmol) in THF 
(10 mL) at −100 °C under Ar.  After 15 min, the reaction was quenched by addition of 
acetone (0.5 mL) followed by Et3N (0.5 mL) and sat. aqueous NaHCO3.  The resulting 
cold mixture was diluted with ethyl acetate and washed sequentially with 1% w/v 
aqueous citric acid (4×), sat. aqueous NaHCO3, brine, dried over Na2SO4, concentrated 
and fractionated by FCC (10-20% ethyl acetate in hexane) to give the bis-silyl enol ether 
262 (13 mg, 11%), recovered diketone 233 (15 mg, 16%) and the titled mono-silyl enol 
ether (−)-261 (75 mg, 71%) ( 25D][α  −1.0; c 5.9, C6H6; >96% ee by 1H NMR as shown in 
Appendix A).  
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IR (DRIFT) νmax:  2928, 2832, 1702, 1666, 1420, 1187 cm-1. 
 
1H NMR  (500 MHz, CDCl3):  δ 5.14 (1H, ddd, J = 2, 2, 6.5 Hz, HC-5'), 4.10 (1H, br s, 
HC-4), 4.01 (1H, dd, J = 2, 9 Hz, HC-1''), 3.84 (1H, dd, J = 1, 10 Hz, HC-1'), 3.51 (3H, s, 
H3COC-4), 3.44 (3H, s, H3COC-1'), 3.38 (1H, ddd, J = 3, 3, 16.5 Hz, HC-6'), 3.31 (3H, s, 
H3COC-1''), 3.06-2.64 (11H, m), 2.60 (1H, ddd, J = 1.5, 5.5, 14 Hz, HC-2'), 2.36 (1H, br 
s, HC-3'), 2.05 (1H, dd, J = 2.5, 16.5 Hz, HC-2, HC-6), 1.99 (1H, dd, J = 2.5, 13 Hz, HC-
2, HC-6), 1.74 (2H, m, HC-3, HC-5), 0.21 (9H, s, (H3C)3SiOC-4'). 
 
13C NMR (125 MHz, CDCl3):  δ 208.8 (s, C-4''), 152.8 (s, C-4'), 104.1 (d, C-5'), 78.1 (d, 
C-1'), 77.3 (d, C-1''), 74.3 (d, C-4), 61.1 (q, CH3OC-4), 59.3 (q, CH3OC-1''), 58.9 (q, 
CH3OC-1'), 54.7 (d, C-3''), 47.7 (d, C-3 or C-5), 47.5 (d, C-3 or C-5), 43.9 (t, C-5''), 42.0 
(d, C-3'), 29.1 (t, C-2'' or C-6''), 28.8 (t, C-2'' or C-6''), 25.4 (t, C-2' or C-6'), 25.4 (t, C-2' 
or C-6'), 24.5 (t, C-2 or C-6), 24.3 (t, C-2 or C-6), 0.5 (q, (CH3)3SiOC-4'). 
 
LRMS (CI, NH3), m/z (relative intensity):  538 ([M+18]+, 13), 521 ([M+7]+, 20), 489 
(68), 464 (32), 457 (42), 447 (39), 415 (49), 333 (41), 301 (60), 227 (100). 
 
HRMS m/z calcd. for C23H40O5S3Si:  520.1807 (527.1967 for M+Li); found:  527.1956 
(FAB, LiBr/NBA). 
 
Anal. Calcd. for C23H40O5S3Si:  C, 53.04; H, 7.74. Found:  C, 53.42; H, 7.65. 
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262 
((S)-3-((R)-Methoxy((3R,4s,5S)-4-methoxy-5-((S)-methoxy((R)-4-(trimethylsilyloxy)-
3,6-dihydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-thiopyran-3-yl)methyl)-3,6-
dihydro-2H-thiopyran-4-yloxy)trimethylsilane 
 
IR (DRIFT) νmax:  2922, 2839, 1660, 1420, 1241, 1086 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 5.15 (2H, ddd, J = 2, 6.5, 6.5 Hz, HC-5, HC-5''), 4.13 
(1H, br s, HC-4), 3.84 (2H, dd, J = 1, 10 Hz, HC-1', HC-1''), 3.55 (3H, s, H3COC-4), 3.44 
(6H, s, H3COC-4', H3COC-4''), 3.39 (2H, ddd, J = 3, 3, 16.5 Hz, HC-6', HC-6''), 3.00 
(2H, dd, J = 10, 14 Hz, HC-2', HC-2''), 2.91 (2H, ddd, J = 1.5, 6.5, 16.5 Hz, HC-6', HC-
6''), 2.76 (2H, dd, J = 12.5, 12.5 Hz, HC-2, HC-6), 2.61 (2H, ddd, J = 1.5, 5.5, 14 Hz, 
HC-2', HC-2''), 2.37 (2H, br s, HC-3', HC-3''), 2.06 (2H, dd, J = 3, 12.5 Hz, HC-2, HC-6), 
1.75 (2H, br ddd, J = 3, 10, 12.5 Hz, HC-3, HC-5), 0.22 (18H, s, (H3C)3SiOC-4', 
(H3C)3SiOC-4''). 
 
13C NMR (125 MHz, CDCl3): δ  152.9 (s ×2, C-4, C-4''), 104.1 (s ×2, C-5', C-5''), 78.3 (d 
×2, C-1', C-1''), 74.5 (d, C-4), 61.5 (q, CH3OC-4), 59.0 (q ×2, CH3OC-1', CH3OC-1''), 
47.3 (d ×2, C-3, C-5), 42.0 (d ×2, C-3', C-3''), 25.5 (t ×2, C-2', C-2'' or C-6', C-6''), 25.5 (t 
×2, C-2', C-2'' or C-6', C-6''), 24.4 (t ×2, C-2, C-6), 0.5 (q ×6, (CH3)3SiOC-4', 
(CH3)3SiOC-4'' ). 
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LRMS (CI, NH3), m/z (relative intensity):  593 ([M+1]+, 11), 561 (28), 405 (11), 373 
(13), 227 (100), 185 (18), 90 (35), 71 (31). 
 
HRMS m/z calcd. for C26H48O5S3Si2:  592.2202 (599.2363 for M+Li); found:  592.2139 
(FAB, LiBr/NBA). 
 
Anal. Calcd. for C26H48O5S3Si2:  C, 52.66; H, 8.16. Found:  C, 52.90; H, 8.12. 
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(−)-271 
(S)-3-((R)-((3R,4S,5R)-5-((R)-((3S,4R)-4-Hydroxytetrahydro-2H-thiopyran-3-
yl)(methoxy)methyl)-4-methoxytetrahydro-2H-thiopyran-3-
yl)(methoxy)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
L-Selectride® (0.8 M in THF; 0.83 mL, 0.7 mmol) was added dropwise to a stirred 
solution of mono-silyl enol ether (−)-261 (138 mg, 0.265 mmol) in THF (13 mL) at −78 
°C.  After 30 min, the reaction was quenched by dropwise addition of MeOH (0.5 mL) 
and the resulting mixture was warmed to 0 °C over 10 min.  Phosphate buffer (0.1 M in 
water, pH 7; 2.0 mL) and  aqueous H2O2 (30% w/v; 0.5 mL) were added.  After vigorous 
stirring for 10 min, the mixture was diluted with ice-cold aqueous Na2SO3 (2% w/v; 50 
mL) and extracted with CH2Cl2.  The combined organic layers were dried over Na2SO4, 
concentrated and fractionated by FCC (10-50% ethyl acetate in CH2Cl2) to give the titled 
ketol (−)-271 (97mg, 82%) ( 24D][α  −40; c 0.8, CH2Cl2).  
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IR (DRIFT) νmax:  3430, 2928, 2832, 1696, 1420 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.09 (1H, br s, HC-4''), 4.05 (1H, br d, J = 9.5 Hz, HC-
1'), 3.96 (1H, br s, HC-4), 3.53 (3H, s, H3COC-4), 3.49 (3H, s, H3COC-1''), 3.32 (1H, dd, 
J = 3.5, 7.5 Hz, HC-1''), 3.30 (3H, s, H3COC-1'), 3.17 (1H, br dd, J = 13.5, 13.5 Hz, HC-
6''), 3.09 (1H, br dd, J = 13, 13 Hz, HC-2''), 3.04-2.79 (7H, m), 2.75-2.64 (2H, m, HC-3', 
HC-5'), 2.29 (1H, br d, J = 13 Hz, HC-2''), 2.24 (1H, br d, J = 13.5 Hz, HC-6''), 2.20-2.10 
(2H, m, HC-6, HC-5''), 2.08-1.93 (4H, m, HC-2,HC-3'',HC-3,HO-4''), 1.86 (1H, br ddd, J 
= 3.5, 13, 13 Hz, HC-3''), 1.77 (1H, br dd, J = 9.5, 10 Hz, HC-3). 
 
13C NMR (125 MHz, CDCl3):  δ 208.52 (s, C-4'), 87.23 (d, C-1''), 76.86 (d, C-1'), 74.34 
(d, C-4), 69.60 (d, C-4''), 60.55 (q, CH3OC-4), 59.57 (q, CH3OC-1''), 59.24 (q, CH3OC-
1'), 54.74 (d, C-3'), 48.54 (d, C-3), 47.62 (d, C-5), 45.06 (d, C-3''), 43.83 (t, C-5'), 35.39 
(t, C-5''), 29.10 (t, C-2' or C-6'), 28.66 (t, C-2' or C-6'), 24.65 (t, C-2 or C-6), 24.49 (t, C-2 
or C-6), 22.33 (t, C-2'' or C-6''), 22.09 (t, C-2'' or C-6''). 
 
LRMS (EI), m/z (relative intensity):  450 ([M]+, 74), 386 (35), 301 (100), 232 (54), 159 
(63). 
 
HRMS m/z calcd. for C20H34O5S3:  450.1568; found:  450.1571. 
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272 
(R)-((3S,4R)-3-((R)-Methoxy((3R,4S,5R)-4-methoxy-5-((R)-methoxy((S)-4-
oxotetrahydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-thiopyran-3-
yl)methyl)tetrahydro-2H-thiopyran-4-yl)-2-acetoxy-2-phenylacetate 
 
DCC (11 mg, 0.054 mmol) was added to a stirred solution of ketol (−)-271 (8 mg, 
0.02 mmol), (R)-OAM (10 mg, 0.054 mmol) and DMAP (ca. 1 mg) in CH2Cl2 (2 mL) at 
0 °C under Ar.  After 30 min, the reaction was diluted with ethyl acetate (2 mL) and 
filtered through Celite®.  The combined filtrate and washings were washed sequentially 
with 10% w/v aqueous citric acid (3×), sat. aqueous NaHCO3 and brine (1× 20 mL), 
dried over Na2SO4, concentrated, and fractionated by PTLC (50% ethyl acetate in 
hexane) to give crude 272 that was refractionated by PTLC (1% CH3OH in CH2Cl2) to 
give the titled compound 272 (7 mg, 64%) containing ca. 10% (by 1H NMR) of the 
diastereoisomeric ester from the (S)-acid. 
 
IR (DRIFT) νmax:  2934, 2827, 1738, 1696, 1432 cm-1. 
 
1H NMR (500 MHz, CDCl3): 7.56-7.35 (5H, m, Ph), 5.91 (1H, s, HCPhCO2C-4''), 4.97 
(1H, dd, J = 2, 2.5 Hz, HC-4''), 3.95 (1H, dd, J = 2, 9 Hz, HC-1'), 3.71 (1H, dd, J = 1.5, 
1.5 Hz, HC-4), 3.32 (3H, s, H3COC-4), 3.29 (3H, s, H3COC-1'), 3.03-2.57 (13H, m), 2.94 
(3H, s, H3COC-1''), 2.41-2.30 (2H, m, HC-6'', HC-5''), 2.22 (3H, s, H3CCO2CHPhCO2C-
4''), 2.16 (1H, dd, J = 4, 8 Hz, HC-1''), 2.13 (1H, dddd, J = 2, 4, 8, 9 Hz, HC-3''), 1.94 
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(1H, dd, J = 3, 13 Hz, HC-2), 1.89 (1H, dddd, J = 2.5, 4, 14.5, 14.5 Hz, HC-5''), 1.61 (1H, 
dddd, J = 1.5, 3, 9, 12 Hz, HC-3), 1.49 (1H, dd, J = 10, 12 Hz, HC-6), 1.44 (1H, dddd, J 
= 1.5, 4, 4, 12 Hz, HC-5). 
 
13C NMR (125 MHz, CDCl3): 208.8 (s, C-4'), 170.7 (s, CO2CHPhCO2C-4''), 168.3 (s, 
CO2C-4''), 134.2 (s, Ph), 129.8 (d, Ph), 129.3 (d ×2, Ph), 128.1 (d ×2, Ph), 84.7 (d, C-1''), 
77.2 (d, C-1'), 74.8 (d, CHPhCO2C-4''), 74.1 (d, C-4), 70.7 (d, C-4''), 61.1 (q, CH3OC-1''), 
60.0 (q, CH3OC-1'), 59.6 (q, CH3OC-4), 54.7 (d, C-3'), 48.5 (d, C-3), 47.5 (d, C-5), 45.2 
(d, C-3''), 43.9 (t, C-5'), 32.1 (t, C-5''), 29.1 (t, C-2' or C-6'), 28.9 (t, C-2' or C-6'), 25.6 (t, 
C-6), 24.8 (t, C-2 or C-2''), 24.8 (t, C-2 or C-2''), 22.4 (t, C-6''), 20.9 (q, 
CH3CO2CHPhCO2C-4''). 
 
LRMS (EI), m/z (relative intensity):  626 ([M]+, 3), 562 (3), 479 (3), 407 (2), 337 (33), 
224 (40), 143 (100), 108 (37), 71 (54). 
 
HRMS m/z calcd. for C30H42O8S3:  626.2042; found:  626.2040. 
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273 
(S)-((3S,4R)-3-((R)-Methoxy((3R,4S,5R)-4-methoxy-5-((R)-methoxy((S)-4-
oxotetrahydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-thiopyran-3-
yl)methyl)tetrahydro-2H-thiopyran-4-yl)-2-acetoxy-2-phenylacetate 
 
DCC (7 mg, 0.03 mmol) was added to a stirred solution of ketol (−)-271 (5 mg, 
0.01 mmol), (S)-OAM (6 mg, 0.03) and DMAP (ca. 0.5 mg) in CH2Cl2 (2 mL) at 0 °C.  
After 30 min, the reaction was diluted with ethyl acetate (2 mL) and filtered through 
Celite®.  The combined filtrate and washings were washed sequentially with 10% w/v 
aqueous citric acid (3×), sat. aqueous NaHCO3 and brine (1× 20 mL), dried over Na2SO4, 
concentrated, and fractionated by PTLC (50% ethyl acetate in hexane) to give crude 273 
that was refractionated by PTLC (1% CH3OH in CH2Cl2) to give the titled compound 273 
(3 mg, 44%) containing ca. 10% (by 1H NMR) of the diastereoisomeric ester from the 
(R)-acid. 
 
IR (DRIFT) νmax:  2928, 1744, 1696, 1432, 1373, 1169 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 7.56-7.36 (5H, m, Ph), 5.95 (1H, s, HCPhCO2C-4''), 5.08 
(1H, br s, HC-4''), 4.00 (1H, dd, J = 1.5, 9 Hz, HC-1'), 3.96 (1H, br s, HC-4), 3.45 (3H, s, 
H3COC-4), 3.41 (3H, s, H3COC-1''), 3.31 (3H, s, H3COC-1'), 3.04-2.80 (9H, m), 2.75-
2.66 (2H, m, HC-3', HC-5'), 2.51 (1H, br d, J = 13.5 Hz, HC-2 or HC-6), 2.26-2.19 (5H, 
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m, H3CCO2CHPhCO2C-4'', HC-3'',HC-2'' or HC-6''), 2.12-1.95 (3H, m), 2.03 (1H, m, 
HC-5''), 1.82-1.72 (3H, m, HC-3, HC-5, HC-5''). 
 
13C NMR (125 MHz, CDCl3):  δ 208.8 (s, C-4'), 170.5 (s, CO2CHPhCO2C-4''), 168.4 (s, 
CO2C-4''), 133.9 (s, Ph), 129.7 (d, Ph), 129.2 (d ×2, Ph), 127.6 (d ×2, Ph), 84.6 (d, C-1''), 
77.1 (d, C-1'), 74.9 (d, CHPhCO2C-4''), 74.0 (d, C-4), 71.6 (d, C-4''), 60.5 (q, CH3OC-4), 
60.3 (q, CH3OC-1''), 59.4 (q, CH3OC-1'), 54.7 (d, C-3'), 48.6 (d, C-3 or C-5), 48.2 (d, C-3 
or C-5), 45.2 (d, C-3''), 43.9 (t, C-5'), 32.1 (t, C-5''), 29.1 (t, C-2' or C-6'), 28.8 (t, C-2' or 
C-6'), 25.1 (t), 24.8 (t), 24.7 (t), 22.3 (t, C-2'' or C-6''), 20.9 (q, CH3CO2CHPhCO2C-4''). 
 
LRMS (EI), m/z (relative intensity):  626 ([M]+, 2), 337 (36), 143 (100), 107 (12), 97 
(15), 71 (39). 
 
HRMS m/z calcd. for C30H42O8S3:  626.2042; found:  626.2046. 
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(−)-278 
(4S,5R,6R,7S,8R,9R,10S,11R)-11-Hydroxy-5,7,9-trimethoxy-4,6,8,10-
tetramethyltridecan-3-one 
 
Sodium acetate buffer (1.0 M in water, pH 5.2; 1.5 mL), sodium hypophosphite 
monohydrate (1 M in water; 1.5 mL) and Raney Ni (W-2) (ca. 1 mL settled volume; 
added as a suspension in ethanol) were sequentially added to a well-stirred solution of a 
ketol (−)-271 (31 mg, 0.069 mmol) in ethanol (2 mL) and THF (2 mL).  The resultant 
mixture was heated under reflux and additional Raney Ni was added every 2 h.  After 8 h, 
the reaction mixture was filtered through a pad of Celite® and the filter cake was rinsed 
sequentially with hot methanol (2× 20 mL), CH2Cl2 (2× 20 mL) and acetone (2× 20 mL).  
The combined filtrate and washings were concentrated and the residue was taken up in 
dichloromethane and washed with water, dried over Na2SO4, concentrated and 
fractionated by FCC (10-20% ethyl acetate in hexane) to give the titled ketol (−)-278 (15 
mg, 60%) ( 27D][α  –9; c 0.7, CH3OH). 
 
IR (DRIFT) νmax:  3436, 2926, 2835, 1703, 1654, 1354 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 3.65-3.57 (2H, m, HC-5, HC-11), 3.50-3.46 (4H, m, HC-
7, H3COC-7), 3.43 (3H, s, H3COC-9), 3.31 (3H, s, H3COC-5), 3.21 (1H, dd, J = 3, 6.5 
Hz, HC-9), 3.11-2.90 (1H, br s, HOC-11), 2.70-2.41 (3H, m, HC-4, H2C-2), 1.98 (1H, 
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ddq, J = 6.5, 6.5, 7 Hz, HC-8), 1.75-1.65 (2H, m, HC-6, HC-10), 1.60-1.37 (2H, m, H2C-
12), 1.11 (3H, d, J = 7 Hz, H3CC-4), 1.08 (3H, dd, J = 7.5, 7.5 Hz, H3C-1), 0.98 (3H, d, J 
= 7 Hz, H3CC-8), 0.93 (3H, t, J = 7.5 Hz, H3C-13), 0.92 (3H, t, J = 7 Hz, H3CC-6 or 
H3CC-10), 0.89 (3H, t, J = 7 Hz, H3CC-6 or H3CC-10). 
 
13C NMR (125 MHz, CDCl3):  δ 214.4 (s, C-3), 87.2 (d, C-9), 83.9 (d, C-5), 81.1 (d, C-
7), 77.7 (d, C-11), 61.1 (q, H3COC-7), 59.7 (q, H3COC-5), 58.6 (q, H3COC-9), 48.4 (d, 
C-4), 40.3 (d, C-6), 39.9 (d, C-8), 37.9 (d, C-10), 34.5 (t, C-2), 27.7 (t, C-12), 11.6 (q), 
11.0 (q), 10.8 (q), 9.9 (q), 8.2 (q), 7.6 (q). 
 
LRMS (CI, NH3), m/z (relative intensity):  361 ([M+1]+, 77), 329 (73), 297 (50), 239 
(313), 201 (76), 169 (100), 73 (65). 
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279 
(4R,5S,6S,7s,8R,9R,10S)-5,7,9-Trimethoxy-4,6,8,10-tetramethyltridecane-3,11-dione 
 
DMP (55 mg, 0.125 mmol) was added to a stirred solution of ketol (−)-278 (9 mg, 
0.025 mmol) in water-saturated CH2Cl2 (0.5 mL).  After 30 min, the mixture was diluted 
with ether and washed sequentially with a 1:1 mixture of 10% w/v aqueous Na2S2O3 and 
sat. aqueous NaHCO3, respectively, water and brine (20 mL). The aqueous washings 
were extracted with ether and the combined organic layers were dried over Na2SO4, 
concentrated and fractionated by PTLC (20% ethyl acetate in hexane) to give the titled 
diketone 279 (7 mg, 75%). 
 
IR (DRIFT) νmax:  2622, 1714, 1660, 1457, 1373, 1092 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 3.56-3.48 (3H, m, HC-5, HC-7, HC-9), 3.43 (3H, s, 
H3COC-7), 3.32 (6H, s, H3COC-5, H3COC-9), 2.72-2.45 (6H, m, H2C-2, HC-4, HC-10, 
H2C-12), 1.64 (2H, ddq, J = 4, 7, 7 Hz, HC-6, HC-8), 1.11 (6H, d, J = 7 Hz, H3CC-4, 
H3CC-10), 1.07 (6H, dd, J = 7.5, 7.5 Hz, H3C-1, H2C-13), 0.91 (6H, d, J = 7 Hz, H3CC-6, 
H3CC-8). 
 
13C NMR (125 MHz, CDCl3):  δ 214.46 (s ×2, C-3, C-11), 84.05 (d ×2, C-5, C-9), 79.73 
(d, C-7), 60.51 (q, H3COC-7), 59.84 (q ×2, H3COC-5, H3COC-9), 48.43 (d ×2, C-4,  C-
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10), 41.78 (q ×2, C-6, C-8), 34.59 (t ×2, C-2, C-12), 11.65 (q ×2, CH3C-4, CH3C-10), 
10.78 (t ×2, C-1, C-13), 8.11 (q ×2, CH3C-6, CH3C-8). 
 
LRMS (CI, NH3), m/z (relative intensity):  359 ([M+1]+, 8), 327 (40), 295 (38), 201 (39), 
169 (100), 129 (30), 57 (32). 
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297 
(3S,4r,5R)-3-((S)-Hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-5-((R)-
hydroxy((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)tetrahydro-2H-thiopyran-
4-ol 
 
Et2BOMe (1.00 mL, 761 mg, 7.61 mmol) was added to a stirred solution of bisaldol 
212a (3.12 g, 6.33 mmol) in MeOH (20 mL) and THF (80 mL) at −78 °C under argon.  
After 30 min, NaBH4 (1.92 g, 50.6 mmol) was added.  After 30 min, the reaction mixture 
was diluted with 3 M aqueous NaOH (40 mL) and warmed to room temperature over 1 h.  
The mixture was diluted with brine and extracted with CH2Cl2 (3×).  The combined 
organic layers were dried over Na2SO4 and concentrated.  To this residue was added 3 M 
aqueous NaOH (20 mL) and THF (20 mL) and after vigorous stirring for 24 h at room 
temperature, the mixture was diluted with brine and extracted with CH2Cl2 (3×).  The 
combined organic layers were dried over Na2SO4, concentrated, and fractionated by FCC 
(50-100% ethyl acetate in CH2Cl2) to give the titled triol 297 (2.20 g, 70%). 
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From mono-silyl diol 311: 
 
10% vol aqueous HF (1.5 mL) was added dropwise to a stirred solution of mono-
silyl diol 311 (146 mg, 0.258 mmol) in THF (15 mL) at room temperature.  After 30 min, 
sat. aqueous NaHCO3 was slowly added (caution:  effervescence) and the resulting 
mixture was diluted with EtOAc and washed sequentially with sat. aqueous NaHCO3 
(3×), brine, dried over Na2SO4, concentrated and fractionated by FCC (50-100% ethyl 
acetate in CH2Cl2) to give the titled triol 297 (113 mg, 95%). 
 
From mono-silyl bis-benzyl bis-ketal 313: 
 
Anhydrous NH3 (ca. 10 mL) was condensed to a solution of 313 (310 mg, 0.628 
mmol) in THF (10 mL) at −78 °C under Ar.  Lithium (2-3 2 mm3 pieces) were added 
over 5-10 min until a blue color persisted.  After 30 min, methanol (ca. 5 mL) was added 
dropwise followed by sat. aqueous NH4Cl (ca. 5 mL).  The mixture was warmed to room 
temperature over 2 h and diluted with sat. aqueous NaHCO3.  The mixture was extracted 
with CH2Cl2 (3×), dried over Na2SO4, concentrated and fractionated by PTLC (50-100% 
ethyl acetate in CH2Cl2) to give the titled triol 297 (209 mg, >95%). 
 
IR (DRIFT) νmax:  3412, 2906, 1429, 1173, 1042, 912 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 5.61 (1H, s, HOC-4), 4.17 (2H, d, J = 8 Hz, HC-1', HC-
1''), 4.13 (2H, s, HOC-1', HOC-1''), 4.11-3.90 (8H, m, H2C-2', H2C-3', H2C-2'', H2C-3''), 
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3.74 (1H, dd, J = 9.5, 9.5 Hz, HC-4), 3.07 (2H, dd, J = 12, 14 Hz, HC-7', HC-7''), 2.86 
(2H, ddd, J = 2, 13, 13 Hz, HC-9', HC-9''), 2.66 (2H, br d, J = 14 Hz, HC-7', HC-7''), 2.51 
(4H, m, HC-2, HC-6, HC-9', HC-9''), 2.34 (2H, dd, J = 12, 12 Hz, HC-2, HC-6), 2.14 
(2H, ddd, J = 3, 3, 13 Hz, HC-10', HC-10''), 2.08 (2H, dd, J = 2.5, 12 Hz, HC-6', HC-6''), 
1.98 (2H, dddd, J = 3.5, 9, 9, 11.5 Hz, HC-3, HC-5), 1.74 (2H, ddd, J = 3.5, 13, 13 Hz, 
HC-10', HC-10''). 
 
13C NMR (125 MHz, CDCl3):  δ 110.1 (s ×2, C-5', C-5''), 77.5 (d, C-4), 73.4 (d ×2, C-1', 
C-1''), 65.0 (t ×2, C-2', C-2'' or C-3', C-3''), 64.6 (t ×2, C-2', C-2'' or C-3', C-3''), 48.1 (d 
×2, C-3, C-5), 47.9 (d ×2, C-6', C-6''), 37.1 (t ×2, C-10', C-10''), 29.8 (t ×2, C-2, C-6), 
26.8 (t ×2, C-9', C-9''), 26.4 (t ×2, C-7', C-7''). 
 
LRMS (EI), m/z (relative intensity):  494 ([M]+, 2), 477 (2), 433 (3), 414 (6), 273 (11), 
159 (11), 99 (100). 
 
HRMS m/z calcd. for C21H34O7S3:  494.1467; found:  494.1484. 
 
 
 
 
 
 
 
  133
S S S
OO OHOO OO
9'' 7''
10''
2'' 3''
1''
3
26
5
1'
9'
10'
3' 2'
7'  
298 
(R)-((4S,4aS,8S,8aS)-2,2-Dimethyl-4-((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)hexahydrothiopyrano[4,3-d][1,3]dioxin-8-yl)((S)-1,4-dioxa-8-thiaspiro[4.5]decan-
6-yl)methanol 
 
A suspension of FeCl3⋅SiO2176 (3 mg) and triol 297 (10 mg, 0.02 mmol) in acetone 
(1 mL) was stirred at room temperature for 2 h.  The reaction mixture was filtered 
through SiO2 and was rinsed with ethyl acetate, concentrated and fractionated by PTLC 
(50% ethyl acetate in hexane) to obtain the titled 298 (8 mg, 74%). 
 
IR (DRIFT) νmax:  3498, 2627, 1706, 1431, 1388, 1248, 1043, 888 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.10-3.81 (10H, m), 3.69 (1H, dd, J = 10, 10 Hz, HC-4), 
3.26 (1H, m, HOC-1'), 3.03 (2H, ddd, J = 13.5, 13.5, 13.5 Hz), 2.91 (1H, dd, J = 13, 13 
Hz, HC-10' or HC-10''), 2.81 (1H, dd, J = 12, 12 Hz, HC-10' or HC-10''), 2.72-2.54 (5H, 
m), 2.47 (2H, dd, J = 12.5, 12.5 Hz), 2.29 (1H, dd, J = 12.5, 12.5 Hz, HC-3 or HC-5), 
2.16-1.99 (5H, m), 1.84 (1H, dd, J = 10.5, 10.5 Hz, HC-3 or HC-5), 1.74 (2H, dd, J = 
11.5, 11.5 Hz, HC-10', HC-10''), 1.45 (3H, s, H3CCO-1''), 1.34 (3H, s, H3CCO-1''). 
 
13C NMR (125 MHz, CDCl3):  δ 109.6 (s, C-5' or C-5''), 109.1 (s, C-5' or C-5''), 98.3 (s, 
COC-1''), 75.8 (d, C-4), 71.4 (d, C-1' or C-1''), 69.0 (d, C-1' or C-1''), 65.1 (t, C-2' or C-2'' 
or C-3' or C-3''), 65.0 (t ×2, C-2' or C-2'' or C-3' or C-3''), 64.8 (t, C-2' or C-2'' or C-3' or 
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C-3''), 48.3 (d, C-3' or C-5'' or C-6' or C-6''), 48.2 (d, C-3' or C-5'' or C-6' or C-6''), 47.5 
(d, C-3' or C-5'' or C-6' or C-6''), 44.1 (d, C-3 or C-5), 38.5 (t, C-10' or C-10''), 36.8 (t, C-
10' or C-10''), 30.5 (t), 30.2 (q, CH3COC-1''), 28.2 (t), 27.5 (t), 27.0 (t), 26.8 (t ×2), 19.4 
(q, CH3COC-1''). 
 
LRMS (EI), m/z (relative intensity):  534 ([M]+, 11), 414 (11), 199 (11), 159 (28), 99 
(100). 
 
HRMS m/z calcd. for  C24H38O7S3:  534.1780; found:  534.1781. 
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299 
(S)-3-((R)-((4S,4aS,8S,8aS)-2,2-Dimethyl-4-((R)-4-oxotetrahydro-2H-thiopyran-3-
yl)hexahydrothiopyrano[4,3-d][1,3]dioxin-8-yl)(hydroxy)methyl)dihydro-2H-
thiopyran-4(3H)-one 
 
A suspension of FeCl3⋅SiO2176 (10 mg) and triol 297 (50 mg, 0.10 mmol) in acetone 
(5 mL) was stirred at room temperature for 2 h and then refluxed for 1 h.  The reaction 
mixture was cooled to room temperature, filtered through SiO2, rinsed with ethyl acetate, 
concentrated and fractionated by FCC (20-40% ethyl acetate in hexane) to obtain the 
titled 299 (35 mg, 70%). 
 
IR (DRIFT) νmax:  3484, 2918, 1709, 1417, 1382, 1203, 1066, 900 cm-1. 
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1H NMR (500 MHz, CDCl3):  δ 4.40 (1H, dd, J = 2.5, 2.5 Hz, HC-1''), 4.16 (1H, dd, J = 
6, 6 Hz, HC-1'), 3.77 (1H, dd, J = 9.5, 9.5 Hz, HC-4), 3.46 (1H, d, J = 4 Hz, HOC-1'), 
3.20-2.20 (18H, m), 1.99 (1H, dddd, J = 3.5, 6, 9.5, 13 Hz, HC-3), 1.90 (1H, dddd, J = 
3.5, 10.5, 10.5, 10.5 Hz, HC-5), 1.54 (3H, s, H3CCOC-1''), 1.35 (3H, s, H3CCOC-1''). 
 
13C NMR (125 MHz, CDCl3):  δ 209.5 (s, C-4'), 207.4 (s, C-4''), 99.4 (s, COC-1''), 77.7 
(d, C-4), 73.5 (d, C-1'), 69.7 (d, C-1''), 56.7 (d, C-3'), 53.3 (d, C-3''), 46.5 (d, C-3), 44.2 (t, 
C-5' or C-5''), 43.7 (t, C-5' or C-5''), 43.3 (d, C-5), 30.1 (t), 29.9 (t), 29.9 (q, CH3COC-1''), 
29.6 (t, C-2), 28.4 (t), 28.2 (t, C-6), 27.5 (t), 19.7 (q, CH3COC-1''). 
 
LRMS (EI), m/z (relative intensity):  446 ([M]+, 15), 370 (91), 225 (10), 152 (35), 114 
(32). 
 
HRMS m/z calcd. for C20H30O5S3:  446.1255; found:  446.1260. 
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(3S,4r,5R)-4-Methoxymethoxy-3-((S)-(methoxymethoxy)((R)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methyl)-5-((R)-(methoxymethoxy)((S)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methyl)tetrahydro-2H-thiopyran 
 
i-Pr2EtN (0.094 mL, 69 mg, 0.54 mmol) was added to a stirred solution of triol 297 
(20 mg, 0.04 mmol) and n-Bu4NI (44 mg, 0.12 mmol) in CH2Cl2 (0.4 mL) at room 
temperature under Ar.  After 2 min, MOMCl (0.028 mL, 29 mg, 0.361 mmol) was added 
and the reaction was stirred vigorously for 3 d.  The mixture was diluted with 1% w/v 
aqueous citric acid and extracted with CH2Cl2 (3×). The combined organic layers were 
washed with sat. aqueous NaHCO3, dried over Na2SO4 and concentrated.  The residue 
was dissolved with CH2Cl2, filtered through a short silica pad (50% ethyl acetate in 
hexane then 100% ethyl acetate) and concentrated to give the titled 302 (25 mg, 95%). 
 
IR (DRIFT) νmax:  2917, 1412, 1264, 1146, 1022, 923 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.77 (2H, s, H2COC-4), 4.64 (4H, ap dd, J = 6.5, 6.5 Hz, 
H2COC-1', H2COC-1''), 4.08 (2H, dd, J = 3, 3 Hz, HC-1', HC-1''), 4.05-3.90 (8H, m, 
H2C-2', H2C-3', H2C-2'', H2C-3''), 3.60 (1H, dd, J = 9, 9 Hz, HC-4), 3.39 (6H, s, H3CO 
×2), 3.38 (3H, s, H3CO), 2.94-2.63 (8H, m), 2.55-2.42 (4H, m, HC-2, HC-6, HC-9', HC-
9''), 2.32-2.20 (4H, m, HC-3, HC-5, HC-6', HC-6''), 2.12 (2H, ddd, J = 3.5, 3.5, 13.5 Hz, 
HC-10', HC-10''), 1.71 (2H, ddd, J = 3.5, 13, 13 Hz, HC-10', HC-10''). 
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13C NMR (125 MHz, CDCl3):  δ 109.2 (s ×2, C5', C5''), 97.0 (t ×2, CH2OC-1'', CH2OC-
1'), 96.8 (t, CH2OC-4), 77.0 (d, C-4), 76.2 (d ×2, C-1', C-1''), 64.7 (t ×2, C-2', C-2'' or C-
3', C-3''), 64.6 (t ×2, C-2', C-2'' or C-3', C-3''), 56.3 (q, CH3O), 56.1 (q ×2, CH3O), 50.3 (d 
×2, C-3, C-5), 48.6 (d ×2, C-6', C-6''), 36.7 (t ×2, C-10', C-10''), 29.1 (t ×2, C-7', C-7''), 
27.7 (t ×2, C-2, C-6), 26.9 (t ×2, C-9', C-9''). 
 
LRMS (EI), m/z (relative intensity):  626 ([M]+, 2), 549 (11), 487 (6), 361 (6), 199 (12), 
159 (15). 
 
HRMS m/z calcd. for C27H46O10S3:  626.2253; found:  626.2258. 
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(3S,4r,5R)-3-((S)-(Methoxymethoxy)((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)methyl)-5-((R)-(methoxymethoxy)((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)methyl)tetrahydro-2H-thiopyran-4-ol 
 
i-Pr2EtN (10.5 mL, 7.79 g, 60.1 mmol) was added to a stirred solution of triol 297 
(2.20 g, 4.45 mmol) and n-Bu4NI (4.9 g, 13 mmol) in CH2Cl2 (75 mL) at room 
temperature under Ar.  After 2 min, MOMCl (3.00 mL, 3.18 g, 40.0 mmol) was added 
and the reaction was stirred vigorously for 2 d.  The mixture was diluted with ethyl 
acetate and washed with 1% w/v aqueous citric acid (3×).  The combined organic layers 
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were washed with sat. aqueous NaHCO3, dried over Na2SO4, concentrated and 
fractionated by MPC (15% acetone in hexane) to give the titled 303 (1.82 g, 70%). 
 
IR (DRIFT) νmax:  3498, 2916, 1466, 1426, 1260, 1099, 913 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 4.68 (2H, d, J = 7 Hz, H2COC-1', H2COC-1''), 4.56 (2H, 
d, J = 7 Hz, H2COC-1', H2COC-1''), 4.10 (2H, br s, HC-1', HC-1''), 4.09-3.90 (8H, m, 
H2C-2', H2C-3', H2C-2'', H2C-3''), 3.58 (1H, d, J = 3.5 Hz, HOC-4), 3.43-3.30 (7H, m, 
HC-4, H3CO ×2), 2.85-2.76 (4H, m, HC-7', HC-7'', HC-9', HC-9''), 2.69 (2H, br d, J = 
13.5 Hz, HC-2, HC-6), 2.62 (2H, br d, J = 14 Hz, HC-7', HC-7''), 2.53-2.43 (4H, m, HC-
2, HC-6, HC-9', HC-9''), 2.26 (2H, br d, J = 11 Hz, HC-6', HC-6''), 2.15-2.06 (4H, m, 
HC-3, HC-5, HC-10', HC-10''), 1.73 (2H, ddd, J = 3.5, 13.5, 13.5 Hz, HC-10', HC-10''). 
 
13C NMR (125 MHz, CDCl3):  δ 109.6 (s ×2, C-5', C-5''), 96.3 (t ×2, CH2OC-1', CH2OC-
1''), 73.2 (d ×2, C-1', C-1''), 69.7 (d, C-4), 64.9 (t ×2, C-2', C-2'' or C-3', C-3''), 64.7 (t ×2, 
C-2', C-2'' or C-3', C-3''), 56.1 (q ×2, CH3O), 52.5 (d ×2, C-3, C-5), 48.0 (d ×2, C-6', C-
6''), 36.6 (t ×2, C-10',C-10''), 29.1 (t ×2, C-7', C-7''), 28.3 (t ×2, C-2, C-6), 26.8 (t ×2, C-
9', C-9''). 
 
LRMS (EI), m/z (relative intensity):  582 ([M]+, 2), 488 (7), 458 (14), 269 (2), 159 (14), 
133 (27), 131 (65), 99 (100), 67 (10). 
 
HRMS m/z calcd. for C25H42O9S3:  582.1991; found:  582.2013. 
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(3S,4r,5R)-4-(Benzyloxy)-3-((S)-(methoxymethoxy)((R)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methyl)-5-((R)-(methoxymethoxy)((S)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methyl)tetrahydro-2H-thiopyran 
 
A solution of alcohol 303 (1.77 g, 3.04 mmol) in THF (10 mL, plus 2× 10 mL 
washings) was added dropwise via syringe to a stirred suspension of 30% w/v KH in oil 
(ca. 30 mmol) in THF (15 mL) at 0 °C under Ar.  The resulting mixture was warmed to 
room temperature over 1 h and benzylbromide (0.80 mL, 1.14 g, 6.7 mmol) was added.  
After 1 h, the mixture was cooled to 0 °C and methanol (2 mL) was added dropwise via 
syringe (caution:  H2 evolution).  The mixture was diluted with H2O and extracted with 
CH2Cl2 (3×) and the combined organic layers were dried over Na2SO4, concentrated and 
fractionated by FCC (5-20% acetone in hexane) to give the titled product 304 (1.90 g, 
93%). 
 
IR (DRIFT) νmax:  2919, 1432, 1336, 1253, 1217, 1145, 1091 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 7.51-7.18 (5H, m, Ph), 4.70 (2H, d, J = 6.5 Hz, H2COC-
1', H2COC-1''), 4.68 (2H, s, H2COC-4), 4.63 (2H, d, J = 6.5 Hz, H2COC-1', H2COC-1''), 
4.15 (2H, s, HC-1', HC-1''), 4.00-3.79 (6H, m, H2C-2', H2C-3', H2C-2'', H2C-3''), 3.68-
3.60 (3H, m, H2C-2', H2C-3', H2C-2'', H2C-3'', HC-4), 3.43 (6H, s, H3CO ×2), 2.87 (2H, 
dd, J = 12.5, 12.5 Hz, HC-7', HC-7''), 2.85-2.75 (4H, m, HC-2, HC-6, HC-9', HC-9''), 
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2.63 (2H, br d, J = 14.5 Hz, HC-7', HC-7''), 2.59 (2H, dd, J = 12.5, 12.5 Hz, HC-2, HC-
6), 2.54-2.45 (4H, m, HC-3, HC-5, HC-9', HC-9''), 2.30 (2H, br d, J = 11 Hz, HC-6', HC-
6''), 2.10 (2H, br d, J = 13 Hz, HC-10', HC-10''), 1.72 (2H, ddd, J = 3, 13, 13 Hz, HC-10', 
HC-10''). 
 
13C NMR (125 MHz, CDCl3):  δ 139.8 (s, Ph), 128.3 (d ×2, Ph), 127.4 (d ×2, Ph), 127.1 
(d, Ph), 109.1 (s ×2, C-5, C-5''), 97.2 (t ×2, CH2OC-1', CH2OC-1''), 75.2 (d, C-4), 74.9 (d 
×2, C-1', C-1''), 66.7 (t, CH2OC-4), 64.59 (t ×2, C-2', C-2'' or C-3', C-3''), 64.58 (t ×2, C-
2', C-2'' or C-3', C-3''), 56.0 (q ×2, CH3O), 49.4 (d ×2, C-3, C-5), 48.2 (d ×2, C-6', C-6''), 
36.7 (t ×2, C-10', C-10''), 29.2 (t ×2, C-7', C-7''), 28.4 (t ×2, C-2, C-6), 26.9 (t ×2, C-9', C-
9''). 
 
LRMS (EI), m/z (relative intensity):  672 ([M]+, 1), 578 (9), 489 (12), 233 (12), 159 (9), 
99 (100). 
 
HRMS m/z calcd. for C32H48O9S3:  672.2460; found:  672.2441. 
 
 
 
 
 
 
 
  141
S S S
OBnO OO O
2
35
62''6''
5'' 1'
2'
5'
6'
1''
 
305 
(3R,3'S)-3,3'-((1R,2R,6S,7S,11r)-11-(Benzyloxy)-3,5-dioxa-9-
thiabicyclo[5.3.1]undecane-2,6-diyl)bis(dihydro-2H-thiopyran-4(3H)-one) 
 
A stirred suspension of FeCl3⋅SiO2176 (1 g) and bis-MOM ketal 304 (100 mg, 0.15 
mmol) in acetone (20 mL) was heated under reflux for 2 h.  The reaction mixture was 
cooled to room temperature and filtered.  The combined filtrate and washings (20% 
methanol in CH2Cl2) were concentrated and the residue was dissolved in CH2Cl2, washed 
with sat. aqueous NaHCO3, dried over Na2SO4, concentrated, and fractionated by FCC 
(5-30% acetone in hexane) to obtain diketone 307 (41 mg, 55%) and the titled diketone 
305 (34 mg, 45%). 
 
IR (DRIFT) νmax:  2916, 1706, 1427, 1274, 1129, 1020, 754 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.30-7.09 (5H, m, Ph), 5.46 (1H, d, J = 8 Hz, H2COC-1', 
H2COC-1''), 5.28 (2H, dd, J = 2, 11 Hz, HC-1', HC-1''), 5.16 (1H, d, J = 8 Hz, H2COC-1', 
H2COC-1''), 4.25 (2H, s, H2COC-4), 4.19 (1H, dd, J = 3.5, 3.5 Hz, HC-4), 3.27 (2H, dd, J 
= 3, 14.5 Hz, HC-2, HC-6), 2.98 (2H, dd, J = 11, 14 Hz, HC-2', HC-2''), 2.51 (2H, ddd, J 
= 2.5, 4.5, 14 Hz, HC-2', HC-2''), 2.45-2.29 (6H, m), 2.22-2.09 (4H, m), 1.95 (2H, br dd, 
J = 2.5, 11 Hz, HC-3, HC-5), 1.53 (2H, d, J = 14 Hz, HC-2, HC-6). 
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13C NMR (125 MHz, C6D6):  δ 205.9 (s ×2, C-4', C-4''), 139.4 (s, Ph), 128.3 (d ×2, Ph), 
127.8 (d ×2, Ph), 127.7 (d, Ph), 100.8 (t, CH2OC-1', CH2OC-1''), 76.4 (d ×2, C-1', C-1''), 
74.3 (d, C-4), 72.1 (t, CH2OC-4), 56.9 (d ×2, C-3', C-3''), 44.3 (d ×2, C-5', C-5''), 37.0 (d 
×2, C-3, C-5), 26.3 (t ×2, C-6', C-6''), 29.0 (t ×2, C-2', C-2''), 25.6 (t ×2, C-2, C-6). 
 
LRMS (EI), m/z (relative intensity):  508 ([M]+, 6), 399 (2), 384 (2), 226 (8), 91 (100), 
67 (31). 
 
HRMS m/z calcd. for C25H32O5S3:  508.1412; found:  508.1411. 
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306 
(3R,3'S)-3,3'-((1S,1'R)-((3R,4r,5S)-4-(Benzyloxy)tetrahydro-2H-thiopyran-3,5-
diyl)bis((methoxymethoxy)methylene))bis(dihydro-2H-thiopyran-4(3H)-one) 
 
FeCl3⋅6H2O (600 mg, 2.22 mmol) was added to a well-stirred solution of bis-MOM 
ketal 304 (100 mg, 0.15 mmol) in 20% acetone in CH2Cl2 (10 mL).  After 4 h, the 
mixture was diluted with ethyl acetate and washed with 1% w/v aqueous citric acid (3×).  
The combined organic layers were washed with sat. aqueous NaHCO3, dried over 
Na2SO4 and concentrated to give crude diketones (87 mg) which was a mixture (ca. 1:1) 
of MOM protected and MOM deprotected diketones by 1H NMR.  The crude was 
subjected to MOM protection by addition of i-Pr2EtN (0.37 mL, 0.27 g, 2.12 mmol) and 
n-Bu4NI (129 mg, 0.35 mmol) in CH2Cl2 (4 mL) at room temperature under Ar.  After 2 
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min, MOMCl (0.08 mL, 85 mg, 1.1 mmol) was added and the reaction was stirred 
vigorously for 1 d.  The mixture was diluted with ethyl acetate and washed with 1% w/v 
aqueous citric acid (3×).  The combined organic layers were washed with sat. aqueous 
NaHCO3, dried over Na2SO4, concentrated, and recrystallized from benzene to give the 
titled diketone 306 (47 mg, 54%). 
 
IR (DRIFT) νmax:  2910, 1693, 1420, 1103, 1033, 919 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 7.49-7.28 (5H, m, Ph), 4.80 (2H, d, J = 6.5 Hz, H2COC-
1', H2COC-1''), 4.72 (2H, d, J = 6.5 Hz, H2OC-1', H2COC-1''), 4.60 (2H, s, H2COC-4), 
4.51 (2H, dd, J = 2.5, 7.5 Hz, HC-1', HC-1''), 3.43 (6H, s, H3CO ×2), 3.29 (1H, dd, J = 
10, 10 Hz, HC-4), 3.08 (2H, ddd, J = 4, 8, 8 Hz, HC-3', HC-3''), 3.03-2.91 (4H, m, H2C-
2', H2C-2''), 2.89-2.84 (4H, m, H2C-6', H2C-6''), 2.80 (2H, br d, J = 13 Hz, HC-2, HC-6), 
2.78-2.71 (2H, m, HC-5', HC-5''), 2.63 (2H, dd, J = 12, 12 Hz, HC-2, HC-6), 2.59-2.52 
(2H, m, HC-5', HC-5''), 2.41 (2H, dddd, J = 2.5, 2.5, 10.5, 10.5 Hz, HC-3, HC-5). 
 
13C NMR (125 MHz, CDCl3):  δ 209.8 (s ×2, C-5', C-5''), 138.1 (s, Ph), 128.8 (d ×2, Ph), 
128.6 (d ×2, Ph), 128.0 (d, Ph), 95.5 (t ×2, CH2OC-1', CH2OC-1''), 77.1 (d, C-4), 76.5 (d 
×2, C-1', C-1''), 67.9 (t, CH2OC-4), 56.3 (q ×2, CH3O), 55.7 (d ×2, C-3', C-3''), 48.7 (d 
×2, C-3, C-5), 44.3 (d ×2, C-5', C-5''), 33.6 (t ×2, C-2', C-2''), 31.3 (t ×2, C-6', C-6''), 29.6 
(t ×2, C-2, C-6). 
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LRMS (EI), m/z (relative intensity):  584 ([M]+, 10), 553 (48), 490 (92), 353 (76), 351 
(48), 289 (14), 281 (28), 265 (43), 215 (100). 
 
HRMS m/z calcd. for C28H40O7S3:  584.1936; found:  584.1942. 
 
S S S
OBnOH OHO O
2
35
62''6''
5'' 1'
2'
5'
6'
1''
 
307 
(3R,3'S)-3,3'-((1S,1'R)-((3R,4s,5S)-4-(Benzyloxy)tetrahydro-2H-thiopyran-3,5-
diyl)bis(hydroxymethylene))bis(dihydro-2H-thiopyran-4(3H)-one) 
 
FeCl3⋅6H2O (10.30 g, 38.11 mmol) was added to a well-stirred solution of bis-TMS 
ketal 314 (1.72 g, 2.36 mmol) in 20% acetone in CH2Cl2 (170 mL).  After 12 h, the 
mixture was diluted with 1% w/v aqueous citric acid and extracted with CH2Cl2 (4×).  
The combined organic layers were washed with sat. aqueous NaHCO3, dried over 
Na2SO4, concentrated, and fractionated by FCC (30% acetone in hexane) to obtain the 
titled diketone 307 (0.95 g, 81%). 
 
From bis-MOM ketal 304: 
 
A stirred suspension of FeCl3⋅SiO2176 (1 g) and bis-MOM ketal 304 (100 mg, 0.15 
mmol) in acetone (20 mL) was heated under reflux for 2 h.  The reaction mixture was 
cooled to room temperature and filtered.  The combined filtrate and washings (20% 
methanol in CH2Cl2) were concentrated and the residue was dissolved in CH2Cl2, washed 
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with sat. aqueous NaHCO3, dried over Na2SO4, concentrated and fractionated by FCC (5-
30% acetone in hexane) to obtain diketone 305 (34 mg, 45%) and the titled diketone 307 
(41 mg, 55%). 
 
IR (DRIFT) νmax:  3474, 2916, 1699, 1610, 1458, 1109, 817 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.35-7.06 (5H, m, Ph), 4.87 (2H, d, J = 9.5 Hz, HC-1', 
HC-1''), 4.41 (2H, s, H2COC-4), 4.21 (1H, dd, J = 4, 4 Hz, HC-4), 3.53 (2H, br s, HOC-
1', HOC-1''), 3.01 (2H, dd, J = 3, 14 Hz, HC-2, HC-6), 2.89 (2H, dd, J = 11.5, 13.5 Hz, 
HC-2', HC-2''), 2.61 (2H, ddd, J = 3, 4.5, 11.5 Hz, HC-3', HC-3''), 2.49 (2H, ddd, J = 2.5, 
4.5, 13.5 Hz, HC-2', HC-2''), 2.42 (2H, ddd, J = 4, 11.5, 15 Hz, HC-6', HC-6''), 2.32 (2H, 
ddd, J = 3.5, 3.5, 13 Hz, HC-5', HC-5''), 2.22-2.08 (4H, m, HC-5', HC-5'', HC-6', HC-6''), 
2.05 (2H, dddd, J = 3, 4, 4.5, 9.5 Hz, HC-3, HC-5), 1.86 (2H, dd, J = 4.5, 14 Hz, HC-2, 
HC-6). 
 
13C NMR (125 MHz, C6D6):  δ 210.2 (s ×2, C-3', C-3''), 139.6 (s, Ph), 129.0 (d ×2, Ph), 
128.7 (d ×2, Ph), 128.2 (d, Ph), 74.8 (d, C-4), 71.8 (t, CH2OC-4), 69.3 (d ×2, C-1', C-1''), 
55.7 (d ×2, C-3', C-3''), 44.9 (t ×2, C-5', C-5''), 40.9 (d ×2, C-3, C-5), 30.2 (t ×2, C-6', C-
6''), 29.6 (t ×2, C-2', C-2''), 25.9 (t ×2, C-2, C-2). 
 
HRMS m/z calcd. for C24H32O5S3:  496.1412 (519.1304 for M+Na); found:  519.1328 
(TOF, CH3OH). 
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308 
(3R,3'S)-3,3'-((1S,1'R)-((3R,4r,5S)-4-(Benzyloxy)tetrahydro-2H-thiopyran-3,5-
diyl)bis((triethylsilyloxy)methylene))bis(dihydro-2H-thiopyran-4(3H)-one) 
 
2,6-Lutidine (2.21 mL, 2.04 g, 19.1 mmol) was added to a stirred solution of 
diketone 307 (0.95 g, 1.91 mmol) in CH2Cl2 (95 mL) at 0 °C under Ar.  After 2 min, 
TESOTf (2.15 mL, 2.28 g, 9.53 mmol) was added and the reaction was stirred vigorously 
for 15 min.  Methanol (2 mL) was added and the mixture was diluted with ethyl acetate 
and washed with 1% w/v aqueous citric acid (3×).  The combined organic layers were 
washed with sat. aqueous NaHCO3, dried over Na2SO4, concentrated, and fractionated by 
FCC (30% ether in hexane) to give bis-silyl diketone 308 (1.11 g, 83%). 
 
From bis-silyl enol ether 316:  
 
Aqueous sat. NaHCO3 (0.2 mL) was added dropwise to a stirred solution of bis-
silyl enol ether 316 (19 mg, 0.02 mmol) in methanol (1 mL) and THF (1 mL) at room 
temperature.  After 1 h, the reaction was diluted with water and extracted with CH2Cl2 
(3×).  The combined organic extracts were dried over Na2SO4, concentrated and 
fractionated by PTLC (50% ether in hexane) to give the titled bis-silyl diketone 308 (15 
mg, >95%). 
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IR (DRIFT) νmax:  2948, 1703, 1142, 1245, 1084, 763 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.84-7.03 (5H, m, Ph), 4.85 (2H, br s, HC-1', HC-1''), 4.74 
(2H, br s, H2COC-4), 3.52 (1H, dd, J = 10, 10 Hz, HC-4), 3.27 (2H, br s, HC-3', HC-3''), 
3.00 (2H, br d, J = 13 Hz, HC-2', HC-2''), 2.94 (2H, br d, J = 13 Hz, HC-2, HC-6), 2.81 
(2H, dd, J = 13, 13 Hz, HC-2', HC-2''), 2.54 (2H, dd, J = 12.5, 12.5 Hz, HC-2, HC-6), 
2.47-2.35 (4H, m, HC-3, HC-5, HC-6', HC-6''), 2.33 (2H, ddd, J = 4.5, 4.5, 13 Hz, HC-5', 
HC-5''), 2.23 (2H, dddd, J = 2.5, 5, 5, 13 Hz, HC-6', HC-6''), 2.13 (2H, ddd, J = 5, 13, 13 
Hz, HC-5', HC-5''), 0.96 (18H, m, (H3CC)3Si, ×2), 0.62 (12H, m, (H2C)3Si, ×2). 
 
13C NMR (125 MHz, C6D6):  δ 209.1 (s ×2, C-4', C-4''), 138.8 (s, Ph), 129.4 (d ×2, Ph), 
129.2 (d ×2, Ph), 128.7 (d, Ph), 78.6 (d, C-4), 71.7 (t, CH2OC-4), 71.3 (d ×2, C-1', C-1''), 
57.1 (d ×2, C-3', C-3''), 53.4 (d ×2, C-3, C-5), 45.1 (t ×2, C-5', C-5''), 33.9 (t ×2, C-2', C-
2''), 31.2 (t ×2, C-2, C-6), 31.0 (t ×2, C-6', C-6''), 7.7 (t ×6, (CH2)Si), 6.0 (q ×6, 
(CH3C)Si). 
 
LRMS (EI), m/z (relative intensity):  724 ([M]+, 1), 589 (8), 457 (12), 259 (32), 171 (65), 
91 (100). 
 
HRMS m/z calcd. for C36H60O5S3Si2:  724.3141; found:  724.3142. 
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311 
(R)-((3S,4s,5R)-5-((S)-Hydroxy((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-4-
(trimethylsilyloxy)tetrahydro-2H-thiopyran-3-yl)((S)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methanol 
 
IR (DRIFT) νmax:  3462, 3341, 2954, 1616, 1420, 1331, 1147, 1052 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 4.90 (2H, d, J = 11 Hz, HC-1', HC-1''), 4.72 (1H, dd, J = 
3, 3 Hz, HC-4), 4.00 (2H, s, HOC-1', HOC-1''), 3.74-3.27 (8H, m, H2C-2', H2C-3', H2C-
2'', H2C-3''), 3.31-3.23 (4H, m, HC-7', HC-7'', HC-2, HC-6), 2.77 (2H, ddd, J = 3, 13, 13 
Hz, HC-9', HC-9''), 2.68 (2H, ddd, J = 3, 3, 14 Hz, HC-7', HC-7''), 2.21 (2H, ddd, J = 3.5, 
6, 13 Hz, HC-9', HC-9''), 2.10-2.01 (4H, m, HC-2, HC-6, HC-6', HC-6''), 1.86-1.77 (4H, 
m, HC-3, HC-5, HC-10', HC-10''), 1.69 (2H, ddd, J = 3.5, 13, 13 Hz, HC-10', HC-10''), 
0.12 (9H, s, (H3C)3Si). 
 
13C NMR (125 MHz, C6D6):  δ 110.8 (s ×2, C-5', C-5''), 67.8 (d ×2, C-1', C-1''), 65.9 (d, 
C-4), 65.5 (t ×2, C-2', C-2'' or C-3', C-3''), 64.9 (t ×2, C-2', C-2'' or C-3', C-3''), 49.6 (d 
×2, C-6', C-6''), 44.6 (d ×2, C-3, C-5), 38.1 (t ×2, C-10', C-10''), 27.2 (t ×2, C-9', C-9''), 
26.5 (t ×2, C-7', C-7''), 25.9 (t ×2, C-2, C-6), 0.3 (q ×3, (CH3)Si). 
 
LRMS (EI), m/z (relative intensity):  566 ([M]+, 4), 476 (11), 373 (1), 287 (2), 199 (4), 
189 (18), 159 (11), 99 (100), 73 (43). 
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HRMS m/z calcd. for C24H42O7S3Si:  566.1862; found:  566.1856. 
 
LRMS (EI), m/z (relative intensity):  341 ([M−29]+, 3), 279 (3), 145 (6), 143 (3), 101 
(100), 69 (10), 57 (11). 
 
HRMS m/z calcd. for C21H38O5:  370.2719 (341.2328 for M−C2H5); found:  341.2316. 
 
S S S
OH
TMS
OOO OO
9'' 7''
10''
2'' 3''
1''
3
26
5
1'
9'
10'
3' 2'
7'
TMS
O
 
312 
(3R,4r,5S)-3-((R)-((S)-1,4-Dioxa-8-thiaspiro[4.5]decan-6-
yl)(trimethylsilyloxy)methyl)-5-((S)-((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-
yl)(trimethylsilyloxy)methyl)tetrahydro-2H-thiopyran-4-ol 
 
i-Pr2EtN (6.23 mL, 4.65 g, 36.0 mmol) was added to a stirred solution of triol 297 
(1.78 g, 3.60 mmol) in CH2Cl2 (180 mL) at room temperature under Ar.  After 2 min, 
TMSCl (2.28 mL, 1.95 g, 17.9 mmol) was added and the reaction was stirred vigorously 
for 2 d.  The mixture was diluted with ethyl acetate and washed with 1% w/v aqueous 
citric acid (3×).  The combined organic layers were washed with sat. aqueous NaHCO3, 
dried over Na2SO4, concentrated, and fractionated by FCC (20% ethyl acetate in hexane) 
to give mono-silyl diol 311 (0.32 g, 15%) and the titled bis-TMS alcohol 312 (1.97 g, 
85%). 
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IR (DRIFT) νmax:  3493, 2916, 1724, 1426, 1242, 1039, 887 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 4.33 (2H, dd, J = 3, 3 Hz, HC-1', HC-1''), 3.65 (1H, ddd, J 
= 4, 9.5, 9.5 Hz, HC-4), 3.56 (1H, d, J = 4 Hz, HOC-4), 3.52-3.20 (8H, m, H2C-2', H2C-
3', H2C-2'', H2C-3''), 3.03 (2H, dd, J = 11, 14 Hz, HC-7', HC-7''), 2.84 (2H, ddd, J = 3, 3, 
14 Hz, HC-7', HC-7''), 2.76 (2H, br d, J = 13 Hz, HC-2, HC-6), 2.67 (2H, ddd, J = 3, 13, 
13 Hz, HC-9', HC-9''), 2.53 (2H, ddd, J = 3.5, 3.5, 11 Hz, HC-6', HC-6''), 2.46 (2H, dd, J 
= 12.5, 12.5 Hz, HC-2, HC-6), 2.38 (2H, dddd, J = 2.5, 2.5, 10, 12 Hz, HC-3, HC-5), 
2.22 (2H, ddd, J = 4, 4, 13.5 Hz, HC-9', HC-9''), 1.71 (2H, ddd, J = 4, 4, 13.5 Hz, HC-10', 
HC-10''), 1.57 (2H, ddd, J = 3.5, 13, 13 Hz, HC-10', HC-10''), 0.16 (18H, s, (H3C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 110.4 (s ×2, C-5', C-5''), 70.3 (d ×2, C-1', C-1''), 70.2 (d, 
C-4), 64.1 (t ×2, C-2', C-2'' or C-3', C-3''), 64.0 (t ×2, C-2', C-2'' or C-3', C-3''), 54.9 (d 
×2, C-3, C-5), 48.3 (d ×2, C-6', C-6''), 36.2 (t ×2, C-10', C-10''), 29.5 (t ×2, C-7', C-7''), 
29.1 (t ×2, C-2, C-6), 26.7 (t ×2, C-9', C-9''), 0.5 (q ×6, (CH3)Si). 
 
LRMS (EI), m/z (relative intensity):  638 ([M]+, 1), 533 (10), 489 (1), 377 (1), 261 (50), 
132 (30), 129 (100), 75 (12). 
 
HRMS m/z calcd. for C27H50O7S3Si2:  638.2257; found:  638.2242. 
 
 
 
  151
S S S
OBnOBn
TMS
O
OO OO
9'' 7''
10''
2'' 3''
1''
3
26
5
1'
9'
10'
3' 2'
7'  
313 
((R)-((3R,4R,5S)-4-(Benzyloxy)-5-((S)-benzyloxy((R)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methyl)tetrahydro-2H-thiopyran-3-yl)((S)-1,4-dioxa-8-
thiaspiro[4.5]decan-6-yl)methoxy)trimethylsilane 
 
IR (DRIFT) νmax:  2912, 1495, 1305, 1153, 948 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.49-7.00 (10H, m, Ph), 4.97 (2H, ap dd, J = 12.5, 12.5 
Hz, H2COC-4), 4.64 (1H, d, J = 11 Hz, H2COC-1''), 4.50 (1H, d, J = 11 Hz, H2COC-1''), 
4.34 (1H, br s), 4.23 (1H, d, J = 5 Hz, HC-1'), 4.01 (1H, dd, J = 3.5, 3.5 Hz, HC-1''), 3.90 
(1H, dd, J = 8, 8 Hz, HC-4), 3.55-3.25 (7H, m, H2C-2', H2C-3', H2C-2'', H2C-3''), 3.22 
(1H, dd, J = 10.5, 13.5 Hz, HC-6), 2.99 (1H, dd, J = 10, 13.5 Hz), 2.89-2.5 (12H, m), 
2.28 (2H, m, H2C-9' or H2C-9''), 1.79 (1H, ddd, J = 3, 3, 13.5 Hz, H2C-10' or H2C-10''), 
1.74 (1H, ddd, J = 3, 6, 13.5 Hz, H2C-10' or H2C-10''), 1.69-1.58 (1H, m, H2C-10' or 
H2C-10''), 1.52 (1H, ddd, J = 3.5, 11, 13.5 Hz, H2C-10' or H2C-10''), 0.20 (9H, s, 
(H3C)3Si). 
 
13C NMR (125 MHz, C6D6):  δ 140.8 (s, Ph), 139.9 (s, Ph), 128.91 (d, Ph), 128.87 (d, 
Ph), 128.7 (d, Ph), 128.0 (d, Ph), 127.8 (d, Ph), 127.4 (d, Ph), 127.3 (d, Ph), 127.2 (d, Ph), 
110.2 (s, C-5'), 109.9 (s, C-5''), 78.8 (d, C-1''), 77.8 (d, C-4), 74.5 (t, CH2OC-1''), 73.3 (d, 
C-1'), 70.6 (t, CH2OC-4), 65.3 (t, C-2', C-2'' or C-3', C-3''), 64.7 (t, C-2', C-2'' or C-3', C-
3''), 64.5 (t, C-2', C-2'' or C-3', C-3''), 64.3 (t, C-2', C-2'' or C-3', C-3''), 52.7 (d, C-3), 50.5 
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(d, C-5), 50.0 (d, C-6''), 49.2 (d, C-6'), 36.9 (t, C-10' or C-10''), 36.4 (t, C-10' or C-10''), 
30.1 (t ×3), 29.6 (t, C-6), 27.3 (t), 27.1 (t), 1.2 (q ×3, (CH3)Si). 
 
LRMS (EI), m/z (relative intensity):  746 ([M]+, 15), 656 (35), 549 (72), 459 (42), 261 
(36), 99 (100). 
 
HRMS m/z calcd. for C38H54O7S3Si:  746.2801; found:  746.2823. 
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314 
((S)-((3S,4r,5R)-5-((R)-((S)-1,4-Dioxa-8-thiaspiro[4.5]decan-6-
yl)(trimethylsilyloxy)methyl)-4-(benzyloxy)tetrahydro-2H-thiopyran-3-yl)((R)-1,4-
dioxa-8-thiaspiro[4.5]decan-6-yl)methoxy)trimethylsilane 
 
A solution of alcohol 312 (552 mg, 0.864 mmol) in THF (10 mL, plus 2× 5 mL 
washings) was added dropwise via syringe to a stirred suspension of 30% w/v KH in oil 
(ca. 2 mmol) in THF (10 mL) at 0 °C under Ar.  The resulting mixture was warmed to 
room temperature over 1 h and benzylbromide (1.03 mL, 1.47 g, 8.64 mmol) was added.  
After 8-12 h, the mixture was cooled to 0 °C and 2-propanol (2 mL) was added dropwise 
via syringe (caution:  H2 evolution).  The mixture was diluted with aqueous phosphate 
buffer (0.1 M, pH 7; 2.0 mL) and extracted with CH2Cl2 (3×) and the combined organic 
layers were dried over Na2SO4, concentrated and fractionated by FCC (5-10% ethyl 
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acetate in hexane) to give bis-benzyl mono-silyl 313 (97 mg, 15%) and the titled bis-silyl 
314 (512 mg, 81%). 
 
IR (DRIFT) νmax:  2947, 1415, 1254, 1099, 895 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.58-7.09 (5H, m, Ph), 5.11 (2H, s, H2COC-4), 4.17 (2H, 
br d, J = 4.5 Hz, HC-1', HC-1''), 3.79 (1H, dd, J = 8.5, 8.5 Hz, HC-4), 3.55-3.24 (8H, m, 
H2C-2', H2C-3', H2C-2'', H2C-3''), 2.95 (2H, dd, J = 10, 13.5 Hz, HC-7', HC-7''), 2.83 (2H, 
br d, J = 14 Hz, HC-9', HC-9''), 2.80-2.63 (8H, m), 2.58 (2H, ddd, J = 2.5, 10.5, 13 Hz, 
HC-6', HC-6''), 2.33 (2H, br d, J = 14 Hz, HC-9', HC-9''), 1.75 (2H, ddd, J = 3, 6, 13.5 
Hz, HC-10', HC-10''), 1.57 (2H, ddd, J = 3, 10.5, 13.5 Hz, HC-10', HC-10''), 0.20 (18H, s, 
(H3C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 140.7 (s, Ph), 128.9 (d ×2, Ph), 127.5 (d ×2, Ph), 127.2 
(d, Ph), 110.2 (s ×2, C-5', C-5''), 71.5 (d ×3, C-1', C-1'', C-4), 64.4 (t ×2, C-2', C-2'' or C-
3', C-3''), 64.3 (t ×3, C-2', C-2'' or C-3', C-3'', CH2OC-4), 53.3 (d ×2, C-3, C-5), 49.4 (d 
×2, C-6', C-6''), 36.3 (t ×2, C-10', C-10''), 30.1 (t ×4), 27.1 (t ×2, C-9', C-9''), 1.3 (q ×6, 
(CH3)Si) 
 
LRMS (EI), m/z (relative intensity):  728 ([M]+, 1), 548 (7), 261 (72), 99 (100), 73 (71), 
55 (3)  
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HRMS m/z calcd. for C34H56O7S3Si2:  728.2727 (751.2618 for M+Na); found:  728.2733; 
751.2640 (ESI, CH3OH). 
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315 
(S)-3-((R)-((3R,4R,5S)-4-(Benzyloxy)-5-((S)-(triethylsilyloxy)((R)-4-
(trimethylsilyloxy)-3,6-dihydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-
thiopyran-3-yl)(triethylsilyloxy)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
A solution of n-BuLi in hexanes (2.2 M; 0.086 mL, 0.19 mmol) was added 
dropwise via syringe to a solution of (S,S)-bis(1-phenylethyl)amine (0.044 mL, 43 mg, 
0.19 mmol) in THF (5 mL) at –78 °C under Ar.  After stirring for 30 min at –78 °C the 
resulting pink solution was quickly transferred via cannula (ca. 15-30 sec.) into a well-
stirred solution of diketone 308 (92 mg, 0.127 mmol) and TMSCl (0.16 mL, 138 mg, 
1.27 mmol) in THF (13 mL) at –100 °C under Ar.  After 15 min, the reaction was 
quenched by addition of acetone (0.5 mL) followed by Et3N (0.5 mL) and sat. aqueous 
NaHCO3.  The resulting cold mixture was diluted with ethyl acetate and washed 
sequentially with 1% w/v aqueous citric acid (4×), sat. aqueous NaHCO3 and brine, dried 
over Na2SO4, concentrated, and fractionated by FCC (5-30% ether in hexane) to give the 
bis-silyl enol ether 316 (19 mg, 17%), recovered diketone 308 (8 mg, 8%) and the titled 
mono-silyl enol ether 315 (67 mg, 66%) ( 23D][α −21; c 4.0, C6H6; >90% ee by 1H NMR 
analysis of Mosher's ester 360 and/or 361). 
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IR (DRIFT) νmax:  2953, 1712, 1660, 1497, 1377, 1156, 1070 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.88-7.09 (5H, m, Ph), 5.30 (1H, br s, HC-1'), 4.95 (1H, 
br d, J = 8 Hz, HC-1''), 4.90 (1H, dd, J = 4, 4 Hz, HC-5''), 4.83 (1H, d, J = 9.5 Hz, 
H2COC-4), 4.48 (1H, d, J = 9.5 Hz, H2COC-4), 3.65 (1H, dd, J = 10, 10 Hz, HC-4), 3.27 
(1H, br dd, J = 12.5, 12.5 Hz), 3.18 (1H, dd, J = 3, 13 Hz), 3.13-2.87 (6H, m), 2.67-2.21 
(10H, m), 1.01 (9H, m, (H3CC)3Si), 0.99 (9H, m, (H3CC)3Si), 0.79 (6H, m, (H2C)3Si), 
0.69 (6H, m, (H2C)3Si), 0.19 (9H, s, (H3C)3SiOC-4''). 
 
13C NMR (125 MHz, C6D6):  δ 207.3 (s, C-4'), 152.1 (s, C-4''), 139.5 (s, Ph), 129.4 (d, 
Ph), 128.9 (d, Ph), 128.7 (d, Ph), 128.4 (d, Ph), 128.2 (d, Ph), 107.1 (d, C-5''), 77.8 (d, C-
4), 74.2 (t, CH2OC-4), 73.5 (d, C-1' or C-1''), 73.4 (d, C-1' or C-1''), 56.3 (d ×3, t), 45.1 
(t), 43.9 (d), 33.1 (t), 30.4 (t), 29.5 (t), 28.9 (t), 25.1 (t), 7.68 (t ×3, (CH2)3Si), 7.62 (t ×3, 
(CH2)Si), 6.2 (q ×3, (CH3C)Si), 5.8 (q ×3, (CH3C)Si), 0.8 (q ×3, (CH3)SiOC-4''). 
 
HRMS m/z calcd. for C39H68O5S3Si3:  796.3537 (819.3428 for M+Na); found:  819.3416 
(ESI, CH3OH). 
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316 
((S)-((3S,4r,5R)-4-(Benzyloxy)-5-((R)-(triethylsilyloxy)((S)-4-(trimethylsilyloxy)-3,6-
dihydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-thiopyran-3-yl)((R)-4-
(trimethylsilyloxy)-3,6-dihydro-2H-thiopyran-3-yl)methoxy)triethylsilane 
 
IR (DRIFT) νmax:  2955, 1660, 1458, 1413, 1156, 1095, 873 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.65-7.10 (5H, m, Ph), 5.02 (2H, dd, J = 4.5, 4.5 Hz, HC-
5', HC-5''), 4.94 (4H, m, HC-1', HC-1'', H2COC-4), 3.92 (1H, dd, J = 10, 10 Hz, HC-4), 
3.18 (2H, dd, J = 6.5, 13.5 Hz, HC-2', HC-2''), 3.09-3.03 (4H, m, H2C-2, H2C-6), 3.00 
(2H, dd, J = 3.5, 17 Hz, HC-6', HC-6''), 2.86 (2H, dd, J = 5, 17 Hz, HC-6', HC-6''), 2.75 
(2H, dd, J = 4.5, 13.5 Hz, HC-2', HC-2''), 2.71-2.64 (4H, m, HC-3', HC-3'', HC-3, HC-5), 
1.02 (18H, m, (H3CC)3Si, ×2), 0.72 (12H, m, (H2C)3Si, ×2), 0.11 (18H, s, (H3C)3SiOC-4', 
(H3C)3SiOC-4''). 
 
13C NMR (125 MHz, C6D6):  δ 152.3 (s ×2, C-4', C-4''), 140.1 (s, Ph), 128.8 (d ×2, Ph), 
128.7 (d ×2, Ph), 127.7 (d, Ph), 106.5 (d ×2, C-5', C-5''), 78.0 (d, C-4), 72.5 (d ×2, C-1', 
C-1''), 71.8 (t, CH2OC-4), 54.3 (d ×2, C-3, C-5), 44.6 (d ×2, C-3', C-3''), 29.4 (t ×2, C-2, 
C-6), 28.7 (t ×2, C-2', C-2''), 25.4 (t ×2, C,6', C-6''), 7.7 (q ×6, (CH3C)Si), 6.1 (t ×6, 
(CH2)Si), 0.7 (q ×6, (CH3)SiOC-4''). 
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HRMS m/z calcd. for C42H76O5S3Si4:  868.3932 (891.3824 for M+Na); found:  891.3857 
(ESI, CH3OH). 
 
O OO
SS 26
5 3
3' 2'
6'
7' 9'
10'1'
TES
O
 
317sa 
(R)-3-((R)-((R)-1,4-Dioxa-8-thiaspiro[4.5]decan-6-
yl)(triethylsilyloxy)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
2,6-Lutidine (0.43 mL, 0.40 g, 3.69 mmol) was added to a stirred solution of ketone 
209sa (255 mg, 0.84 mmol) in CH2Cl2 (20 mL) at 0 °C under Ar.  After 2 min, TESOTf 
(0.42 mL, 0.49 g, 1.84 mmol) was added and the reaction was stirred vigorously for 15 
min.  Methanol (2 mL) was added and the mixture was diluted with ethyl acetate and 
washed with 1% w/v aqueous citric acid (3×).  The combined organic layers were washed 
with sat. aqueous NaHCO3, dried over Na2SO4, concentrated and fractionated by FCC 
(30% ethyl acetate in hexane) to give silyl ketone 317sa (331 mg, 94%). 
 
IR (DRIFT) νmax:  2942, 1715, 1429, 1221, 1072, 745 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 5.43 (1H, dd, J = 2.5, 2.5 Hz, HC-1'), 3.60-3.32 (2H, m, 
H2C-2' or H2C-3'), 3.28 (1H, ddd, J = 2.5, 5, 11.5 Hz, HC-3), 3.20-3.08 (2H, m, H2C-2' or 
H2C-3'), 3.01-2.83 (4H, m, H2C-2, H2C-7), 2.70 (1H, ddd, J = 3.5, 13, 13 Hz, HC-9'), 
2.57 (1H, br dd, J = 10, 11 Hz, HC-6), 2.48-2.41 (2H, m, HC-5, HC-6'), 2.36-2.26 (2H, 
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m, HC-5, HC-6), 2.13 (1H, ddd, J = 3.5, 3.5, 13.5 Hz, HC-9'), 1.69-1.56 (2H, m, H2C-
10'), 1.01 (9H, m, (H3CC)3Si), 0.69 (6H, m, (H2C)3Si). 
 
13C NMR (125 MHz, C6D6):  δ 207.4 (s, C-4), 108.7 (s, C-5'), 65.4 (d, C-1'), 64.5 (t, C-2' 
or C-3'), 64.2 (t, C-2' or C-3'), 56.6 (d, C-3), 54.9 (d, C-6'), 44.8 (t, C-5), 37.8 (t, C-10'), 
32.4 (t, C-2), 30.2 (t, C-6), 27.7 (t, C-7'), 27.4 (t, C-9'), 7.6 (q ×3, (CH3C)Si), 5.7 (t ×3, 
(CH2)Si). 
 
LRMS (EI), m/z (relative intensity):  418 ([M]+, 2), 389 (35), 333 (9), 286 (15), 229 
(100), 171 (64), 99 (98). 
 
HRMS m/z calcd. for C19H34O4S2Si:  418.1668; found:  418.1660. 
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318sa 
(3R,5R)-3-((R)-(Methoxymethoxy)((R)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-
5-((E)-2-methylpent-2-enyl)dihydro-2H-thiopyran-4(3H)-one 
 
t-BuLi (1.7 M in pentane; 0.19 mL, 0.32 mmol) was added dropwise via syringe to 
a solution of ketone 210sa (100 mg, 0.29 mmol) in THF (6 mL) at −30 °C under Ar.  
After 30 min, allyl bromide (0.10 mL, 140 mg, 0.85 mmol) and HMPA (0.15 mL, 155 
mg, 0.86 mmol) were added sequentially.  After 2 h, the mixture was diluted with sat. 
aqueous NH4Cl and extracted with CH2Cl2 (3×).  The combined organic layers were dried 
over Na2SO4, concentrated and fractionated by FCC (10-50% ethyl acetate in hexane) to 
give recovered 210sa (20 mg, 20%) and the titled C-alkylated 318sa (98 mg, 79%; dr 
20:1). 
 
IR (DRIFT) νmax:  2961, 1701, 1414, 1169, 1103, 1038, 888 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 5.28 (1H, br dd, J = 7, 7 Hz, HC=C), 5.10 (1H, dd, J = 3, 
3 Hz, HC-1'), 4.67 (1H, d, J = 6.5 Hz, H2COC-1'), 4.51 (1H, d, J = 6.5 Hz, H2COC-1'), 
3.59 (1H, m, H2C-2' or H2C-3'), 3.47 (1H, ddd, J = 2.5, 5, 11.5 Hz, HC-3), 3.44-3.37 (2H, 
m, H2C-2' or H2C-3'), 3.18 (1H, m, H2C-2' or H2C-3'), 3.14 (3H, s, H3CO), 3.17 (1H, dd, 
J = 11.5, 13.5 Hz, HC-2), 2.97 (1H, dd, J = 12.5, 12.5 Hz, HC-7'), 2.87-2.70 (5H, m), 
2.68 (1H, ddd, J = 3, 3, 12 Hz, HC-6'), 2.56 (1H, dd, J = 10, 13.5 Hz, H2CC-5), 2.46 (1H, 
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ddd, J = 2, 5, 13 Hz, HC-6), 2.37 (1H, dd, J = 4, 13.5 Hz, H2CC-5), 2.17 (1H, dddd, J = 
2,5, 4, 4, 13.5 Hz, HC-9'), 1.94-1.84 (2H, m, H2CCH=C), 1.72-1.59 (2H, m, HC-10'), 
1.42 (3H, s, H3CC=C), 0.87 (3H, t, J = 7.5 Hz, H3CCCH=C). 
 
13C NMR (125 MHz, C6D6):  δ 211.0 (s, C-4), 131.2 (s, C=CH), 130.6 (d, CH=C), 109.5 
(s, C-5'), 98.1 (t, CH2OC-1'), 73.6 (d, C-1'), 64.7 (t, C-2' or C-3'), 64.3 (t, C-2' or C-3'), 
56.0 (q, CH3O), 53.8 (d, C-3), 52.0 (d, C-6'), 49.0 (d, C-5), 40.8 (t, CH2C-5), 37.9 (t, C-
10'), 32.5 (t, C-6), 31.0 (t, C-2), 29.1 (t, C-7'), 27.4 (t, C-9'), 21.9 (t, CH2CH=C), 15.9 (q, 
CH3C=C), 14.7 (q, CH3CCH=C). 
 
LRMS (EI), m/z (relative intensity):  430 ([M]+, 4), 368 (9), 199 (6), 159 (11) 132 (74). 
 
HRMS m/z calcd. for C21H34O5S2:  430.1848; found:  430.1833. 
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319sa 
(3R,5R)-3-((R)-((R)-1,4-Dioxa-8-thiaspiro[4.5]decan-6-yl)(triethylsilyloxy)methyl)-5-
((E)-2-methylpent-2-enyl)dihydro-2H-thiopyran-4(3H)-one 
 
t-BuLi (1.7 M in pentane; 0.06 mL, 0.10 mmol) was added dropwise via syringe to 
a solution of ketone 317sa (38 mg, 0.09 mmol) in THF (2 mL) at −30 °C under Ar.  After 
30 min, allyl bromide (0.030 mL, 42 mg, 0.26 mmol) and HMPA (0.050 mL, 52 mg, 0.27 
mmol) were added sequentially.  After 2h, the mixture was diluted with sat. aqueous 
NH4Cl and extracted with CH2Cl2 (3×).  The combined organic layers were dried over 
Na2SO4, concentrated and fractionated by FCC (10-50% ethyl acetate in hexane) to give 
recovered 317sa (5 mg, 13%) and the titled C-alkylated 319sa (40 mg, 87%; dr 20:1). 
 
IR (DRIFT) νmax:  2960, 1703, 1417, 1167, 1054, 739 cm-1. 
 
1H NMR (500 MHz, CDCl3):  δ 5.24 (1H, dd, J = 7, 7 Hz, HC=C), 5.05 (1H, dd, J = 2, 2 
Hz, HC-1'), 3.99-3.73 (4H, m, H2C-2', H2C-3'), 3.24 (1H, ddd, J = 1.5, 5, 11.5 Hz, HC-3), 
3.02-2.70 (7H, m), 2.58 (1H, ddd, J = 2, 5, 13 Hz, HC-2), 2.51 (1H, dd, J = 11, 13.5 Hz, 
H2CC-5), 2.44 (1H, dddd, J = 3.5, 3.5, 3.5, 13.5 Hz, HC-10'), 2.21-2.12 (2H, m), 2.05-
1.93 (3H, m), 1.66 (1H, ddd, J = 3.5, 13.5, 13.5 Hz, HC-10'), 1.54 (3H, s, H3CC=C), 
0.95-0.89 (12H, m, (H3CC)3Si, H3CCC=C), 0.58 (6H, m, (H2C)3Si). 
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13C NMR (125 MHz, CDCl3):  δ 212.1 (s, C-4), 130.8 (d, CH=C), 130.3 (s, CCH3CH2C-
5), 108.9 (s, C-5'), 65.4 (d, C-1'), 64.6 (t, C-2' or C-3'), 64.2 (t, C-2' or C-3'), 54.3 (d, C-
6'), 53.2 (d, C-3), 48.5 (d, C-5), 40.2 (t, CH2C-5), 37.4 (t, C-10'), 31.5 (t, C-2), 30.1 (t, C-
6), 27.4 (t, C-7'), 27.0 (t, C-9'), 21.5 (t, CH2CH=C), 15.7 (q, CH3C=C), 14.4 (q, 
CH3CCH=C), 7.1 (q ×3, (CH3C)Si), 5.1 (t ×3, (CH2)Si). 
 
LRMS (EI), m/z (relative intensity):  500 ([M]+, 10), 471 (20), 368 (20), 310 (31), 245 
(57), 171 (50), 98 (100). 
 
HRMS m/z calcd. for C25H44O4S2Si:  500.2450; found:  500.2402. 
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320sa 
(2R,3R,4R,6R,E)-2-(2-Ethyl-1,3-dioxolan-2-yl)-3-(methoxymethoxy)-4,6,8-
trimethylundec-8-en-5-one 
 
Raney Ni (W-2) (ca. 1 mL settled volume; added as a suspension in ethanol) was 
added to a well-stirred solution of a ketone 318sa (35 mg, 0.081 mmol) in methanol (10 
mL).  The resultant mixture was heated under reflux and additional Raney Ni was added 
every 2 h.  After 4 h, the reaction mixture was filtered through a pad of Celite® and the 
filter cake was rinsed sequentially with hot methanol (2× 20 mL), CH2Cl2 (2× 20 mL) 
and acetone (2× 20 mL).  The combined filtrate and washings were concentrated and the 
residue was taken up in dichloromethane and washed with water, dried over Na2SO4, 
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concentrated and fractionated by PTLC (20% ethyl acetate in hexane) to give the titled 
320sa (22 mg, 73%). 
 
IR (DRIFT) νmax:  2955, 1707, 1464, 1324, 1157, 1032, 811 cm-1. 
 
1H NMR (500 MHz, C6D6): δ 5.22 (1H, dd, J = 7, 7 Hz, HC-9), 4.75 (1H, d, J = 6.5 Hz, 
H2COC-3), 4.61 (1H, d, J = 6.5 Hz, H2COC-3), 4.45 (1H, br s, HC-3), 3.56-3.40 (4H, m, 
H2CO ×2), 3.31 (1H, dq, J = 3, 7 Hz, HC-2), 3.22 (3H, s, H3CO), 2.95 (1H, m, HC-6), 
2.55-2.43 (2H, m), 2.01-1.89 (2H, m), 1.78-1.60 (2H, m, H2CC-1), 1.54 (3H, s, 
H3CC=C), 1.31 (3H, d, J = 7 Hz, H3CC-4), 1.78 (3H, d, J = 7 Hz, H3CC-2 or H3CC-6), 
1.56 (3H, d, J = 7 Hz, H3CC-2 or H3CC-6), 1.00 (3H, t, J = 7.5 Hz, H3CCC-1), 0.91 (3H, 
t, J = 7.5 Hz, H3C-11). 
 
13C NMR (125 MHz, C6D6):  δ 215.2 (s, C-5), 129.8 (d, CH=C), 128.7 (s, C-8), 113.4 (s, 
CC-2), 97.5 (t, CH2OC-3), 76.5 (d, C-3), 65.9 (t, CH2O), 65.0 (t, CH2O), 56.0 (q, CH3O), 
47.7 (d), 44.4 (t, C-7), 43.7 (d), 43.0 (d), 29.5 (t, CH2C-1), 22.0 (t, C-10), 16.9 (q), 16.2 
(q), 14.8 (q), 12.9 (q), 10.7 (q), 8.6 (q). 
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321sa 
(2R,3R,4R,6R,E)-2-(2-Ethyl-1,3-dioxolan-2-yl)-4,6,8-trimethyl-3-
(triethylsilyloxy)undec-8-en-5-one 
 
Raney Ni (W-2) (ca. 1 mL settled volume; added as a suspension in ethanol) was 
added to a well-stirred solution of ketone 319sa (15 mg, 0.03 mmol) in methanol (10 
mL).  The resultant mixture was heated under reflux.  After 1 h, the reaction mixture was 
filtered through a pad of Celite® and the filter cake was rinsed sequentially with hot 
methanol (2× 20 mL), CH2Cl2 (2× 20 mL) and acetone (2× 20 mL).  The combined 
filtrate and washings were concentrated and the residue was taken up in dichloromethane 
and washed with water, dried over Na2SO4, concentrated, and fractionated by PTLC 
(20% ether in hexane) to give the titled 321sa (10 mg, 77%). 
 
IR (DRIFT) νmax:  2955, 1706, 1452, 1053, 989, 723 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 5.25 (1H, dd, J = 7, 7 Hz, HC-9), 4.76 (1H, dd, J = 3, 3 
Hz, HC-3), 3.61-3.39 (5H, m), 3.32 (1H, dq, J = 3.5, 7 Hz, HC-4), 2.86 (1H, ddd, J = 6.5, 
6.5, 8 Hz), 2.57 (1H, dd, J = 6.5, 13.5 Hz), 2.33 (1H, dq, J = 3, 7 Hz, HC-2), 2.01-1.91 
(2H, m), 1.72-1.57 (2H, m), 1.54 (3H, s, H3CC-8), 1.28 (3H, d), 1.20 (3H, d), 1.12-1.05 
(12H, m), 0.99-0.91 (6H, m, (H2C)3Si), 0.79 (3H, d), 0.78 (3H, d). 
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13C NMR (125 MHz, C6D6):  δ 215.0 (s, C-5), 132.3 (d, CH=C), 129.3 (s, C=C), 113.1 
(s, C-1), 69.5 (d, C-3), 65.3 (t, CH2O), 64.4 (t, CH2O), 47.0 (d), 46.2 (t, CH2C-6), 43.3 
(d), 42.5 (d), 28.9 (t, CH2C-1), 21.5 (t, C-10), 16.6 (q), 15.6 (q), 14.3 (q), 13.1 (q), 9.6 
(q), 8.2 (q), 7.2 (q ×3, (CH3)Si), 5.5 (t ×3, (CH2)Si). 
 
LRMS (EI), m/z (relative intensity):  411 ([M−29]+, 3), 215 (22), 163 (15), 101 (100). 
 
HRMS m/z calcd. for C25H48O4Si:  440.3322 (411.2931 for M−C2H5; 463.3219 for 
M+Na); found:  411.2932 (EI); 463.3209 (ESI, CH3OH). 
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322 
(3R,4R)-3-((S)-((3R,4S,5S)-4-(Benzyloxy)-5-((S)-(triethylsilyloxy)((R)-4-
(trimethylsilyloxy)-3,6-dihydro-2H-thiopyran-3-yl)methyl)tetrahydro-2H-
thiopyran-3-yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-4-ol 
 
Zn(BH4)2 (0.1 M in ether; 3.5 mL, 0.35 mmol) was added dropwise via syringe to a 
solution of mono-silyl enol ether 315 (187 mg, 0.23 mmol) in THF (24 mL) at room 
temperature under Ar.  After 1 d, excess Zn(BH4)2 was quenched by dropwise addition of 
1% w/v aqueous citric acid  (ca. 2 mL) at 0 °C and the resulting mixture was diluted with 
ethyl acetate, washed sequentially with sat. aqueous NaHCO3 and brine, dried over 
Na2SO4, and concentrated to give crude alcohol 322 (264 mg) that was a 8-10:1 mixture 
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of diastereomers by 1H NMR.  Fractionation of the crude by FCC (5-10% ether in 
hexane) gave the titled alcohol 322 (196 mg, 77%). 
 
IR (DRIFT) νmax:  3433, 2896, 1669, 1257, 1076, 741 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.79-7.06 (5H, m, Ph), 5.11-4.8 (5H, m, HC-1', HC-1'', 
HC-5'', H2COC-4), 3.90 (1H, dd, J = 10, 10 Hz, HC-4), 3.27 (1H, br s, HC-4'), 3.17 (1H, 
dd, J = 2.5, 13 Hz), 3.13-3.00 (4H, m), 2.82-2.55 (6H, m), 2.50 (1H, br dd, J = 10, 10 
Hz), 2.44-2.33 (2H, m), 2.24 (1H, br d, J = 13.5 Hz), 1.95 (1H, m), 1.76 (1H, m), 1.69-
1.50 (2H, m), 1.02 (18H, m, (H3CC)3Si ×2), 0.78-0.59 (12H, m, (H2C)3Si ×2), 0.23 (9H, 
s, (H3C)3SiOC-4''). 
 
13C NMR (125 MHz, C6D6):  δ 151.8 (s, C-4''), 140.3 (s, Ph), 128.8 (d ×2, Ph), 128.71 (d, 
Ph), 128.69 (d, Ph), 128.0 (d, Ph), 106.9 (d, C-5''), 77.4 (d, C-4), 72.8 (d, C-1'), 72.5 (d, 
C-4'), 71.5 (d, C-1''), 68.9 (t, CH2OC-4), 56.3 (d ×2), 48.6 (d), 43.9 (d), 39.5 (t), 30.1 (t), 
29.2 (t), 28.8 (t), 28.4 (t), 28.3 (t), 25.1 (t), 7.7 (q ×6, (CH3C)Si), 6.5 (t ×3, (CH2)Si), 5.9 
(t ×3, (CH2)Si), 0.9 (q ×3, (CH3)SiOC-4''). 
 
LRMS (EI), m/z (relative intensity):  798 ([M]+, 1), 617 (13), 575 (40), 331 (60), 171 
(94), 115 (87). 
 
HRMS m/z calcd. for C39H70O5S3Si3:  798.3693 (821.3585 for M+Na); found:  798.3668 
(EI); 821.3610 (ESI, CH3OH). 
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323 
(R)-3-((S)-((3S,4S,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-hydroxytetrahydro-2H-
thiopyran-3-yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
Aqueous sat. NaHCO3 (2 mL) was added dropwise to a stirred solution of mono-
silyl enol ether 322 (196 mg, 0.25 mmol) in methanol (10 mL) and THF (10 mL) at room 
temperature.  After 2 h, the reaction was diluted with water and extracted with CH2Cl2 
(3×).  The combined organic extracts were dried over Na2SO4, concentrated and 
fractionated by FCC (30% ether in hexane) to give the titled ketol 323 (172 mg, >95%). 
 
IR (DRIFT) νmax:  3474, 2953, 1708, 1379, 1238, 886 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.74-7.08 (5H, m, Ph), 4.94 (1H, d, J = 10 Hz, H2COC-4), 
4.91 (1H, br s, HC-1'), 4.85 (1H, br s, HC-1''), 4.75 (1H, d, J = 10 Hz, H2COC-4), 3.60 
(1H, dd, J = 10, 10 Hz, HC-4), 3.31 (1H, ddd, J = 4, 10, 10 Hz, HC-4'), 3.05 (1H, m, HC-
3''), 2.99-2.80 (5H, m), 2.77-2.64 (2H, m, H2C-7'), 2.59-2.04 (10H, m), 1.98 (1H, br dd, J 
= 9.5, 9.5 Hz, HC-3'), 1.88 (1H, ddd, J = 4, 4, 13 Hz, HC-5'), 1.62 (1H, ddd, J = 4, 13, 13 
Hz, HC-5'), 1.02-0.94 (18H, m, (H3CC)3Si ×2), 0.69-0.58 (12H, m, (H2C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 209.7 (s, C-4''), 139.1 (s, Ph), 129.1 (d, Ph), 128.8 (d, 
Ph), 128.6 (d, Ph), 128.4 (d, Ph), 128.2 (d, Ph), 77.7 (d, C-4), 71.6 (d, C-4'), 70.7 (d, C-
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1''), 69.6 (d, C-1'), 69.4 (t, CH2OC-4), 56.5 (d, C-3''), 53.3 (d, C-3 or C-5), 51.9 (d, C-3 or 
C-5), 48.8 (d, C-3'), 44.7 (t, C-5''), 38.9 (t, C-5'), 33.7 (t, C-2''), 31.0 (t, C-6''), 30.5 (t, C-2 
or C-6), 30.3 (t, C-2 or C-6), 29.7 (t, C-2'), 28.1 (t, C-6'), 7.70 (q ×3, (CH3C)3Si), 7.65 (q 
×3, (CH3C)3Si), 6.1 (t ×3, (CH2)3Si), 6.0 (t ×3, (CH2)3Si). 
 
LRMS (EI), m/z (relative intensity):  726 ([M]+, 46), 565 (37), 459 (27), 243 (28), 171 
(100), 91 (61). 
 
HRMS m/z calcd. for C36H62O5S3Si2:  726.3298; found:  726.3304. 
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324 
(R)-3-((S)-((3S,4S,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)dihydro-2H-thiopyran-4(3H)-one 
 
i-Pr2EtN (0.85 mL, 0.63 g, 4.9 mmol) was added to a stirred solution of ketol 323 
(178 mg, 0.24 mmol) and n-Bu4NI (90 mg, 0.24 mmol) in CH2Cl2 (12 mL) at room 
temperature under Ar.  After 2 min, MOMCl (0.19 mL, 0.20 g, 2.5 mmol) was added and 
the reaction was stirred vigorously for 4 d.  The mixture was diluted with ethyl acetate 
and washed with 1% w/v aqueous citric acid (3×).  The combined organic layers were 
washed with sat. aqueous NaHCO3, dried over Na2SO4, concentrated and fractionated by 
FCC (30% ether in hexane) to give the titled 324 (172 mg, 91%). 
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IR (DRIFT) νmax:  2940, 1701, 1451, 1235, 1064 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.59-7.02 (5H, m, Ph), 5.02 (1H, d, J = 11 Hz, H2COC-4), 
4.81-4.71 (2H, m, HC-1', HC-1''), 4.74 (1H, d, J = 11 Hz, H2COC-4), 4.35 (1H, d, J = 7 
Hz, H2COC-4'), 4.24 (1H, d, J = 7 Hz, H2COC-4'), 3.52 (1H, dd, J = 9, 9 Hz, HC-4), 3.42 
(1H, dddd, J = 1.5, 3.5, 8.5, 8.5 Hz, HC-4'), 2.92 (3H, s, H3CO), 2.92-2.63 (6H, m), 2.56-
2.01 (13H, m), 1.65 (1H, dddd, J = 3, 9, 9, 13 Hz, HC-5'), 1.00-0.90 (18H, m, (H3CC)3Si 
×2), 0.68-0.54 (12H, m, (H2C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 208.9 (s, C-4''), 139.7 (s, Ph), 128.4 (d, Ph), 128.2 (d, 
Ph), 128.1 (d, Ph), 127.7 (d, Ph), 127.5 (d, Ph), 96.8 (t, CH2OC-4'), 78.4 (d, C-4), 78.8 (d, 
C-4'), 71.3 (t, CH2OC-4), 70.65 (d, C-1' or C-1''), 70.62 (d, C-1' or C-1''), 57.0, 56.0, 53.8, 
53.0, 46.1, 45.0, 37.0, 33.2, 30.7, 29.1, 27.4, 26.9, 26.8, 7.8 (q ×3, (CH3C)Si), 7.7 (q ×3, 
(CH3C)Si), 6.2 (t ×3, (CH2)Si), 6.1 (t ×3, (CH2)Si). 
 
LRMS (EI), m/z (relative intensity):  770 ([M]+, 1), 609 (6), 243 (22), 171 (35), 91 (100). 
 
HRMS m/z calcd. for C38H66O6S3Si2:  770.3560 (793.3452 for M+Na); found:  770.3560 
(EI); 793.3438 (ESI, CH3OH). 
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325 
(3R,5R)-3-((S)-((3S,4S,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-yl)(triethylsilyloxy)methyl)-5-
((E)-2-methylpent-2-enyl)dihydro-2H-thiopyran-4(3H)-one 
 
t-BuLi (1.5 M in pentane; 1.2 mL, 1.8 mmol) was added dropwise via syringe to a 
solution of ketone 324 (138 mg, 0.18 mmol) in THF (9 mL) at −50 °C under Ar.  After 2 
min, allyl bromide (0.42 mL, 584 mg, 3.58 mmol) and HMPA (0.62 mL, 640 mg, 3.6 
mmol) were added sequentially.  After 2 h, the mixture was diluted with ethyl acetate and 
washed with aqueous phosphate buffer (0.1 M, pH 7; 3× 40 mL).  The combined organic 
layers were dried over Na2SO4 and concentrated.  The residue was dissolved in CH2Cl2 
and applied to a bed of silica and eluted with 50% CH2Cl2 in hexane followed by ether.  
The ether eluate was were concentrated to give crude C-alkylated products that was a 2:1 
mixture of diastereomers by 1H NMR.  Fractionation of the crude by PTLC (CH2Cl2) 
gave recovered 324 (30 mg, 22%), minor C-alkylated product 326 (25 mg, 16%) and the 
titled C-alkylated product 325 (73 mg, 48%). 
 
IR (DRIFT) νmax:  2958, 1702, 1451, 1241, 1097, 1020, 727 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.66-7.09 (5H, m, Ph), 5.24 (1H, dd, J = 6.5, 6.5 Hz, 
HC=C), 5.11 (1H, d, J = 10.5 Hz, H2COC-4), 4.94-4.68 (2H, m), 4.44 (1H, d, J = 7 Hz, 
H2COC-4'), 4.31 (1H, d, J = 7 Hz, H2COC-4'), 3.61 (1H, dd, J = 9.5, 9.5 Hz), 3.46 (1H, 
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dd, J = 9.5, 9.5 Hz), 3.40 (1H, br s), 2.98 (3H, s, H3CO), 2.97-2.78 (6H, m), 2.76-2.68 
(2H, m), 2.64-2.40 (5H, m), 2.37-2.16 (7H, m), 1.96 (2H, m, H2CCH=C), 1.72 (1H, m), 
1.41 (3H, s, H3CC=C), 1.07-0.98 (18H, m, (H3CC)3Si ×2), 0.95 (3H, t, J = 7.5 Hz, 
H3CCCH=C), 0.74-0.61 (12H, m, (H2C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 211.9 (s, C-4''), 139.8 (s, C=CH), 131.3 (s, Ph), 130.4 (d, 
CH=C), 128.9 (d ×2, Ph), 128.7 (d, Ph), 128.1 (d, Ph), 128.0 (d, Ph), 96.9 (t, CH2OC-4'), 
78.4 (d ×3), 71.1 (d, t), 55.5 (q, CH3O), 54.0, 53.7, 50.4, 46.4 (×4), 40.6, 34.4, 33.0, 31.3, 
29.2, 27.0, 22.0 (t, CH2CH=C), 16.0 (q, CH3C=C), 14.9 (q, CH3CCH=C), 7.79 (q ×3, 
(CH3C)Si), 7.77 (q ×3, (CH3C)Si), 6.19 (t ×3, (CH2)Si), 6.17 (t ×3, (CH2)Si). 
 
HRMS m/z calcd. for C44H76O6S3Si2:  852.4343 (875.4234 for M+Na); found:  875.4240 
(ESI, CH3OH). 
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326 
(3R,5S)-3-((S)-((3S,4S,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-yl)(triethylsilyloxy)methyl)-5-
((E)-2-methylpent-2-enyl)dihydro-2H-thiopyran-4(3H)-one 
 
IR (DRIFT) νmax:  2958, 1702, 1455, 1135, 1101, 739 cm-1. 
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1H NMR (500 MHz, C6D6):  δ 7.63-7.06 (5H, m, Ph), 5.15 (1H, d, J = 10.5 Hz), 5.04 
(1H, dd, J = 6.5, 6.5 Hz, HC=C''), 4.90-4.56 (2H, m), 4.38 (1H, d, J = 6 Hz), 4.25 (1H, d, 
J = 6 Hz), 3.66 (1H, dd, J = 9, 9 Hz), 3.46 (2H, br s), 3.12 (1H, d, J = 13 Hz), 2.98-2.90 
(2H, m), 2.95 (3H, s, H3CO), 2.88-2.06 (16, m), 1.94-1.77 (3H, m), 1.66 (1H, m), 1.31 
(3H, m, H3CC=C), 1.08-0.99 (18H, m, (H3CC)3Si ×2), 0.89 (3H, t, J = 7.5 Hz, 
H3CCCH=C), 0.75-0.57 (12H, m, (H2C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 211.1 (s, C-4''), 139.8 (s, Ph), 131.7 (s, C=CH), 129.6 (d, 
CH=C), 128.9 (d ×2, Ph), 128.7 (d, Ph), 128.01 (d, Ph), 128.96 (d, Ph), 95.8 (t, CH2OC-
4'), 78.6 (d), 72.1 (d, t), 58.6 (d ×2), 55.4 (q, CH3O), 52.8, 46.2 (×2), 39.4, 37.4, 35.5, 
31.7 (×3), 29.0 (×3), 26.8, 21.9 (t, CH2CH=C), 16.8 (q, CH3C=C), 14.9 (q, CH3CCH=C), 
7.8 (q ×6, (CH3C)Si), 6.2 (t ×3, (CH2)Si), 6.1 (t ×3, (CH2)Si). 
 
LRMS (EI), m/z (relative intensity):  852 ([M]+, 1), 720 (1), 691 (2), 341 (6), 115 (38), 
91 (100), 87 (30). 
 
HRMS m/z calcd. for C44H76O6S3Si2:  852.4343; found:  852.4379. 
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327 
(3S,4S,5R)-3-((R)-((3S,4R,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-yl)(triethylsilyloxy)methyl)-5-
((E)-2-methylpent-2-enyl)tetrahydro-2H-thiopyran-4-ol 
 
NaBH3CN (70 mg, 1.1 mmol) was added to a solution of ketone 325 (47 mg, 0.055 
mmol) and citric acid (116 mg, 0.55 mmol) in ethanol (3 mL) and THF (3 mL) at 0 °C 
under Ar.  After 4-8 h, excess NaBH3CN was quenched by dropwise addition of sat. 
aqueous NaHCO3 (ca. 2 mL) at 0 °C and the resulting mixture was diluted with water and 
extracted with CH2Cl2 (3×), dried over Na2SO4, concentrated and fractionated by PTLC 
(CH2Cl2 ) to give the titled alcohol 327 (37 mg, 79%). 
 
IR (DRIFT) νmax:  3495, 2952, 1463, 1412, 1073, 728 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.65-6.96 (5H, m, Ph), 5.31 (1H, dd, J = 6.5, 6.5 Hz, 
HC=C), 5.09 (2H, br s), 4.75 (1H, br s), 4.63 (1H, br s), 4.31 (1H, br s), 4.15 (1H, br s), 
3.90 (1H, br s), 3.71 (1H, dd, J = 9, 9 Hz), 3.56 (1H, br s), 2.96 (3H, s, H3CO), 2.91-2.14 
(19H, m), 2.13-1.98 (3H, m), 1.85 (1H, br s), 1.68 (1H, m), 1.60 (3H, s, H3CC=C), 1.16-
0.95 (21H, m), 0.83-0.65 (12H, m, (H2C)3Si ×2). 
 
LRMS (EI), m/z (relative intensity):  854 ([M]+, 8), 693 (25), 571 (11), 325 (52), 243 
(80), 171 (76), 91 (100). 
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HRMS m/z calcd. for C44H78O6S3Si2:  854.4499; found: 854.4499. 
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328 
(3S,4S,5R)-3-((R)-((3R,4R,5R)-4-(Benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-yl)(hydroxy)methyl)-5-((E)-2-
methylpent-2-enyl)tetrahydro-2H-thiopyran-4-ol 
 
TBAF (55 mg, 0.21 mmol) was added to a solution of alcohol 327 (18 mg, 0.021 
mmol) in CH2Cl2 (2 mL) at room temperature under Ar.  After 15 min, the mixture was 
diluted with ethyl acetate and washed sequentially with 1% w/v aqueous citric acid, sat. 
aqueous NaHCO3 and brine, dried over Na2SO4, concentrated, and fractionated by PTLC 
(50% ethyl acetate in hexane) to give the titled diol 328 (16 mg, >95%). 
 
1H NMR (500 MHz, C6D6):  δ 7.46-6.95 (5H, m, Ph), 5.50 (1H, br s, HOC-1'' or HOC-
4''), 5.36 (1H, dd, J = 6, 6 Hz), 4.84 (1H, d, J = 11 Hz), 4.71 (1H, br s), 6.68 (1H, d, J = 
11 Hz), 4.36 (1H, d, J = 7 Hz), 4.24 (1H, d, J = 7 Hz), 4.17 (1H, br s), 3.82 (1H, br d, J = 
6 Hz), 3.60 (1H, dd, J = 8.5, 8.5 Hz), 3.51 (br s), 3.25 (br s, HOC-1'' or HOC-4''), 2.97 
(3H, s, H3CO), 2.94 (1H, br s), 2.83 (1H, br d, J = 11.5 Hz), 2.78-2.30 (10H, m), 2.29-
1.93 (9H, m), 1.72 (2H, m), 1.56 (3H, s, H3CC=C), 1.04 (9H, m, (H3CC)3Si), 0.95 (3H, t, 
J = 7 Hz, H3CCCH=C), 0.71 (6H, m, (H2C)3Si). 
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329a 
(3S,4S,5R)-3-((S)-Acetoxy((3S,4R,5R)-4-(benzyloxy)-5-((S)-((3R,4R)-4-
(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-yl)methyl)-5-((E)-2-
methylpent-2-enyl)tetrahydro-2H-thiopyran-4-yl acetate 
 
Ac2O (0.020 mL, 22 mg, 0.22 mmol) was added to a solution of diol 328 (16 mg, 
0.02 mmol) and DMAP (50 mg, 0.42 mmol) in CH2Cl2 (2 mL) at room temperature under 
Ar.  After 15 min, the mixture was diluted with ethyl acetate and washed sequentially 
with 1% w/v aqueous citric acid (3×), sat. aqueous NaHCO3 and brine, dried over 
Na2SO4, concentrated, and fractionated by PTLC (5% ether in CH2Cl2) to give 329a (15 
mg, 88%). 
 
1H NMR (500 MHz, C6D6):  δ 7.57-7.07 (5H, m, Ph), 5.79 (1H, dd, J = 3, 8 Hz), 5.28 
(1H, dd, J = 7, 7 Hz), 4.94 (1H, dd, J = 3.5, 8.5 Hz), 4.78 (1H, br s), 4.71 (1H, d, J = 11 
Hz), 4.62 (1H, d, J = 11 Hz), 4.53 (1H, d, J = 6.5 Hz), 4.47 (1H, d, J = 6.5 Hz), 3.54 (1H, 
br d), 3.43 (1H, br dd), 3.07 (3H, s, H3CO), 2.95 (2H, m), 2.87-2.70 (2H, m), 2.68-2.17 
(16H, m), 1.98-1.85 (3H, m), 1.95 (3H, s, H3CCO), 1.84 (3H, s, H3CCO), 1.39 (3H, s, 
H3CC=C), 1.02 (9H, m, (H3CC)3Si), 0.90 (3H, t, J = 7 Hz, H3CCCH=C), 0.68 (6H, m, 
(H2C)3Si). 
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330 
(1R,2S,3S,4R,E)-1-((3S,4R,5R)-4-(Benzyloxy)-5-((5R,6R,7S)-5,9,9-triethyl-6-
methyl-2,4,8-trioxa-9-silaundecan-7-yl)tetrahydro-2H-thiopyran-3-yl)-2,4,6-
trimethylnon-6-ene-1,3-diyl diacetate 
 
Raney Ni (W-2) (ca. 1 mL settled volume; added as a suspension in ethanol) was 
added to a well-stirred solution of 329a (10 mg, 0.01 mmol) in ethanol (10 mL).  The 
resultant mixture was heated under reflux and additional Raney Ni was added every 2 h.  
After 8 h, the reaction mixture was filtered through a pad of Celite® and the filter cake 
was rinsed sequentially with hot methanol (2× 20 mL), CH2Cl2 (2× 20 mL) and acetone 
(2× 20 mL).  The combined filtrate and washings were concentrated and the residue was 
taken up in dichloromethane and washed with water, dried over Na2SO4, concentrated 
and fractionated by PTLC (10% ethyl acetate in hexane) to give 330 (6 mg, 67%). 
 
IR (DRIFT) νmax:  2906, 1729, 1451, 1366, 1246, 1030, 740 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.55-7.03 (5H, m, Ph), 5.63 (1H, br d, J = 9 Hz, HC-9), 
5.29 (1H, dd, J = 7, 7 Hz, HC-15), 5.06 (1H, dd, J = 3, 9 Hz, HC-11), 4.76-4.53 (4H, m), 
4.42 (1H, br s, HC-5), 3.57 (1H, dd, J = 4.5, 10.5 Hz, HC-7), 3.48 (1H, ddd, J = 3, 6, 6 
Hz, HC-3), 3.16-3.13 (1H, m), 3.15 (3H, s, H3CO), 3.03 (1H, dd, J = 2, 13.5 Hz), 2.76 
(1H, dd, J = 12.5, 12.5 Hz), 2.65-2.50 (2H, m), 2.41-2.20 (4H, m), 2.11-1.95 (3H, m), 
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1.93 (3H, s), 1.83-1.79 (1H, m), 1.81 (3H, s), 1.79-1.68 (1H, m), 1.60 (1H, m), 1.55 (3H, 
s, H3CC-14), 1.12-0.88 (24H, m), 0.77-0.63 (6H, (H2C)3Si). 
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347 
(4R,5S,6S,7S,8R,9S,10R,11R)-7-(Benzyloxy)-11-(methoxymethoxy)-4,6,8,10-
tetramethyl-5,9-bis(triethylsilyloxy)tridecan-3-one 
 
Raney Ni (W-2) (ca. 1 mL settled volume; added as a suspension in ethanol) was 
added to a well-stirred solution of a ketone 324 (31 mg, 0.04 mmol) in ethanol (10 mL).  
The resultant mixture was heated under reflux for 1 h.  The reaction solution was filtered 
through a pad of Celite® and the remaining Raney Ni was sequentially extracted with 
refluxing (ca. 10 min) ethanol (1× 10 mL) and 50% acetone in CH2Cl2 (3× 10 mL).  The 
combined filtrate and washings were concentrated and fractionated by PTLC (30% ether 
in hexane) to give the titled ketone 347 (19 mg, 70%) ( 22D][α  −1.0; c 1, C6H6). 
 
IR (DRIFT) νmax:  2886, 1708, 1378, 1343, 1303, 1214, 970 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ 7.48-7.05 (5H, m, Ph), 4.77 (2H, ap dd, J = 11.5, 11.5 Hz, 
H2COC-7), 4.66 (1H, br dd, J = 4.5, 4.5 Hz, HC-5), 4.61 (1H, d, J = 7 Hz, HCOC-11), 
4.48 (1H, d, J = 7 Hz, HCOC-11), 4.38 (1H, br s, HC-7), 3.51-3.46 (2H, m, HC-9, HC-
11), 3.18 (3H, s, H3CO), 3.08-2.99 (1H, m, HC-4), 2.40-2.32 (1H, m, HC-10), 2.29-2.14 
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(4H, m, H2C-2, HC-6, HC-8), 1.81-1.70 (1H, m, HC-12), 1.63-1.52 (1H, m, HC-12), 
1.26-0.95 (36H, m), 0.82-0.68 (12H, m, (H2C)3Si ×2). 
 
13C NMR (125 MHz, C6D6):  δ 212.8 (s, C-3), 140.2 (s, Ph), 128.8 (d, Ph), 128.7 (d, Ph), 
128.3 (d, Ph), 127.8 (d, Ph), 127.7 (d, Ph), 96.7 (t, CH2O), 84.5 (d, C-9), 82.9 (d, C-11), 
74.5 (t, CH2OC-7), 73.0 (d, C-5), 72.7 (d, C-7), 55.8 (q, CH3O), 49.8 (d, C-4), 43.7 (d, C-
8), 42.5 (d, C-6), 37.9 (d, C-10), 34.8 (t, C-2), 23.6 (t, C-12), 14.6 (q), 13.9 (q), 13.4 (q), 
11.1 (q), 9.4 (q), 8.3 (q), 7.82 (q ×3, (CH3C)Si), 7.77 (q ×3, (CH3C)Si), 6.4 (t ×3, 
(CH2)Si), 6.3 (t ×3, (CH2)Si). 
 
LRMS (CI, NH3), m/z (relative intensity):  698 ([M+18]+, 100), 573 (21), 441 (26), 377 
(28), 132 (54). 
 
HRMS m/z calcd. for C38H72O6Si2:  680.4867 (651.4476 for M−C2H5; 698.5211 for 
M+NH4); found: 651.4475 (EI); 698.5212 (CI, NH3). 
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349 
(8R,9S,10S,11S,12R,13S,14R,15R,E)-11-(benzyloxy)-15-(methoxymethoxy)-
4,6,8,10,12,14-hexamethyl-9,13-bis(triethylsilyloxy)heptadec-3-en-7-one 
 
NaHMDS (1.0 M in THF; 0.51 mL, 0.51 mmol) was added dropwise via syringe to 
a solution of ketone 347 (35 mg, 0.051 mmol) in THF (5 mL) at −78 °C under Ar.  After 
  179
30 min, TMEDA (0.080 mL, 59 mg, 0.51 mmol) was added and after stirring for 5 min 
allyl bromide 47 (0.12 mL, 20 mg, 1.0 mmol) was added.  After 3 h, the mixture was 
quenched with acetone (0.2 mL) and warmed to 0 °C over 15 min.  Phosphate buffer (0.1 
M, pH 7) was added and the mixture was diluted with ethyl acetate.  The  organic layer 
was washed with phosphate buffer (0.1 M, pH 7; 3×), dried over Na2SO4 and 
concentrated to give starting material and crude alkylated products which were a 4:1 
mixture of diastereomers by 1H NMR.  Fractionation on the crude by PTLC (5% ether in 
hexanes) gave recovered 347 (10 mg, 29%) and C-alkylated products 349 as a mixture of 
diastereomers (25 mg, 65%; dr 4.6:1). 
 
IR (DRIFT) νmax:  2946, 2880, 1708, 1456, 1366, 1229, 721 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 7.49-7.03 (5H, m, Ph), 5.20 (1H, 
dd, J = 7, 7 Hz, HC-15), 4.84-4.67 (3H, m, HC-9, H2COC-7), 4.65 (1H, d, J = 7 Hz, 
HCOC-3), 4.53-4.47 (1H, m, HC-5), 4.51 (1H, d, J = 7 Hz, HCOC-3), 3.52 (1H, dd, J = 
5, 8 Hz, HC-7), 3.51-3.46 (1H, m, HC-3), 3.20-3.16 (1H, m, HC-10), 3.19 (3H, s, H3CO), 
2.93-2.78 (1H, m, HC-12), 2.45 (1H, dd, J = 4.5, 13.5 Hz, HC-13), 2.30 (1H, br dd, J = 7, 
7 Hz, HC-4), 2.28 (2H, m, HC-6, HC-8), 1.99 (1H, dd, J = 10, 13.5 Hz, HC-13), 1.98-
1.91 (2H, m, HC-16), 1.86-1.76 (1H, m, HC-2), 1.65-1.52 (1H, m, HC-2), 1.47 (3H, s, 
H3CC-14), 1.26 (3H, d, J = 7 Hz, H3CC-10), 1.21 (3H, d, J = 7 Hz, H3CC-6 or H3CC-8), 
1.19 (3H, d, J = 7 Hz, H3CC-6 or H3CC-8), 1.15-1.07 (27H, m), 1.05 (3H, d, J = 7 Hz, 
H3CC-12), 1.00 (3H, t, J = 7.5 Hz, H3C-1), 0.92 (3H, t, J = 7.5 Hz, H3C-17), 0.76 (6H, m, 
(H2C)3Si). 
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13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 215.3 (s, C-11), 140.3 (s, Ph), 
132.1 (s, C-14), 129.9 (d, C-15), 128.8 (d, Ph), 128.7 (d ×2, Ph), 127.8 (d, Ph), 127.6 (d, 
Ph), 96.9 (t, CH2O), 83.8 (d, C-7), 83.4 (d, C-3), 73.6 (t, CH2OC-7), 72.1 (d, C-5), 71.6 
(d, C-9), 55.8 (q, CH3O), 48.5 (d, C-10), 44.4 (d, C-6 or C-8), 44.2 (t, C-13), 42.8 (d, C-6 
or C-8), 41.9 (d, C-12), 37.6 (d, C-4), 23.8 (t, C-2), 22.0 (t, C-16), 16.0 (q, C-1), 15.9 (q, 
CH3C-14), 14.8 (q, C-17), 13.9 (q, CH3C-6 or CH3C-8), 13.3 (q, CH3C-6 or CH3C-8), 
12.4 (q, CH3C-10), 10.9 (q, CH3C-12), 9.4 (q, CH3C-4), 7.9 (q ×3, (CH3C)Si), 7.8 (q ×3, 
(CH3C)Si), 6.4 (t ×6, (CH2)Si). 
 
LRMS (EI), m/z (relative intensity): 734 ([M−29]+, 1), 201 (12), 271 (12), 115 (26). 
 
HRMS m/z calcd. for C44H82O6Si2:  762.5650 (733.5259 for M−C2H5); found:  733.5259. 
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350 
(8R,9S,10R,11S,12S,13S,14S,15R,E)-11-(Benzyloxy)-9,13-dihydroxy-15-
(methoxymethoxy)-4,6,8,10,12,14-hexamethylheptadec-3-en-7-one 
 
10% vol aqueous HF (0.01 mL) was added dropwise to a stirred solution of 349 (22 
mg, 0.030 mmol; dr 4.6:1) in acetonitrile (10 mL) at 0 °C.  After 30 min, the reaction was 
diluted with sat. aqueous NaHCO3 and extracted with ethyl acetate (3×).  The combined 
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organic extracts were dried over Na2SO4, concentrated and fractionated by PTLC (50% 
ethyl acetate in hexane) to give the titled diols 350 (14 mg, 93%; dr 4.6:1). 
 
IR (DRIFT) νmax: 3496, 2981, 2868, 1701, 1450, 1307, 954 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 7.35-7.02 (5H, m, Ph), 5.19 (1H, 
dd, J = 7, 7 Hz, HC-15), 4.60 (1H, ap d, J = 6.5 Hz), 4.56 (1H, ap d, J = 6.5 Hz), 4.52-
4.43 (2H, m), 4.23-4.11 (2H, m), 4.03 (1H, dd, J = 5, 5 Hz), 3.92 (1H, d, J = 1.5 Hz), 
3.83 (1H, d, J = 1.5 Hz), 3.66 (1H, q, J = 5.5 Hz), 3.19 (3H, s, H3CO), 2.87 (1H, q, J = 7 
Hz), 2.66 (1H, dq, J = 3, 7 Hz), 2.49 (1H, dd, J = 6.5, 13.5 Hz), 2.31-2.19 (2H, m), 2.05-
1.88 (3H, m), 1.85-1.60 (2H, m), 1.55 (1H, dq, J = 1.5, 7 Hz), 1.48 (3H, s, H3CC-14), 
1.15 (3H, d, J = 7 Hz), 1.01 (3H, d, J = 7 Hz), 0.98 (3H, d, J = 7 Hz), 0.96-0.87 (12H, m). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 218.0 (s, C-11), 139.2 (s, Ph), 
132.3 (s, C-14), 129.9 (d, C-15), 129.0 (d, Ph), 128.7 (d ×4, Ph), 97.4 (t, CH2OC-3), 86.4 
(d), 82.8 (d), 73.8 (t, CH2O), 73.2 (d), 72.0 (d), 55.9 (q, CH3O), 48.1 (d), 44.2 (t, C-13), 
42.9 (d), 39.3 (d), 39.0 (d), 37.7 (d), 25.5 (t), 22.0 (t), 17.2 (q), 16.2 (q), 14.82 (q), 14.78 
(q), 14.2 (q), 9.8 (q), 9.4 (q), 8.9 (q). 
 
LRMS (EI), m/z (relative intensity): 534 ([M]+, 13), 326 (58), 286 (1), 275 (100). 
 
HRMS m/z calcd. for C32H54O6:  534.3920; found:534.3943. 
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351 
(3R,4S,5S,6S,7R,8R,9R,10S,11R,E)-7-(benzyloxy)-3-(methoxymethoxy)-
4,6,8,10,12,14-hexamethylheptadec-14-ene-5,9,11-triol 
 
Et2BOMe (0.010 mL, 10 mg, 0.10 mmol) was added to a stirred solution of 350 (14 
mg, 0.03 mmol; dr 4.6:1) in MeOH (1 mL) and THF (4 mL) at −78 °C under argon.  
After 30 min, NaBH4 (11 g, 0.30 mmol) was added.  After 2 h at −78°C, the reaction 
mixture was warmed to 0 °C for 30 min (caution:  effervescence) and then diluted with 3 
M aqueous NaOH (5 mL) and warmed to room temperature over 2 h.  The mixture was 
diluted with brine and extracted with CH2Cl2 (3×).  The combined organic layers were 
dried over Na2SO4, concentrated and fractionated by PTLC (50% ethyl acetate in 
hexanes) to give the titled triols 351 as a mixture of three diastereomers (13 mg, 93%; dr 
6:1:1). 
 
IR (DRIFT) νmax:  3454, 2962, 1450, 1381, 1089, 969 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 7.39-6.95 (5H, m, Ph), 5.38-5.19 
(1H, m, HC-15), 5.07-4.79 (1H, br s), 4.55-4.30 (4H, m), 4.11 (1H, d, J = 10 Hz), 3.95 
(1H, dd, J = 3.5, 6 Hz), 3.90 (1H, br d, J = 9.5 Hz), 3.70 (1H, dd, J = 2.5, 7.5 Hz), 3.60 
(1H, br s), 3.43-3.31 (1H, m), 3.06 (3H, s, H3CO), 2.39-2.18 (2H, m), 2.15-1.90 (5H, m), 
1.79 (1H, dd, J = 10, 13 Hz), 1.75-1.64 (2H, m), 1.58 (3H, s, H3CC-14), 1.56-1.46 (2H, 
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m), 1.24 (3H, d, J = 6.5 Hz), 1.18 (3H, d, J = 7 Hz), 1.03-0.84 (12H, m), 0.78 (3H, t, J = 
7.5 Hz). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 138.9 (s, Ph), 133.8 (s, C-14), 
129.8 (d), 128.8 (d), 128.5 (d), 128.4 (d), 128.3 (d), 128.1 (d), 97.3 (t, CH2OC-3), 87.3 
(d), 84.1 (d), 81.7 (d), 80.3 (d), 74.0 (t, CH2OC-7), 71.3 (d), 55.9 (q, CH3OCH2OC-3), 
44.9 (t, C-13), 39.9 (d), 39.1 (d), 37.2 (d), 36.2 (d), 34.5 (d), 25.7 (t), 21.9 (t), 16.4 (q), 
16.1 (q), 15.9 (q), 15.0 (q), 13.3 (q), 10.2 (q), 9.8 (q), 5.9 (q). 
 
LRMS (EI), m/z (relative intensity):  536 ([M]+, 2), 414 (1), 241 (6), 91 (100). 
 
HRMS m/z calcd. for C32H56O6:  536.4077; found:  536.4074. 
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352 
(2S,3S,4S,5S,6S,7R)-3-(Benzyloxy)-7-(methoxymethoxy)-4,6-dimethyl-2-((4S,5S,6R)-
2,2,5-trimethyl-6-((E)-4-methylhept-4-en-2-yl)-1,3-dioxan-4-yl)nonan-5-ol 
 
PTSA (ca. 0.5 mg) was added to a stirred solution of triols 351 (13 mg, 0.024 
mmol; dr 6:1:1) and 2,2-dimethoxypropane (0.2 mL) in CH2Cl2 (4 mL) at room 
temperature under Ar.  After 10 min, the reaction quenched by addition of sat. aqueous 
NaHCO3 (ca. 1 mL).  The mixture was diluted with sat. aqueous NaHCO3 and extracted 
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with CH2Cl2 (3×).  The combined organic layers were dried over Na2SO4, concentrated 
and fractionated by PTLC (20% ethyl acetate in hexanes) to give the titled alcohols 352 
(13 mg, 93%; dr 6:1:1). 
 
IR (DRIFT) νmax:  3504, 2963, 1454, 1200, 1040 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 7.40-6.98 (5H, m, Ph), 5.25 (1H, 
dd, J = 7, 7 Hz, HC-15), 4.89 (1H, d, J = 6.5 Hz, HCOC-3), 4.77 (1H, d, J = 6.5 Hz, 
HCOC-3), 4.55 (1H, d, J = 11 Hz, HCOC-7), 4.46 (1H, d, J = 11 Hz, HCOC-7), 4.20 
(1H, ddd, J = 1.5, 1.5, 9.5 Hz, HC-5), 4.16 (1H, s, HOC-5), 3.96-3.89 (1H, m, HC-3), 
3.87 (1H, dd, J = 2, 10 Hz, HC-9), 3.62 (1H, dd, J = 2, 7.5 Hz, HC-7), 3.32 (3H, s, 
H3CO), 3.27 (1H, dd, J = 2, 9.5 Hz, HC-11), 2.42 (1H, ddd, J = 7, 7, 9 Hz, HC-6), 2.19 
(1H, ddd, J = 2, 7, 9.5 Hz, HC-8), 2.12-1.80 (6H, m), 1.66-1.29 (5H, m), 1.54 (3H, s, 
H3CCOC-9), 1.51 (3H, s, H3CC-14), 1.32 (3H, s, H3CCOC-9), 1.07-0.96 (4H, m), 1.04 
(3H, d, J = 7 Hz), 1.02 (3H, d, J = 7 Hz, H3CC-12), 0.99 (3H, d, J = 7 Hz), 0.93 (3H, d, J 
= 7 Hz, H3CC-8), 0.85 (3H, d, J = 7 Hz, H3CC-6). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 139.1 (s, Ph), 133.0 (s, C-14), 
129.24 (d, C-15), 129.23 (d, Ph), 129.1 (d, Ph), 128.7 (d, Ph), 128.6 (d, Ph), 128.4 (s, Ph), 
99.3 (t, COC-9), 97.7 (d, CH2OC-3), 89.0 (d, C-7), 81.3 (d, C-3), 79.5 (t, C-11), 74.85 (d, 
CH2OC-7), 78.81 (d, C-9), 73.1 (q, C-5), 55.9 (t, CH3OCH2OC-3), 42.3 (t, C-13), 39.0 (d, 
C-6), 38.5 (d), 38.1 (d, C-8), 32.9 (d), 31.5 (q), 30.7 (t, CH3COC-9), 25.3 (t, C-2), 22.0 
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(q, C-16), 20.0 (q, CH3COC-9), 16.5 (q), 15.94 (q), 15.86 (q, CH3C=C), 15.0 (q), 13.0 
(q), 9.4 (q), 9.0 (q), 5.3 (q). 
 
LRMS (EI), m/z (relative intensity):  561 ([M−15]+, 1), 91 (100), 181 (20), 69 (26). 
 
HRMS m/z calcd. for C35H60O6:  576.4390 (561.4155 for M−CH3); found:  561.4152. 
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353 
(2S,3S,4S,5R,6S,7R)-7-(Methoxymethoxy)-4,6-dimethyl-2-((4S,5S,6S)-2,2,5-
trimethyl-6-((R,E)-4-methylhept-4-en-2-yl)-1,3-dioxan-4-yl)nonane-3,5-diol 
 
Anhydrous NH3 (ca. 5 mL) was condensed onto a solution of 352 (13 mg, 0.02 
mmol; dr 6:1:1) in THF (5 mL) at −78 °C under Ar.  Lithium (2-3 2 mm3 pieces) were 
added over 5-10 min until a blue color persisted.  After 30 min, methanol (ca. 0.5 mL) 
was added and the mixture was warmed to room temperature over 2 h and diluted with 
sat. aqueous NH4Cl.  The mixture was extracted with CH2Cl2 (3×), dried over Na2SO4, 
concentrated and fractionated by PTLC (20% ethyl acetate in hexane) to give a mixture 
of three diastereomeric diols 353 (10 mg, 91%; dr 6:1:1). 
 
IR (DRIFT) νmax:  3454, 2962, 1265, 1200, 1178, 1012 cm-1. 
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1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 5.24 (1H, dd, J = 7, 7 Hz, HC-
15), 4.34-4.30 (1H, m), 4.32 (1H, d, J = 6.5 Hz), 4.27 (1H, d, J = 6.5 Hz), 4.19 (1H, d, J 
= 10 Hz), 4.14-3.90 (2H, br s), 3.79 (1H, dd, J = 3, 7.5 Hz), 3.36 (1H, br d, J = 6.5 Hz), 
3.32 (1H, ddd, J = 6, 6, 6 Hz), 3.04 (3H, s, H3CO), 2.44-2.34 (1H, m), 2.34-2.25 (1H, m), 
2.15-1.96 (3H, m), 1.88 (1H, br s), 1.81 (1H, m), 1.66-1.22 (15H, m), 1.14 (3H, d, J = 7 
Hz), 1.07 (3H, d, J = 6.5 Hz), 1.05-1.01 (6H, m), 0.98 (2H, t, J = 7.5 Hz), 0.95 (3H, d, J = 
6.5 Hz), 0.75 (2H, t, J = 7.5 Hz). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 133.1 (s, C-14), 129.1 (d, C-15), 
99.0 (s, COC-9), 97.4 (t, CH2OC-3), 84.8 (d), 83.3 (d), 79.8 (d), 76.0 (d), 753.6 (d), 56.0 
(q, CH3OCH2OC-3), 42.3 (t, C-13), 39.6 (d), 37.6 (d), 37.5 (d), 33.0 (d), 31.7 (d), 30.8 (q, 
CH3COC-9), 25.9 (t, C-2), 22.0 (t, C-16), 20.3 (q, CH3COC-9), 16.5 (q), 15.9 (q), 15.1 
(q), 15.0 (q), 14.8 (q), 10.9 (q), 10.0 (q), 5.6 (q). 
 
LRMS (EI), m/z (relative intensity):  486 ([M]+, 1), 341 (2), 239 (11), 69 (100). 
 
HRMS m/z calcd. for C28H54O6:  486.3920; found:  486.3960. 
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354 
(5R,6S,7S,8S,9S)-11-tert-Butyl-5-ethyl-6,8,12,12-tetramethyl-9-((1R)-1-((4R,5S,6R)-
2,2,5-trimethyl-6-((E)-4-methylhept-4-en-2-yl)-1,3-dioxan-4-yl)ethyl)-2,4,10-trioxa-
11-silatridecane-5,11-diol 
 
2,6-Lutidine (0.02 mL, 18 mg, 0.17 mmol) was added to a stirred solution of diols 
353 (10 mg, 0.02 mmol; dr 6:1:1) in CH2Cl2 (2 mL) at rt under Ar.  After 2 min, t-
Bu2(OTf)2 (0.020 mL, 27 mg, 0.060 mmol) was added and the reaction was stirred 
vigorously for 7 h.  Methanol (0.2 mL) was added and the mixture was diluted with ethyl 
acetate and washed with 1% w/v aqueous citric acid (3×).  The combined organic layers 
were washed with sat. aqueous NaHCO3, dried over Na2SO4, concentrated and 
fractionated by PTLC (20% ethyl acetate in hexane) to give 354 as a mixture of 
diastereomers (10 mg, 77%; dr 6:1:1). 
 
IR (DRIFT) νmax:  3492, 2964, 1470, 1352, 1180 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 5.25 (1H, dd, J = 7, 7 Hz, HC-
15), 4.91 (1H, d, J = 6 Hz, HCOC-3), 4.79 (1H, d, J = 6 Hz, HCOC-3), 4.58 (1H, dd, J = 
1.5, 7 Hz), 4.35 (1H, d, J = 9 Hz), 4.21 (1H, s), 4.10 (1H, s), 3.91 (1H, ddd, J = 4.5, 4.5, 
8.5 Hz), 3.59 (1H, dd, J = 1.5, 11 Hz), 3.31 (3H, s, H3CO), 3.18 (1H, dd, J = 1.5, 9.5 Hz), 
2.46-2.35 (1H, m), 2.19-2.10 (1H, m), 2.07-1.89 (5H, m), 1.88-1.76 (1H, m), 1.69-1.59 
(1H, m), 1.49 (3H, s, H3CC-14), 1.48-1.37 (1H, m), 1.47 (3H, s, H3CCOC-9), 1.27-1.18 
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(18H, m), 1.11 (3H, s), 1.09-1.03 (6H, m), 1.00 (3H, d, J = 6.5 Hz), 0.99-0.93 (9H, m), 
0.88 (3H, d, J = 7 Hz). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 132.9 (s, C-14), 129.4 (d, C-15), 
99.7 (s, COC-9), 98.5 (t, CH2O), 82.1 (d), 79.4 (d), 78.9 (d), 76.4 (d), 72.6 (d), 55.9 (q, 
CH3O), 43.9 (d), 42.3 (t, C-13), 38.3 (d), 38.2 (d), 32.8 (d), 31.5 (d), 30.4 (q, CH3COC-
9), 28.5 (q ×3), 28.3 (q ×3), 25.7 (t, C-2), 22.1 (s), 22.0 (t, C-16), 20.8 (s), 20.1 (q, 
CH3COC-9), 16.6 (q), 16.0 (q), 15.8 (q, CH3C-14), 15.0 (q), 9.7 (q), 9.5 (q), 9.0 (q), 4.9 
(q). 
 
LRMS (EI), m/z (relative intensity):  629 ([M−15]+, 1), 479 (10), 181 (69), 95 (37), 69 
(100). 
 
HRMS m/z calcd. for C36H72O7Si:  644.5047 (629.4813 for M−CH3); found: 629.4186. 
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355 
(4S,5S,6R)-2,2-Di-tert-butyl-4-((2R,3R)-3-(methoxymethoxy)pentan-2-yl)-5-methyl-
6-((1R)-1-((4R,5S,6R)-2,2,5-trimethyl-6-((E)-4-methylhept-4-en-2-yl)-1,3-dioxan-4-
yl)ethyl)-1,3,2-dioxasilinane 
 
TFA (0.5 mL) was added dropwise to a stirred solution of diols 354 (21 mg, 0.03 
mmol; dr 6:1:1) in THF (0.5 mL) and water (0.5 mL) at rt.  After 15 min, ethyl acetate 
was added and the reaction was washed with sat. aqueous NaHCO3 (3×), brine, dried 
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over Na2SO4, concentrated, and fractionated by PTLC (10% ether in hexane) to give 355 
as a mixture of diastereomers (15 mg, 75%; dr 6:1:1). 
 
IR (DRIFT) νmax:  2964, 1468, 1200, 1101, 923 cm-1. 
 
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 5.21 (1H, dd, J = 6.5, 6.5 Hz, 
HC-15), 4.92 (1H, d, J = 6.5 Hz, HCOC-3), 4.77 (1H, d, J = 6.5 Hz, HCOC-3), 4.23 (1H, 
dd, J = 1.5, 4.5 Hz, HC-5 or HC-9), 4.21 (1H, dd, J = 1.5, 4.5 Hz, HC-5 or HC-9), 3.90 
(1H, dd, J = 1.5, 9.5 Hz, HC-7), 3.82 (1H, ddd, J = 4.5, 4.5, 8.5 Hz, HC-3), 3.41 (1H, dd, 
J = 1.5, 9.5 Hz, HC-11), 3.30 (3H, s, H3CO), 2.39-2.26 (1H, m, HC-6), 2.18-1.95 (6H, 
m), 1.94-1.82 (1H, m, HC-12), 1.66-1.53 (1H, m, HC-2), 1.53-1.45 (1H, m, HC-10), 1.50 
(6H, s ×2, H3CCOC-9, H3CC-14), 1.49 (3H, s, H3CCOC-9), 1.35 (1H, dd, J = 1.5, 12 Hz, 
HC-13), 1.20 (9H, s ×3), 1.19 (9H, s ×3), 1.07 (3H, t, J = 7.5 Hz, H3C-1), 1.03 (3H, d, J = 
6.5 Hz, H3CC-12), 1.02-0.98 (6H, m), 0.99-0.95 (6H, m), 0.90 (3H, d, J = 6.5 Hz, H3CC-
6). 
 
13C NMR (125 MHz, C6D6):  δ (for major diastereomer) 133.0 (s, C=CH), 129.2 (d, 
CH=C), 99.8 (s, COC-9), 98.5 (t, CH2O), 85.0 (d, C-7), 82.2 (d, C-3), 81.1 (d, C-5 or C-
9), 79.7 (d, C-11), 73.2 (d, C-5 or C-9), 55.8 (q, CH3O), 42.2 (t, C-13), 40.1 (d, C-6), 38.7 
(d), 37.6 (d), 32.9 (d, C-12), 31.8 (d), 30.8 (q, CH3COC-9), 28.6 (q ×3, CH3CSi), 28.5 (q 
×3, CH3CSi), 25.4 (t, C-2), 23.9 (s, CSi), 22.0 (t, C-16), 21.1 (q, CH3COC-9), 20.9 (s, 
CSi), 16.5 (q), 15.9 (d), 15.2 (q), 15.0 (q), 13.3 (q, CH3C-6), 9.3 (q), 8.6 (q, CH3C-1), 5.5 
(q, CH3C-12). 
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HRMS m/z calcd. for C36H70O6Si:  626.4942 (627.5020 for M+H); found: 627.5027 (CI, 
NH3). 
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360 
(R)-((3R,4R)-3-((S)-((3R,4S,5S)-4-(Benzyloxy)-5-((S)-((R)-4-oxotetrahydro-2H-
thiopyran-3-yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-4-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate 
 
Oxalyl chloride (0.015 mL, 22 mg, 0.17 mmol) was added to a solution of (R)-(+)-
MTPA (8 mg, 0.03 mmol) and DMF (0.003 mL, 3 mg, 0.04 mmol) in hexane (1 mL) at 
room temperature.  A white precipitate formed immediately.   After 1 h the mixture was 
filtered and concentrated.  A solution of ketol 323 (3 mg, 0.004 mmol), Et3N (0.010 mL, 
7 mg, 0.07 mL) and DMAP (ca. 1 mg) in CH2Cl2 (1 mL) was added to the residue.  After 
1 h, excess reagent was quenched with methanol (0.5 mL) and the mixture was diluted 
with ethyl acetate and washed sequentially with 1% w/v aqueous citric acid (3×), sat. 
aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated to give crude Mosher's 
ester which was a 11:1 mixture of diastereomers by 1H NMR.  Fractionation on the crude 
by PTLC (15% ether in hexane) gave a mixture of Mosher's esters 360 (4 mg, >95%) 
which was a 11:1 mixture of diastereomers by 1H NMR. 
 
  191
1H NMR (500 MHz, C6D6):  δ (for major diastereomer) 7.65 (10H, m, Ph), 5.45 (1H, br 
s), 5.06-4.91 (2H, m), 4.79 (1H, d, J = 10.5 Hz), 4.41 (1H, d, J = 8 Hz), 3.75 (1H, dd, J = 
9.5, 9.5 Hz, HC-4), 3.27 (3H, s, H3CO), 3.02 (1H, dd, J = 3, 14 Hz), 2.96 (1H, br d, J = 
12.5 Hz), 2.94-2.25 (14H, m), 2.36-2.26 (1H, m), 1.79 (1H, br d, J = 13 Hz), 1.72-1.62 
(1H, m), 1.61-1.52 (1H, m), 1.08-0.93 (18H, m, (H3CC)3Si ×2), 0.83-0.58 (12H, m, 
(H2C)3Si ×2). 
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361 
(S)-((3R,4R)-3-((S)-((3R,4S,5S)-4-(Benzyloxy)-5-((S)-((R)-4-oxotetrahydro-2H-
thiopyran-3-yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-3-
yl)(triethylsilyloxy)methyl)tetrahydro-2H-thiopyran-4-yl) 3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate 
 
Oxalyl chloride (0.015 mL, 22 mg, 0.17 mmol) was added to a solution of (R)-(+)-
MTPA (8 mg, 0.03 mmol) and DMF (0.003 mL, 3 mg, 0.04 mmol) in hexane (1 mL) at 
room temperature.  A white precipitate formed immediately.   After 1 h the mixture was 
filtered and concentrated.  A solution of ketol 323 (4 mg, 0.006 mmol), Et3N (0.010 mL, 
7 mg, 0.07 mL) and DMAP (ca. 1 mg) in CH2Cl2 (1 mL) was added to the residue.  After 
1 h, excess reagent was quenched with methanol (0.5 mL) and the mixture was diluted 
with ethyl acetate and washed sequentially with 1% w/v aqueous citric acid (3×), sat. 
aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated to give crude Mosher's 
ester that was a 11:1 mixture of diastereomers by 1H NMR.  Fractionation on the crude 
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by PTLC (15% ether in hexane) gave a mixture of Mosher's esters 361 (4 mg, >95%) 
which was a 11:1 mixture of diastereomers by 1H NMR. 
 
1H NMR (500 MHz, C6D6):  (for major diastereomer) δ 7.71-6.96 (10H, m, Ph), 5.35 
(1H, br s), 5.07-4.93 (2H, m), 4.79 (1H, d, J = 10.5 Hz), 4.33 (1H, d, J = 7.5 Hz), 3.79 
(1H, dd, J = 9.5, 9.5 Hz, HC-4), 3.32 (3H, s, H3CO), 3.06-2.22 (17H, m), 1.98-1.80 (2H, 
m), 1.63 (1H, m), 1.07-0.92 (18H, m, (H3CC)3Si ×2), 0.80-0.58 (12H, m, (H2C)3Si ×2). 
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APPENDIX A 
Determination of enantiomeric purity 
230⋅HCl 
A solution of NaOH in D2O (1.1 M 0.05 mL, 0.055 mmol) was added to a solution 
of 230⋅HCl (6.5 mg, 0.025 mmol) and (+)-(R)-TFAE (55 mg, 0.20 mmol) in CDCl3 (0.4 
mL) in a 5 mm NMR tube.  After shaking the sample, the 1H NMR spectrum (500 MHz) 
was obtained.  To verify separation, the chemical shift of the minor enantiomer was 
established by adding a solution of ent-230⋅HCl (ca. 2 mg) in CDCl3 (ca 0.05 mL) to the 
above NMR tube and then reacquiring the NMR spectrum (Figure A.1.). 
 
Figure A.1.  Determination of enantiomeric purity of 230·HCl. 
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Mono-silyl enol ether (−)-261 
A stock solution of (+)-Eu(hfc)3 (0.1 M) and AgO2CCF3 (0.1 M) in CDCl3 was 
prepared.  The above solution of shift reagent (0.025 mL) was added to a solution of 261 
(6 mg, 0.01 mmol) in CDCl3 (0.4 mL) in a 5 mm NMR tube.  After shaking the sample, 
the 1H NMR spectrum (500 MHz) was obtained.  To verify separation, the chemical shift 
of the minor enantiomer was established by adding a solution of ent-261 (obtained by 
enolization of meso 233 using ent-230) (ca. 2 mg) in CDCl3 (ca. 0.05 μL) to the above 
NMR tube and then reacquiring the NMR spectrum (Figure A.2.). 
 
Figure A.2.  Determination of enantiomeric purity of 261. 
Mono-silyl enol ether (−)-315 
Enantiomeric purity of mono-silyl enol ether 315 was determined by analysis of the 
1H NMR spectra of the diastereomeric Mosher's esters resulting from the reaction of ketol 
323 and (R)-MTPCl and (S)-MTPCl.  Both Mosher's esters 360 and 361, respectively, 
were prepared to verify peak identities (Figure A.3.).   
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Figure A.3.  Determination of enantiomeric purity of 315 (83% ee). 
 
Figure A.4.  Determination of enantiomeric purity of 315 (93% ee). 
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APPENDIX B 
X-ray crystallographic data 
 
ORTEP diagram of bis-silyl enol ether 262 
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ORTEP diagram of syn triol 297 
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